Page last updated: 2024-08-23

bromocriptine and Idiopathic Parkinson Disease

bromocriptine has been researched along with Idiopathic Parkinson Disease in 612 studies

Research

Studies (612)

Timeframe	Studies, this research(%)	All Research%
pre-1990	361 (58.99)	18.7374
1990's	143 (23.37)	18.2507
2000's	83 (13.56)	29.6817
2010's	21 (3.43)	24.3611
2020's	4 (0.65)	2.80

Authors

Authors	Studies
Bagli, J; Bogri, T; Voith, K	1
Ali, J; Baboota, S; Dang, S; Kumar Sahoo, P; Nigam, K; Usama Ashhar, M; Vohora, D; Vyas, P	1
Akhtar, MF; Akter, R; Al-Harrasi, A; Berrada, M; Bhatia, S; Damiri, F; Ferdous Mitu, J; Kabir, MT; Rahman, MH; Rahman, MS; Saleem, A	1
Chen, F; Chen, X; Wen, S; Zhang, Q; Zhou, C	1
Ali, J; Ashhar, MU; Baboota, S; Kumar, S	1
Ji, F; Jiang, R; Su, Z; Xue, R; Zhou, Y; Zhu, X; Zhuo, C	1
Michael Besser, G; Pfeiffer, RF; Thorner, MO	1
Agúndez, JA; Alonso-Navarro, H; García-Martín, E; Jiménez-Jiménez, FJ	1
Cautres, M; Cautres, T; Mohty, D	1
Chen, HB; Li, SH; Ma, J; Sun, XR; Tang, RH; Wang, ZF; Yang, JS; Zhang, XY; Zhao, WQ	1
Baxter, LR; Chandra, A; Kamrowski, K; Nguyen, T; Prokai, D; Prokai, L; Talamantes, T	1
Hisanaga, R; Nakamura, M; Nomoto, S; Sato, T	1
Ali, J; Baboota, S; Fazil, M; Haque, S; Kumar, M; Md, S; Sahni, JK	1
Ali, F; Fatima, A; Jyoti, S; Khan, W; Khanam, S; Naqvi, AH; Naz, F; Siddique, YH; Singh, BR	1
Becu-Villalobos, D; Brie, B; Garcia Tornadu, I; Lopez Vicchi, F; Luque, GM; Nogueira, JP	1
Broderick, PA; Li, YS; Wenning, L	1
Ben-Shlomo, Y; Evans, A; Head, J; Katzenschlager, R; Lees, AJ; Schrag, A	1
Au, WL; Chan, YH; Lee, RK; Ng, KK; Tan, LC; Tan, NC	1
Doi, K; Isono, T; Kawamura, T; Kitagawa, N; Kuno, S; Masaki, M; Mizuta, E; Oeda, T; Sawada, H; Taniguchi, S; Yaku, H; Yamamoto, K; Yutani, C	1
Boo, DH; Choi, HJ; Hwang, O; Kang, BY; Kim, EM; Kim, SS; Lim, JH; No, H	1
Audebert, C; Blin, O; Eusebio, A; Jouve, E; Micallef, J; Rey, M; Rouby, F; Tardieu, S	1
Fujioka, S; Iwamoto, K; Kawamura, M; Nakajima, M; Ohno, H	1
Pullan, PT	1
Montgomery, EB	1
Chacun, H; Farinotti, R; Fernandez, C; Lacomblez, L; Milane, A; Vautier, S	1
Awa, Y; Hattori, T; Higuchi, Y; Ichikawa, T; Ito, T; Kobayashi, M; Kuwabara, S; Sakakibara, R; Uchiyama, T; Yamaguchi, C; Yamamoto, T; Yamanishi, T; Yanagisawa, M; Yano, M	1
Schneemilch, C	1
Lee, MR	1
Halliday, GM; Hely, MA; Loy, C; Morris, JG; Reid, WG	1
Au, WL; Lee, RK; Ng, KK; Tan, LC; Tan, NC	1
Assaggaf, S; Azzouni, H; Houissa, S; Mustapha, ME; Rebai, RM	1
Auyeung, M; Cheung, CM; Lee, CN; Li, R; Tang, WK; Tsoi, TH; Yeung, E	1
Asselman, P; Debono, AG; Marsden, CD; Parkes, JD	1
Kumar, JB; Luthra, PM	1
Bamia, C; Kenward, MG; White, IR	1
Ali, J; Baboota, S; Chuttani, K; Khan, RA; Md, S; Mustafa, G; Sahni, JK	1
Hashida, H; Hattori, N; Iijima, M; Kano, O; Kubo, S; Matsumura, M; Murakami, H; Nanri, K; Okuma, Y; Suzuki, M; Suzuki, Y; Tomimitsu, H; Utsumi, H	1
Hauser, RA; Holford, NH	1
Kondo, T	1
Gekht, AB	1
Kuhlmann, A; Müller, T; Reimer, J	1
Cho, IS; Ha, JH; Im, JH; Lee, MC	1
Quinn, NP	1
Han, SY; Ratnagopal, P; Tan, EK; Wong, MC	1
Lai, BC; Marion, S; Schulzer, M; Teschke, K; Tsui, JK	1
Beier, KM; Berger, Ch; Mehrhoff, FW; Meinck, HM	1
Bagheri, H; Montastruc, JL; Schmitt, L	1
Atsumi, M; Iga, T; Kawakami, J; Kotaki, H; Sato, H; Sawada, Y; Sugiyama, E; Yamada, Y	1
Okamoto, K; Tanaka, M	1
Hasegawa, K; Kowa, H; Kuno, S; Mizuno, Y; Origasa, H; Yamamoto, M; Yanagisawa, N	1
Lang, AE; Razmy, A; Shapiro, CM	1
Araki, I; Kuno, S; Mizuta, E; Yamasaki, S	1
Hotta, M; Kamo, T; Kawakami, M; Nemoto, S; Oshima, J; Shimojo, S; Shiraishi, M; Sugihara, H; Takahashi, Y; Yasaki, S	1
Kameyama, M; Kubori, T; Matsui, H; Nishinaka, K; Oda, M; Udaka, F	1
Grosset, D; Grosset, K; Macphee, G; Needleman, F	1
Clarke, CE; Deane, KH; Spieker, S	1
Basu, S; Chaudhuri, KR; Dhawan, V; Jackson, G; Odin, P	1
Hely, MA; Morris, JG; Reid, WG; Trafficante, R	1
Hoffmann, A; Klotz, P; Kraus, PH; Lewe, J; Przuntek, H	1
Jost, WH	1
Goetz, CG; Poewe, W; Rascol, O; Sampaio, C	1
Aley-Medina, P; Avila-Costa, MR; Colín-Barenque, L; Fortoul, TI; Librado, JL; Martínez, EF; Martínez, VA; Montiel-Flores, E; Mussali-Galante, P; Valdez, AL	1
Aguilar, M; Castro-Caldas, A; Cesaro, P; Del Signore, S; Delwaide, P; Jost, W; Lamberti, P; Merello, M; Williams, A	1
Azouvi, P; Ben Smaïl, D; Régnault, J; Rouy-Thenaisy, K; Samuel, C	1
Bonuccelli, U; Ceravolo, R; Del Dotto, P; Gambaccini, G; Logi, C; Lucetti, C; Murri, L; Rossi, G	1
Chan, PL; Holford, NH; Kieburtz, K; Nutt, JG; Shoulson, I	1
Chung, EJ; Kim, JY; Lee, WY; Park, SW	1
Turnbull, GI	1
Marvanova, M; Nichols, CD	1
Lindh, J	1
Ives, NJ; Ramaker, CC; Stowe, R; van Hilten, JJ	2
Daida, H; Hatano, T; Hattori, N; Iwama, Y; Komine-Kobayashi, M; Mizuno, Y; Mochizuki, H; Nakayama, T; Sakai, M; Urabe, T; Yamashiro, K	1
Choi, HJ; Hwang, O; Kim, KM; Kim, SW; Lim, JH	1
Burton, K; Calne, DB	1
Calne, DB; Plotkin, CN; Rosin, AJ; Teychenne, PF	1
Angrist, B; Lieberman, A; Serby, M	2
Calne, DB; Eisler, T; Gopinathan, G; Williams, A	1
Lees, AJ; Stern, GM	3
Besser, GM; Wass, JA	1
Hallett, M	1
König, MP	1
Enna, SJ; Lake, CR; Teychenné, PF; Ziegler, MG	1
de Fine Olivarius, B; Dupont, E; Strong, MJ	1
Larsen, TA; Teräväinen, H	1
Weiner, M	1
Duvoisin, RC; Heikkila, RE; Manzino, L	1
Willner, P	1
Kurako, IuL; Volianskiĭ, VE	1
Chamontin, B; Montastruc, JL; Rascol, A	2
Jellinger, K	1
Fischer, PA; Schneider, E	2
Jörg, J	1
Biesemeyer, H; Ludin, HP; Ringwald, E	1
Calne, DB; Eisler, T; Hall, RP; Kalavar, KA	1
Abensour, P; Agid, Y; Bonnet, AM; Jouvent, R; Lhermitte, F; Widlocher, D	1
Evans, WS; Thorner, MO; Vance, ML	1
Beckman, J; Burton, K; Calne, DB; Martin, WR	1
Destee, A	1
Montastruc, JL; Rascol, A	1
Rinne, UK	9
Laakso, K; Laihinen, A; Lönnberg, P; Rinne, JK; Rinne, JO; Rinne, UK	1
Burns, RS; Calne, DB; LeWitt, PA	1
Calne, DB; Dambrosia, JM; Foster, N; Larsen, TA; LeWitt, PA; Newman, RP; Raphaelson, MI; Ward, CD	1
Fischer, PA; Majer, M; Przuntek, H; Welzel, D	1
Chong, PN; Devathasan, G; Lun, KC; Puvanendran, K; Wong, PK	1
Feely, J; Paterson, CR	1
Birkmayer, W; Danielczyk, W; Jellinger, K; Koppel, H; Reynolds, GP; Riederer, P; Seemann, D; Ulm, G	1
von Werder, K	1
Bihari, K; Csanda, E; Köves, A; Mogyorós, I; Takáts, A; Tárczy, M	1
Alonso, RJ; Covington, TR; Mancall, EL	1
Deupree, JD; Murrin, LC; Pfeiffer, RF; Schneider, MB	1
Da Prada, M; Haefely, WE; Keller, HH; Kettler, R; Pieri, L	1
Lancranjan, I	1
Borowski, GD; Rose, LI	1
Morris, JG	3
Bouchard, S; Grimes, JD; King, DB; Kofman, OS; Molina-Negro, P; Wilson, AF	1
Login, IS	1
Calne, DB; Larsen, TA; LeWitt, P; Newman, R	1
Lustig, A	1
Fischer, PA; Hubener, K; Schneider, E	2
Schiffter, R; Vogel, HP	1
Caraceni, T; Carella, F; Giovannini, P; Grassi, MP; Parati, E; Scigliano, G	2
Lipcsey, A; Peres, A	1
Grimes, JD	2
Montastruc, JL; Rascol, A; Rascol, O	3
Goldstein, M; Gopinathan, G; Hassouri, H; Lieberman, AN; Neophytides, A	1
Calne, DB; Newman, RP	1
Brincat, S; Lang, AE; Marsden, CD; Parkes, JD; Quinn, N	1
Bouchard, S; Grimes, JD; Jones, MW; Kofman, OS; Molina-Negro, P	1
Ledić, P; Sepcić, J	1
Bear, G; Casson, I; Durso, R; Foo, SH; Goldstein, M; Khayali, M; Kupersmith, M; Lieberman, A; Neophytides, A	1
Agnoli, A; Baldassarre, M; D'Urso, R; Del Roscio, S; Falaschi, P; Frajese, G; Mearelli, S; Rocco, A; Ruggieri, S	1
Calne, DB; Gopinathan, G	1
Allain, H; Bentue-Ferrer, D; Pape, D; Reymann, JM; Sabouraud, O; van den Driessche, J	1
Calne, DB; Eisler, T; Kaiser, DL; MacLeod, RM; Thorner, MO	1
Gopinathan, G; Hiesiger, E; Leibowitz, M; Lieberman, AN; Neophytides, A; Walker, R	1
Ford, J; Jackson, JA; Jankovic, J	1
Goldstein, M; Goodgold, A; Gopinathan, G; Leibowitz, M; Lieberman, AN; Neophytides, A; Pact, V; Walker, R	1
Lang, AE; Marsden, CD; Parkes, JD; Quinn, NP; Toone, B	1
Grimes, JD; Hassan, MN	2
Delwaide, PJ; Schoenen, J	1
Hopkins, S	1
Friis, ML; Grøn, U; Pakkenberg, H	1
Besset, A; Passouant, P	1
Calne, DB; Teräväinen, H	1
Calne, DB; Le Witt, PA	1
Glantz, R; Goetz, CG; Klawans, HL; Nausieda, PA; Weiner, WJ	1
Adam, WR; Campbell, DJ; Funder, JW; Mendelsohn, FA	1
Goetz, CG; Nausieda, PA; Tanner, CM	1
Calne, DB; Dambrosia, JM; Durso, R; Gopinathan, G; LeWitt, PA; Sanes, JN; Ward, CD	1
Hirt, D; Markstein, R; Ringwald, E; Vigouret, JM	1
Haas, JA; Lakke, JP	1
Muenter, MD	2
Klawans, HL	1
Gauthier, G; Martins da Silva, A	1
Kaplan, LR; Klawans, HL; Nausieda, PA; Weber, S; Weiner, WJ	1
Clanet, M; Guiraud-Chaumeil, B; Montastruc, JL; Rascol, A	1
Jeske, W	1
Chapler, FK; Sherman, BM	1
Pentland, B; Sawers, JS	1
Calne, DB; Dambrosia, JM; Evarts, EV; Gopinathan, G; Sanes, JN; Stuart, WK; Teräväinen, H; Ward, CD	1
Agid, Y; Illas, A; Lhermitte, F; Quinn, N	2
Bergsrud, D; Elton, RL; Racy, A; Teychenne, PF; Vern, B	1
Lieberman, AN; Plasse, HM	1
Jacquin-Cotton, L; Martini, L; Ndiaye, IP	1
Ulm, G	1
Agid, Y; Lhermitte, F; Quinn, N	1
Stewart, RM	1
Hoehn, MM	2
Bøttcher, J; Grøn, U	1
McGregor, AM	1
Caraceni, T; Giovannini, P; Girotti, F; Parati, E; Pederzoli, M; Scigliano, G	1
Casson, I; Durso, R; Foo, SH; Goldstein, M; Gopinathan, G; Khayali, M; Kupersmith, M; Lieberman, AN; Neophytides, A; Tartaro, T	1
Barrett, RE; Côté, LJ; Fahn, S; Snider, SR	1
Godwin-Austen, RB	1
Lander, CM; Lees, AJ; Shaw, KM; Stern, GM	1
Duvoisin, RC; Mendoza, MM; Yahr, MD	1
Bédard, P; Debono, AG; Dorow, R; Horowski, R; Jenner, P; Keenan, J; Marsden, CD; Parkes, JD; Price, P; Rosenthaler, J; Schachter, M; Smith, B	1
Friis, ML; Hvidberg, EF; Johnsen, T; Larsen, NE; Pakkenberg, H	1
Marsden, CD; Parkes, JD; Schachter, M; Sheehy, MP	1
Kawakami, H; Nakamura, S; Tanaka, K; Yamashita, H; Zhang, YX	1
Bushenbark, K; Esterlitz, J; Gauger, L; Hauser, RA; Hubble, J; Koller, W; Lilienfeld, D; Malapira, T; Olanow, CW	1
Eadie, MJ	1
Ludin, HP	1
Clinnick, S; Fonda, D; Schwarz, J	1
Janjua, R; Roos, RA; van Kempen, GM	1
Boyd, A	1
Danysz, W; Quack, G; Rogoz, Z; Skuza, G	1
Angeleri, V; Bonuccelli, U; Cossutta, E; De Mari, M; Foschi, N; Lamberti, P; Martignoni, E; Muratorio, A; Pacchetti, C; Pezzoli, G	1
Mark, MH; Sage, JI	1
Ogawa, N	2
Goto, I; Kanazawa, I; Kowa, H; Kuno, S; Mizuno, Y; Ogawa, N; Tashiro, K; Yanagisawa, N	3
Gsell, W; Lange, KW; Naumann, M; Oestreicher, E; Rausch, WD; Riederer, P	1
Hineno, T; Horiguchi, J; Kakimoto, Y; Mizobuchi, M; Nishimatsu, O	1
Silverman, PB	1
Eberli, F; Greminger, P; Schmid, PA; Speich, R; Suter, T	1
Angeleri, VA; Bonuccelli, U; Cossutta, E; De Mari, M; Foschi, N; Lamberti, P; Martignoni, E; Muratorio, A; Pacchetti, C; Pezzoli, G	1
Ané, M; Blin, O; Fabre, N; Montastruc, JL; Poulik, J; Rascol, A; Rascol, O; Sabatini, U; Senard, JM	1
Broe, GA; Hely, MA; Margrie, S; Morris, JG; O'Sullivan, DJ; Rail, D; Reid, WG; Williamson, PM	1
Montastruc, JL; Rascol, A; Rascol, O; Senard, JM	1
Yanagisawa, N	2
Dichgans, J; Klockgether, T	1
Lang, AE; Mark, MH; Sage, JI; Zimmerman, TR	1
Lauterbach, EC	1
Cooper, JA; Sagar, HJ; Sullivan, EV	1
Comella, CL; Ristanovic, RK; Tanner, CM	1
Klockgether, T; Löschmann, PA; Schugens, MM	1
Lieberman, A	2
Rumbach, L; Tranchant, C; Viel, JF; Warter, JM	1
Factor, SA; Weiner, WJ	1
Kuno, S	2
Yoshikawa, T	1
Chanter, DO	1
Kornhuber, J; Weller, M	1
Cornelius, L; Factor, SA; Ingenito, A; Sanchez-Ramos, JR; Sheldon, C; Singer, C; Weiner, WJ	1
Filipovic, S; Kostic, VS; Marinkovic, Z; Momcilovic, D	1
Duchek, M; Ekberg, R; Fehling, C; Johansson, F; Johnels, B; Lindvall, B; Nordin, G; Olsson, JE; Sidén, A; Steg, G	1
Falk, M; Künig, G; Neubauer, M; Ransmayr, G; Wagner, M	1
Montastruc, JL; Rascol, O; Senard, JM	3
Agid, Y; Bonnet, AM; Dubois, B; Marconi, R; Serre, I	1
Lees, AJ	2
Angulo Cuesta, J; Guil Cid, M; Jiménez, FJ; López Alvarez, YJ; Sánchez-Chapado, M	1
Calzetti, S; Cassio, A; Negrotti, A	1
Ahlskog, JE	1
Kishore, A; Snow, BJ	1
Klaassen, RJ; Krepel, HP; Troost, RJ; van der Lely, AJ; Verhoeven, GT	1
Benabid, AL; Benazzouz, A; Hoffmann, D; Limousin, P; Perret, JE; Pollak, P	1
Akiguchi, I; Fukuyama, H; Imai, T; Kawamura, J; Kimura, J	1
Bastos-Lima, A; Castro-Caldas, A; Coelho, T; Levy, A; Sampaio, C	1
Dierks, T; Grosse, H; Kuhn, W; Müller, T; Rommelspacher, H	1
Adena, MA; Broe, GA; Hely, MA; Morris, JG; O'Sullivan, DJ; Reid, WG; Williamson, PM	1
Catz, T; Inzelberg, R; Kippervasser, S; Korczyn, AD; Nisipeanu, P; Orlov, E; Rabey, JM; Schechtman, E	1
Blümner, E; Danielczyk, W; Gerlach, M; Kaiser, HJ; Kraus, PH; Letzel, H; Przuntek, H; Riederer, P; Uberla, K; Welzel, D	1
del Toro Cervera, J; García Castaño, J; Muiño Miguez, A; Segado Soriano, A	1
Burguera, JA; Chacón, J; Forcadell, F; Giménez-Roldán, S; Liaño, H; Tolosa, E	1
Korczyn, AD; Nisipeanu, P	1
Mizuno, Y; Yanagisawa, N	1
Agid, Y; Destée, A; Durif, F; Montastruc, JL; Pollak, P	1
Giménez-Roldán, S; Mateo, D	1
Guttman, M	1
Graham, JM; Grünewald, RA; Sagar, HJ	1
de Yébenes, JG; García-Ruiz, PJ; Sánchez-Pernaute, R	1
Kanazawa, I; Kowa, H; Kuno, S; Mizuno, Y; Ogawa, N; Tashiro, K; Yanagisawa, N	1
McCallum, RW; Sarosiek, I; Shifflett, J; Soykan, I; Wooten, GF	1
Brefel, C; Lapeyre-Mestre, M; Montastruc, JL; Raï, S; Rascol, A; Rascol, O; Senard, JM	1
Brooks, DJ; Brunt, ER; Korczyn, AD; Poewe, WH; Rascol, O; Stocchi, F	1
Alegre, M; Martínez Lage, JM; Noé, E	1
Marsden, CD	1
Blomkvist, A; Hillerdal, G; Koyi, H; Lee, J; Rask-Andersen, A; Rasmussen, E; Uddenfeldt, M	1
De Vuyst, P; Gevenois, PA; Knoop, C; Lenclud, C; Mairesse, M	1
Abrams, KR	1
Ben-Shlomo, Y; Churchyard, A; Head, J; Hurwitz, B; Lees, AJ; Ockelford, J; Overstall, P	1
Amano, K; Takakura, K	1
Benito-León, J; Bermejo, F; Porta-Etessam, J	1
Factor, SA	1
Brunt, ER; Korczyn, AD; Larsen, JP; Nagy, Z; Poewe, WH; Ruggieri, S	1
Weiner, WJ	1
Miyoshi, T; Motomura, S; Osoegawa, M; Tamura, K; Yamanaka, H	1
Balmes, P; Blayac, JP; Champagne, S; Coste, E; Davy, JM; Hillaire-Buys, D; Mania, E; Nigond, J; Peyrière, H; Pons, M	1
Chuda, M; Hayabara, T; Ihara, Y; Kuroda, S	1
Antonini, A; Barichella, M; Canesi, M; Mariani, CB; Pezzoli, G; Tesei, S; Zecchinelli, AL	1
Barbanoj, M; Casas, M; Jané, F; Kulisevsky, J; Prat, G; Robledo, P	1
Finken, MJ; Ramaker, C; van de Beek, WJ; van Hilten, BJ	1
Ferreira, JJ; Galitzky, M; Montastruc, JL; Rascol, O	1
Clarke C, E; Speller J, M	1
Finken, MJ; Ramaker, C; Van de Beek, WJ; van Hilten, JJ	1
Clarke, CE; Speller, JM	1
Busenbark, K; Hauser, RA; Hubble, JP; Koller, WC; Malapira, T; Olanow, CW	1
Clarke, CE; Deane, KH	2
Clarke C, E; Clarke J, A; Speller J, M	1
Ramaker, C; van Hilten, JJ	1
Bulckaen, H; Devulder, B; Fauchais, AL; Hachulla, E; Hatron, PY; Michon-Pasturel, U; Queyrel, V	1
Asanuma, M; Ogawa, N; Tanaka, K	1
Hasegawa, K	1
Haapaniemi, TH; Kallio, MA; Korpelainen, JT; Myllylä, VV; Sotaniemi, KA; Suominen, K; Tolonen, U	1
Sternon, J; Supiot, F; Zegers de Beyl, D	1
Clarke, CE; Deane, KD	1
Bizzarri, G; Calzetti, S; Negrotti, A	1
Haapaniemi, TH; Korpelainen, JT; Myllylä, VV; Sotaniemi, KA; Suominen, K; Tolonen, U	1
Chew, EL; Ong, KC; Ong, YY	1
Brefel-Courbon, C; Desboeuf, K; Lapeyre-Mestre, M; Montastruc, JL; Rascol, O; Senard, JM	1
Jankovic, J; Le, WD	1
Diroma, C; Fraddosio, A; Iliceto, G; Lamberti, S; Moramarco, A; Palagano, G; Zenzola, A	1
Debove, P; L'Her, P; Renard, JL; Simon, F; Vaylet, F	1
Bamias, C; Hardy, P; Pocock, S; Warner, J; White, IR	1
Fukui, T; Hira, K; Shimbo, T; Takemura, M	1
Ben-Shlomo, Y; Head, J; Katzenschlager, R; Lees, AJ	1
Hillman, R; Parvez, F; Pendleton, RG; Sayed, M	1
Brooks, DJ; Brunt, ER; Korczyn, AD; Montastruc, JL; Stocchi, F	1
Keens, J; Schrag, A; Warner, J	1
Bittkau, S; Bliesath, H; Büttner, U; Fuchs, G; Glass, J; Haller, H; Klockgether, T; Kraus, P; Lachenmayer, L; Müller, D; Müller, T; Przuntek, H; Rathay, B; Sgonina, J; Steinijans, V; Teshmar, E; Ulm, G; Volc, D	1
Hilten, JJ; Ramaker, C	1
Winkelman, AC	1
Battista, AF; Fuxe, K; Goldstein, M; Lew, JY; Lieberman, A; Nakamura, S	1
Hungerbühler, JP; Regli, F	1
Calne, DB; Eisler, T; Neophytides, A; Nutt, JG; Teychenne, PF; Williams, AC	1
Estey, E; Goldstein, M; Goodgold, A; Gopinathan, G; Kupersmith, M; Lieberman, AN	2
Parkes, JD	1
Przuntek, H	1
Lees, AJ; Shaw, KM; Stern, GM	2
Debono, AG; Donaldson, I; Marsden, CD; Parkes, JD	1
Hayes, S; Lees, AJ; Ross, EJ; Shaw, KM; Stern, GM; Thompson, BD	1
Debono, AG; Marsden, CD; Parkes, JD	2
Calne, DB; Gielen, AC; Gillespie, MM; Kartzinel, R; Perlow, M; Sadowsky, DA; TEYCHENNE, P	1
Lipper, S	1
Duvoisin, RC	1
Marsden, CD; Parkes, JD	1
Calne, DB; Neophytides, A; Nutt, JG; Plotkin, C; Teychenne, PF; Williams, AC	1
Glaubman, H; Rabey, JM; Streifler, M; Vardi, J	1
Lörincz, P; Ludin, HP; Ringwald, E	1
Agid, Y; Bonnet, AM; Lhermitte, F; Pollak, P; Signoret, JL	1
Blackstock, J; Dick, JP; George, RJ; Marsden, CD; Parkes, JD; Schachter, M	1
Daggett, P; Franks, S; Lees, AJ; Shaw, KM; Stern, GM; Thompson, BD	1
Lander, CM; Lees, A; Stern, G	1
Calne, DB; Carter, AC; Chase, TN; Kartzinel, R; Perlow, MD; Shoulson, I	1
Rosa, A	1
Calne, DB; Kartzinel, R; Shoulson, I	3
Andreoli, VM; Frattola, L; Spano, PF; Trabucchi, M	1
Hill, JW	1
Casson, I; Durso, R; Foo, SH; Khayali, M; Kupersmith, M; Lieberman, A; Neophytides, A; Tartaro, T	1
Godwin-Austen, RB; Smith, NJ	1
Gron, U	1
Hansen, E; Kristensen, O	1
Estey, E; Goldstein, M; Gopinathan, G; Kupersmith, M; Lieberman, A	1
Parkes, D	2
Jansen, EN	1
Agnoli, A; Casacchia, M; Ruggieri, S	1
Pearce, I; Pearce, JM	2
Debono, A; Marsden, CD; Parkes, JD; Price, P; Rosenthaler, J	1
Bateman, DN; Coxon, A; Legg, NJ; Reid, JL	1
Lance, JW; Mackenzie, RA	2
Berde, B	1
Agid, Y; Barroche, G; Bonnet, AM; Javoy-Agid, F; Kato, G; Lhermitte, F; Pollak, P; Signoret, JL	1
Dumas, M; Dumond, JJ; Garoux, R; Leger, JM; Lombertie, E	1
Baba, Y; Miyamoto, T; Ohmoto, T	1
Marx, JL	1
Clanet, M; David, J; Guiraud, B; Montastruc, JL; Rascol, A	1
Bender, DA; Earl, CJ; Lees, AJ	1
Friis, ML; Grøn, U; Hvidberg, EF; Larsen, NE; Pakkenberg, H	1
Glaubman, H; Rabey, I; Vardi, J	1
Glaubman, H; Rabey, J; Streifler, M; Vardi, J	2
Allelov, M; Flechter, S; Hertzberg, M; Oberman, Z; Rabey, JM; Streifler, M; Vardi, J	1
Besset, A; Billiard, M; Bonardet, A; Descomps, B; Nègre, C; Passouant, P	1
Hvidberg, EF; Larsen, NE; Larsson, M; Ohman, R	1
Kanapa, DJ; Klawans, HL; Nausieda, PA; Weiner, WJ	1
Barrett, RE; Cote, LJ; Fahn, S; Isgreen, WP; Snider, SR	1
Klawans, HL; Koller, WC; Nausieda, PA; Weiner, WJ	1
Fahn, S; Hutt, CS; Snider, SR	1
Jotkowitz, S	1
Distiller, LA; Joffe, BI; Seftel, HC	1
Agnoli, A; Carolei, A; Masturzo, P; Meco, G; Polleri, A; Rolandi, E	1
Caraceni, TA; Celano, I; Girotti, F; Parati, E	1
Bédard, P; Marsden, CD; Parkes, JD	1
Hyyppä, MT; Långvik, VA; Rinne, UK	1
Pakkenberg, H	1
Calne, DB	2
Bern, SM; Calne, DB; McInturff, D; Pfeiffer, RF; Teychenne, PF	1
Haddad, S; Kohout, LJ; Lees, AJ; Shaw, KM; Stern, GM	1
Marttila, R; Rinne, UK	1
Lees, A; Stern, G	2
Yahr, MD	1
Gilligan, B; Stark, R; Wodak, J	1
Gerlach, J	1
Kunz, F; Lörincz, P; Ludin, HP; Ringwald, E	1
Marttila, R; Rinne, UK; Sonninen, V	2
Rabey, JM; Streifler, M; Vardy, J	1
Calne, DB; Pfeiffer, RF; Teychenne, PF	1
Calne, DB; Kartznel, R	1
Vaisurb, S	1
Bories, F; Bousser, MG; Conard, J; Samama, M	1
McLellan, DL	1
Estey, E; Goldstein, M; Kupersmith, M; Lieberman, A	1
Agnoli, A; Carolei, A; Casacchia, M; Meco, G; Ruggieri, S; Zamponi, A	1
Dipalma, JR	1
Bories, F; Bousser, MG; Castaigne, P; Laplane, D	1
Calne, DB; Kartzinel, R; Perlow, M; Pfeiffer, R; Teychenne, PF	1
Bassendine, MF; Calne, DB; Claveria, LE; Petrie, A; Teychenne, PF	1
Andre, JM; Jacquier, A; Kissel, P	1
Reid, WG	1
Demedts, M; Dom, R; Frans, E	1
Diederich, NJ; Goetz, CG	1
Mizuno, Y	1
Kraus, PH; Letzel, H; Przuntek, H; Schwarzmann, D; Welzel, D	1
Goto, I; Iwata, M; Kanazawa, I; Kowa, H; Mannen, T; Mizuno, Y; Nakanishi, T; Nishitani, H; Ogawa, N; Takahashi, A	6
Blümner, E; Danielczyk, W; Kaiser, HJ; Kraus, PH; Letzel, H; Przuntek, H; Riederer, P; Schwarzmann, D; Welzel, D; Wolf, H	1
Andersson, U; Aquilonius, SM; Freccero-Rosman, K; Lindvall, O; Nylander, B; Odin, P	1
Albani, F; Baruzzi, A; Contin, M; Martinelli, P; Riva, R	1
Levivier, M; Przedborski, S	1
Laihinen, A; Rinne, UK; Suchy, I	1
Cooper, JA; Doherty, SM; Jordan, N; Sagar, HJ; Sullivan, EV; Tidswell, P	1
Haas, JA; Jansen, EN; Lakke, JP; Staal-Schreinemachers, A; van der Sande, JJ	1
Durrieu, G; LLau, ME; Montastruc, JL; Rascol, A; Rascol, O; Senard, JM	1
Grossman, G; Martin, L; Riley, DE	1
Graff, E; Korczyn, AD; Rabey, JM; Shabtai, H; Vered, Y	1
Agid, Y; Emre, M; Lataste, X; Lees, A; Rascol, A; Rinne, UK	1
Cooper, JA; Jordan, N; Sagar, HJ	1
Ahlskog, JE; Carmichael, SW; Kelly, PJ; Nelson, A; Okazaki, H; Richelson, E; Stoddard, SL; Tyce, GM; van Heerden, JA	1
Allain, H; Bentue-Ferrer, D; Decombe, R; Lemaitre, MH; Martinet, JP; Milon, D	1
Cramer, H; Kuntzmann, F; Masson, H; Popescu, I; Strubel, D	1
Allain, H; Bentue-Ferrer, D; Brunet-Bourgin, F; Chaumet-Riffaud, P; Decombe, R; Gandon, JM; Goulley, F; Le Coz, F; Loria, Y; Reymann, JM	1
Graff, E; Harsat, A; Rabey, JM; Schwartz, M; Vered, Y	1
Aguilar, M; Alió, J; Saura, J	1
Nakashima, K; Takahashi, K	1
Chariá, P; Díaz, F; Liberman, C	1
Bonifati, V; Capriani, C; Cusimano, G; Meco, G	1
Jacobs, MB; Varon, J	1
Goto, I; Iwata, M; Kanazawa, I; Kowa, H; Mannen, T; Mizuno, Y; Nishitani, H; Ogawa, N; Takahashi, A; Tashiro, K	1
Eriksson, T; Oberg, B; Pedersen, SW	1
Goetz, CG	1
Kleedorfer, B; Poewe, W; Schelosky, L	1
Durrieu, G; Montastruc, JL; Rascol, A; Senard, JM; Tran, MA	1
Genge, S; Hely, MA; Jeremy, R; Lawrence, S; Morris, JG	1
MacMahon, DG; Marshall, T; Overstall, PW	1
Allain, H; Milon, D; Morel, G; Reymann, JM; Sabouraud, O; Van den Driessche, J	1
Guidi, M; Mauro, AM; Mercante, O; Pelliccioni, G; Scarpino, O	1
Edwards, RL; Oliver, WA; Todman, DH	1
Chevalier, C; Collier, A; Hardy, JC; Kains, JP	1
Cowan, A	1
Olsson, JE	1
Becker, AL; Bilchik, TR; Blumenfeld, A; Fourie, PB; Fritz, VU; Ming, A; Reef, HE; Saling, M; Temlett, JA	1
Diot, E; Diot, P; Guilmot, JL; Jonville, AP; Lasfargues, G; Lavandier, M; Le Rolland, A; Lemarie, E	1
Dufresne, JJ	1
Albani, G; Amabile, G; Fattapposta, F; Morocutti, C; Pozzessere, G; Rizzo, PA; Sanarelli, L	1
Calne, DB; Calne, S; Douglas, J; Postnikoff, D; Poulin, K; Ross, S; Tsui, JK; Woodward, W	1
Beurrier, D; Hirsch, E; Kaminsky, P; Kiesman, M	1
Caron, J; Foissac-Gegoux, P; Petit, H; Vermersch, P	1
Moskowitz, C; Winfield, L	1
Bar, M; Graff, E; Isakov, A; Oberman, Z; Rabey, JM; Scharf, M	1
Itoh, H; Kitagawa, M; Ooka, T; Watanabe, A	1
Raphael, V	1
Broe, GA; Genge, S; Hely, MA; Morris, JG; O'Sullivan, DJ; Rail, D; Reid, WG; Williamson, PM	2
Selby, G	1
Glatt, S; Hassanein, R; Koller, WC; Vetere-Overfield, B	1
Benabid, AL; Champay, AS; Hommel, M; Perret, JE; Pollak, P	1
Ackermann, H; Oertel, WH; Ziegler, W	1
Carroll, VS; Goetz, CG; Klawans, HL; Shannon, KM; Tanner, CM	1
Villares, JC	1
Calne, D; Hertzman, C; Snow, B; Wiens, M	1
Kinnunen, E; Viljanen, A	2
Dichgans, J; Scholz, E	1
Harvey, NS	1
Bowler, JV; Legg, NJ; Ormerod, IE	1
Huber, M	1
Boyce, S; Jenner, P; Marsden, CD	1
Cummings, JL; Friedenberg, DL	1
Braunstein, GD; Melmed, S	1
Bratton, M; Jost, MG; Lannon, MC; Lockhart-Pretti, P; Thomas, CA	1
Christensen, RS	1
Berlan, M; Boneu, B; Caranobe, C; Lafontan, M; Montastruc, JL; Rascol, A; Villeneuve, A	1
Herskovits, E; Leston, J; Yorio, A	1
Laihinen, A; Rinne, UK	2
Baden, DR; Kenny, AM; Murrin, LC; Pfeiffer, RF; Schneider, MB	1
LeWitt, PA	1
Fahn, S; Hassan, MN; Higgins, D; Traub, M	1
Mondal, BK; Mondal, KN	1
Birkmayer, JD; Birkmayer, W	1
Jansen, EN; Meerwaldt, JD	1
Aminoff, MJ	1
Cleeves, L; Findley, LJ	1
Dubuis, R	1
Birkmayer, W	1
Calne, DB; Rinne, UK	1
Holland, OB; Kennedy, B; Lake, CR; Murphy, D; Ziegler, MG	1
Churg, A; Fleetham, JA; McElvaney, NG; Wilcox, PG	1
Berecz, G; Diószeghy, P; Glaub, T; Mechler, F; Pintér, N; Virga, A	1
Bouchard, S; Gawel, MJ; King, DB; Libman, I; McLean, DR; Paulseth, R; Raphy, B; Riopelle, RJ	1
Wallis, WE	2
Factor, SA; Sanchez-Ramos, JR; Weiner, WJ	1
Lang, AE	1
Bouchard, S; Gawel, MJ; Libman, I; Riopelle, RJ	1
Bayes, A; Blesa, R; Forcadell, F; Tolosa, E	1
Allain, H; Bentué-Ferrer, D; Reymann, JM; Sabouraud, O; Van den Driessche, J	1
Wermuth, L	1
Larsen, JP; Nessler, EG; Strandjord, R	1
Honavar, M; Marsden, CD; Quinn, NP; Ring, H	1
Agniel, A; Celsis, P; Demonet, JF; Marc-Vergnes, JP; Montastruc, JL; Rascol, A; Rascol, O	1
Gollomp, SM; Hurtig, HI; Stern, MB; Vernon, GM	1
Robertson, GS; Robertson, HA	1
Agniel, A; Celsis, P; Demonet, JF; Doyon, B; Marc-Vergnes, JP; Montastruc, JL; Puel, M; Rascol, A	1
Kamphuis, DJ; Lakke, JP; Staal-Schreinemachers, AL; vd Burg, W; Wesseling, H	1
Weil, C	1
Bouchard, S; Gawel, M; Libman, I; Riopelle, R	1
Lindvall, B; Olsson, JE	1
Sandyk, R	2
Gibson, JM; Kennard, C; Pimlott, R	1
Lakke, JP; Staal-Schreinemachers, AL	1
Montastruc, JL; Rascol, A; Schmitt, L; Simonetta, M	1
Riopelle, RJ	1
Bouchard, S	1
de Reuck, J; Tack, E	1
Kadykov, AS; Pivovarova, VM; Shvedkov, VV; Stoliarova, LG	1
Bergsrud, D; Elton, RL; Racy, A; Teychenne, PF	1
Demonet, JF; Dueymes, JM; Ioualalen, A; Montastruc, JL; Rascol, A; Rostin, M	1
Klawans, HL; Paleologos, N	1
Lakke, JP; Staal-Schreinemachers, AL; Wesseling, H	1
Draper, IT	1
Wilson, JA	1
D'Alessandro, P; Finali, G; Piccinin, GL; Piccirilli, M; Piccolini, C; Scarcella, MG; Testa, A	1
Calne, DB; Glover, R; Lau, E; Schulzer, M; Waterman, K	1
Johnels, B	1
van der Drift, JH	1
de Pedro, J; Rosenqvist, U	1
Benoit, P; Peutillot, A	1
Jankovic, J	1
Hardie, RJ; Lees, AJ; Stern, GM	1
Bratty, PJ; Burton, K; Calne, DB; Larsen, TA; Martin, WR; Robinson, RG; Schulzer, M	1
Goldstein, M; Lieberman, AN	1
Ito, H; Kameyama, M; Kase, M; Kuroiwa, Y; Mizuno, Y; Nakanishi, T; Narabayashi, H; Sobue, I; Toyokura, Y; Uono, M	1
Feldman, RG; Lannon, MC	1
Dick, DJ; Fletcher, J; Walls, TJ	1
Wirz, D	1
Axelsson, G; Granerus, AK; Noring, L; Tornling, G; Unge, G	1
Schlechte, JA	1
Agid, Y; Dubois, B	1
Elton, RL; Hoehn, MM	1
Di Battista, G; Di Meo, L; Figà-Talamanca, L; Gualandi, C; Lo Russo, F; Neri, G	1
Erkkola, R; Grönroos, M; Liukko, P; Rinne, UK; Salmi, T	1
Delgado, MR; Grimes, JD	1
Kapfhammer, HP; Rüther, E	1
Ando, K; Mano, Y; Satoyoshi, E; Sunohara, N	1
Glantz, RH; Goetz, CG; Klawans, HL; Tanner, CM	1
Baas, H; Fischer, PA; Japp, G; Schneider, E	2
Glaeske, C; Lorenzo, AS; Pfeiffer, RF; Wilken, K	1
Indo, T	1
Grau-Veciana, JM; Peiró Grasa, A	1
Schott, GD	1
Hershey, LA	1
Brottier, E; Domblides, P; Douvier, JJ; Dubos, F; Freour, P; Taytard, A; Vergeret, J	1
Luquin, MR; Martínez Lage, JM; Obeso, JA	1
Bamji, AN; Calne, DB; Greenacre, JK; Leigh, PN; Teychenne, PF	1

Reviews

86 review(s) available for bromocriptine and Idiopathic Parkinson Disease

Article	Year
Therapeutic potential of dopamine agonists in the treatment of type 2 diabetes mellitus. Environmental science and pollution research international, 2022, Volume: 29, Issue:31 Topics: Bromocriptine; Cabergoline; Diabetes Mellitus, Type 2; Dopamine Agonists; Humans; Hyperprolactinemia; Parkinson Disease; Restless Legs Syndrome	2022
Dopamine agonists versus levodopa monotherapy in early Parkinson's disease for the potential risks of motor complications: A network meta-analysis. European journal of pharmacology, 2023, Sep-05, Volume: 954 Topics: Antiparkinson Agents; Bromocriptine; Dopamine Agonists; Dyskinesias; Humans; Levodopa; Network Meta-Analysis; Parkinson Disease; Pergolide; Pramipexole	2023
Comparison for Efficacy and Tolerability among Ten Drugs for Treatment of Parkinson's Disease: A Network Meta-Analysis. Scientific reports, 2017, 04-04, Volume: 8 Topics: Bromocriptine; Cluster Analysis; Dopamine Agonists; Drug Therapy, Combination; Humans; Indoles; Levodopa; Network Meta-Analysis; Parkinson Disease; Picolinic Acids; Pramipexole; Selegiline; Tetrahydronaphthalenes; Thiophenes	2017
ANNIVERSARY REVIEW: 50 years since the discovery of bromocriptine. European journal of endocrinology, 2018, Volume: 179, Issue:2 Topics: Acromegaly; Animals; Anniversaries and Special Events; Antiparkinson Agents; Bromocriptine; Diabetes Mellitus, Type 2; Dopamine Agonists; Drug Discovery; Drug Therapy, Combination; Ergotism; History, 20th Century; Hormone Antagonists; Humans; Hyperprolactinemia; Hypoglycemic Agents; Parkinson Disease; Pituitary Neoplasms	2018
Anti-Parkinson's disease drugs and pharmacogenetic considerations. Expert opinion on drug metabolism & toxicology, 2013, Volume: 9, Issue:7 Topics: Aryl Hydrocarbon Hydroxylases; Benzothiazoles; Benztropine; Bromocriptine; Cabergoline; Catechols; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP1A2 Inhibitors; Cytochrome P-450 CYP2B6; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP3A; Ergolines; Genetic Markers; Humans; Indans; Indoles; Levodopa; Lisuride; Nitriles; Parkinson Disease; Pergolide; Pharmacogenetics; Pramipexole; Receptors, Dopamine D2; Receptors, Dopamine D3; Reproducibility of Results; Selegiline	2013
Dopaminergic drugs in type 2 diabetes and glucose homeostasis. Pharmacological research, 2016, Volume: 109 Topics: Acromegaly; Animals; Bromocriptine; Diabetes Mellitus, Type 2; Dopamine Agents; Glucose; Homeostasis; Humans; Parkinson Disease; Polymorphism, Genetic; Prolactinoma; Receptors, Dopamine D2	2016
Akinetic mutism and parkinsonism after multiple shunt failure: case report and literature review. Journal of neurological surgery. Part A, Central European neurosurgery, 2012, Volume: 73, Issue:5 Topics: Akinetic Mutism; Antiparkinson Agents; Bromocriptine; Child; Female; Humans; Hydrocephalus; Parkinson Disease; Physical Therapy Modalities; Treatment Outcome; Ventriculoperitoneal Shunt	2012
Plausible improvements for selective targeting of dopamine receptors in therapy of Parkinson's disease. Mini reviews in medicinal chemistry, 2012, Volume: 12, Issue:14 Topics: Animals; Antiparkinson Agents; Apomorphine; Bromocriptine; Dopamine Agonists; Drug Delivery Systems; Ergolines; Humans; Parkinson Disease; Receptors, Dopamine	2012
DA agonists -- ergot derivatives: bromocriptine: management of Parkinson's disease. Movement disorders : official journal of the Movement Disorder Society, 2002, Volume: 17 Suppl 4 Topics: Benzophenones; Bromocriptine; Cabergoline; Dopamine Agonists; Drug Therapy, Combination; Enzyme Inhibitors; Ergolines; Ergot Alkaloids; Humans; Levodopa; Lisuride; Nitrophenols; Parkinson Disease; Pergolide; Randomized Controlled Trials as Topic; Tolcapone	2002
DA agonists -- ergot derivatives: pergolide: management of Parkinson's disease. Movement disorders : official journal of the Movement Disorder Society, 2002, Volume: 17 Suppl 4 Topics: Bromocriptine; Dopamine Agonists; Ergot Alkaloids; Humans; Parkinson Disease; Pergolide; Randomized Controlled Trials as Topic	2002
Initial therapy for Parkinson's disease: levodopa vs. dopamine receptor agonists. Journal of neurology, 2002, Volume: 249 Suppl 2 Topics: Animals; Antiparkinson Agents; Bromocriptine; Contraindications; Disease Models, Animal; Disease Progression; Dopamine Agonists; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Humans; Levodopa; Parkinson Disease; Receptors, Dopamine	2002
[Use of dopamine agonists in the treatment of Parkinson's disease]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2002, Volume: 102, Issue:9 Topics: Antiparkinson Agents; Benzothiazoles; Bromocriptine; Cabergoline; Controlled Clinical Trials as Topic; Dopamine Agonists; Ergolines; Humans; Indoles; Lisuride; Parkinson Disease; Pergolide; Piribedil; Placebos; Pramipexole; Serotonin Receptor Agonists; Thiazoles; Time Factors	2002
[Pathological gambling behavior in a patient with Parkinson's disease treated with levodopa and bromocriptine]. Revue neurologique, 2003, Volume: 159, Issue:4 Topics: Antidepressive Agents; Antiparkinson Agents; Bromocriptine; Citalopram; Depressive Disorder; Dopamine Agents; Female; Fluoxetine; Gambling; Humans; Levodopa; Middle Aged; Parkinson Disease	2003
Catechol-O-methyltransferase inhibitors versus active comparators for levodopa-induced complications in Parkinson's disease. The Cochrane database of systematic reviews, 2004, Oct-18, Issue:4 Topics: Antiparkinson Agents; Benzophenones; Bromocriptine; Catechol O-Methyltransferase Inhibitors; Dopamine Agonists; Humans; Levodopa; Nitrophenols; Parkinson Disease; Pergolide; Tolcapone	2004
Ropinirole: current status of the studies. Journal of neurology, 2004, Volume: 251 Suppl 6 Topics: Bromocriptine; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Indoles; Levodopa; Neuroprotective Agents; Parkinson Disease	2004
Evidence-based medical review update: pharmacological and surgical treatments of Parkinson's disease: 2001 to 2004. Movement disorders : official journal of the Movement Disorder Society, 2005, Volume: 20, Issue:5 Topics: Amantadine; Antiparkinson Agents; Apomorphine; Benzophenones; Benzothiazoles; Bromocriptine; Cabergoline; Catechol O-Methyltransferase Inhibitors; Deep Brain Stimulation; Dihydroergocryptine; Ergolines; Fetal Tissue Transplantation; Globus Pallidus; Humans; Indans; Indoles; Levodopa; Lisuride; Mesencephalon; Monoamine Oxidase Inhibitors; Neurosurgical Procedures; Nitrophenols; Parkinson Disease; Pergolide; Piribedil; Pramipexole; Selegiline; Thiazoles; Tolcapone	2005
Bromocriptine versus levodopa in early Parkinson's disease. The Cochrane database of systematic reviews, 2007, Oct-17, Issue:4 Topics: Antiparkinson Agents; Bromocriptine; Humans; Levodopa; Parkinson Disease; Randomized Controlled Trials as Topic	2007
Bromocriptine/levodopa combined versus levodopa alone for early Parkinson's disease. The Cochrane database of systematic reviews, 2007, Oct-17, Issue:4 Topics: Antiparkinson Agents; Bromocriptine; Combined Modality Therapy; Humans; Levodopa; Parkinson Disease; Randomized Controlled Trials as Topic	2007
Update on antiparkinsonian agents. Geriatrics, 1982, Volume: 37, Issue:9 Topics: Aged; Amantadine; Antiparkinson Agents; Blood-Brain Barrier; Bromocriptine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Gastrointestinal Diseases; Histamine H1 Antagonists; Humans; Levodopa; Parasympatholytics; Parkinson Disease; Receptors, Dopamine; Selegiline; Vascular Resistance	1982
Dopamine and depression: a review of recent evidence. I. Empirical studies. Brain research, 1983, Volume: 287, Issue:3 Topics: Amphetamine; Antipsychotic Agents; Brain; Bromocriptine; Depressive Disorder; Dihydroxyphenylalanine; Dopamine; Double-Blind Method; Homovanillic Acid; Humans; Norepinephrine; Parkinson Disease; Piribedil; Receptors, Dopamine; Research	1983
[New directions in contemporary pharmacotherapy of parkinsonism (review)]. Zhurnal nevropatologii i psikhiatrii imeni S.S. Korsakova (Moscow, Russia : 1952), 1984, Volume: 84, Issue:9 Topics: Adrenergic beta-Antagonists; Anti-Anxiety Agents; Antiparkinson Agents; Apomorphine; Aromatic Amino Acid Decarboxylase Inhibitors; Bromocriptine; Drug Therapy, Combination; gamma-Aminobutyric Acid; Humans; Levodopa; Lisuride; Oxprenolol; Parkinson Disease; Piracetam; Piribedil; Propranolol	1984
Drugs five years later. Bromocriptine. Annals of internal medicine, 1984, Volume: 100, Issue:1 Topics: Acromegaly; Adenoma; Bromocriptine; Dyskinesia, Drug-Induced; Edema; Female; Growth Hormone; Hepatic Encephalopathy; Humans; Huntington Disease; Infertility, Female; Lactation; Luteal Phase; Male; Mental Disorders; Parkinson Disease; Pituitary Neoplasms; Pregnancy; Premenstrual Syndrome; Prolactin	1984
[Neurologic indications for bromocriptine (in addition to Parkinson's disease)]. LARC medical, 1984, Volume: 4, Issue:2 Topics: Adult; Bromocriptine; Child; Clinical Trials as Topic; Dyskinesia, Drug-Induced; Dystonia; Dystonia Musculorum Deformans; Female; Humans; Huntington Disease; Male; Movement Disorders; Nervous System Diseases; Parkinson Disease; Shy-Drager Syndrome; Syndrome; Torticollis	1984
The pharmacology of Parkinson's disease: basic aspects and recent advances. Experientia, 1984, Nov-15, Volume: 40, Issue:11 Topics: Animals; Antiparkinson Agents; Aromatic Amino Acid Decarboxylase Inhibitors; Benserazide; Brain; Bromocriptine; Carbidopa; Corpus Striatum; Dopamine; Ergolines; Humans; Kidney; Kinetics; Levodopa; Lisuride; Liver; Methyldopa; Norepinephrine; Parkinson Disease; Pergolide; Receptors, Dopamine; Selegiline; Serotonin; Stereotyped Behavior; Substantia Nigra; Tyramine	1984
The endocrine profile of bromocriptine: its application in endocrine diseases. Journal of neural transmission, 1981, Volume: 51, Issue:1-2 Topics: Bromocriptine; Cushing Syndrome; Endocrine Glands; Growth Hormone; Hormones; Humans; Huntington Disease; Nelson Syndrome; Parkinson Disease; Pituitary Hormones; Prolactin; Thyroxine; Triiodothyronine	1981
Is aldosterone secretion under dopaminergic control? Circulation research, 1981, Volume: 49, Issue:6 Topics: Aldosterone; Bromocriptine; Chlorpromazine; Dopamine; Dopamine Antagonists; Edema; Humans; Levodopa; Methyldopa; Metoclopramide; Parkinson Disease; Sulpiride	1981
The management of Parkinson's disease. Australian and New Zealand journal of medicine, 1982, Volume: 12, Issue:2 Topics: Adult; Aged; Amantadine; Bromocriptine; Diagnosis, Differential; Dyskinesia, Drug-Induced; Humans; Hypotension, Orthostatic; Levodopa; Middle Aged; Nausea; Parasympatholytics; Parkinson Disease	1982
[Stage-adjusted treatment of idiopathic Parkinson syndrome]. Wiener medizinische Wochenschrift (1946), 1995, Volume: 145, Issue:13 Topics: Antiparkinson Agents; Bromocriptine; Carboxy-Lyases; Cholinergic Antagonists; Disability Evaluation; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Humans; Levodopa; Neurologic Examination; Parkinson Disease; Selegiline	1995
Levodopa and dopamine agonists in the treatment of Parkinson's disease: advantages and disadvantages. European neurology, 1994, Volume: 34 Suppl 3 Topics: Animals; Brain; Bromocriptine; Corpus Striatum; Dopamine Agonists; Free Radicals; Humans; Levodopa; Mice; Parkinson Disease; Parkinson Disease, Secondary; Premedication; Reactive Oxygen Species; Receptors, Dopamine D1; Receptors, Dopamine D2; Synaptic Transmission	1994
Neuroprotection by dopamine agonists. Journal of neural transmission. Supplementum, 1994, Volume: 43 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Aging; Animals; Bromocriptine; Dopamine Agonists; Humans; Neuroprotective Agents; Neurotoxins; Parkinson Disease; Pergolide	1994
[Recent progress of therapy in patients with Parkinson's disease]. Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 1993, Jul-10, Volume: 82, Issue:7 Topics: Brain; Bromocriptine; Delayed-Action Preparations; Droxidopa; Drug Resistance; Humans; Levodopa; Monoamine Oxidase Inhibitors; Parkinson Disease; Receptors, Dopamine	1993
Early combination therapy with bromocriptine and levodopa in Parkinson's disease. Movement disorders : official journal of the Movement Disorder Society, 1993, Volume: 8, Issue:3 Topics: Bromocriptine; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Parkinson Disease; Treatment Outcome	1993
Free radicals and their scavengers in Parkinson's disease. European neurology, 1993, Volume: 33 Suppl 1 Topics: Antioxidants; Bromocriptine; Corpus Striatum; Dopamine; Free Radicals; Humans; Lipid Peroxidation; Parkinson Disease; Reactive Oxygen Species; Substantia Nigra	1993
[Retroperitoneal fibrosis secondary to treatment with L-dopa analogues for Parkinson disease]. Archivos espanoles de urologia, 1995, Volume: 48, Issue:10 Topics: Aged; Bromocriptine; Dopamine Agonists; Female; Humans; Male; Middle Aged; Parkinson Disease; Pergolide; Retroperitoneal Fibrosis	1995
Treatment of early Parkinson's disease: are complicated strategies justified? Mayo Clinic proceedings, 1996, Volume: 71, Issue:7 Topics: Animals; Antiparkinson Agents; Bromocriptine; Carbidopa; Drug Therapy, Combination; Humans; Levodopa; Parkinson Disease; Pergolide; Selegiline	1996
Drug management of Parkinson's disease. Canadian family physician Medecin de famille canadien, 1996, Volume: 42 Topics: Amantadine; Antiparkinson Agents; Bromocriptine; Humans; Levodopa; Parkinson Disease; Selegiline; Trihexyphenidyl	1996
New directions in the drug treatment of Parkinson's disease. Drugs & aging, 1996, Volume: 9, Issue:3 Topics: Antiparkinson Agents; Apomorphine; Bromocriptine; Dopamine Agonists; Humans; Levodopa; Neuroprotective Agents; Parkinson Disease; Selegiline	1996
[Treatment of Parkinson's disease with multiple drugs]. Nihon rinsho. Japanese journal of clinical medicine, 1997, Volume: 55, Issue:1 Topics: Amantadine; Bromocriptine; Cholinergic Antagonists; Dopamine Agonists; Drug Therapy, Combination; Humans; Levodopa; Parkinson Disease; Pergolide	1997
Newer therapies for Parkinson's disease. Neurologia i neurochirurgia polska, 1996, Volume: 30 Suppl 2 Topics: Antiparkinson Agents; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Humans; Indoles; Parkinson Disease	1996
Clinical experience with cabergoline in patients with advanced Parkinson's disease treated with levodopa. Drugs, 1998, Volume: 55 Suppl 1 Topics: Antiparkinson Agents; Bromocriptine; Cabergoline; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Drug Therapy, Combination; Ergolines; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Randomized Controlled Trials as Topic	1998
Pregnancy in Parkinson's disease: a review of the literature and a case report. Movement disorders : official journal of the Movement Disorder Society, 1999, Volume: 14, Issue:1 Topics: Adult; Antiparkinson Agents; Bromocriptine; Female; Humans; Infant, Newborn; Male; Parkinson Disease; Pregnancy; Pregnancy Complications	1999
Dopamine agonists. The Medical clinics of North America, 1999, Volume: 83, Issue:2 Topics: Apomorphine; Benzothiazoles; Bromocriptine; Dopamine Agonists; Humans; Indoles; Parkinson Disease; Pergolide; Pramipexole; Randomized Controlled Trials as Topic; Receptors, Dopamine; Thiazoles; Treatment Outcome	1999
The initial treatment of Parkinson's disease should begin with levodopa. Movement disorders : official journal of the Movement Disorder Society, 1999, Volume: 14, Issue:5 Topics: Aged; Antiparkinson Agents; Benzothiazoles; Bromocriptine; Drug Therapy, Combination; Essential Tremor; Female; Humans; Indoles; Levodopa; Male; Middle Aged; Parkinson Disease; Pergolide; Pramipexole; Receptors, Dopamine; Thiazoles; Time Factors	1999
Treatment of Parkinson's disease should begin with a dopamine agonist. Movement disorders : official journal of the Movement Disorder Society, 1999, Volume: 14, Issue:5 Topics: Benzothiazoles; Bromocriptine; Cabergoline; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Therapy, Combination; Ergolines; Humans; Indoles; Levodopa; Lisuride; Parkinson Disease; Pergolide; Pramipexole; Receptors, Dopamine D2; Thiazoles	1999
The efficacy and safety of adjunct bromocriptine therapy for levodopa-induced motor complications: a systematic review. Movement disorders : official journal of the Movement Disorder Society, 2000, Volume: 15, Issue:1 Topics: Antiparkinson Agents; Bromocriptine; Dopamine Agonists; Double-Blind Method; Dyskinesia, Drug-Induced; Humans; Levodopa; Neurologic Examination; Parkinson Disease; Randomized Controlled Trials as Topic; Treatment Outcome	2000
Pergolide versus bromocriptine for levodopa-induced motor complications in Parkinson's disease. The Cochrane database of systematic reviews, 2000, Issue:2 Topics: Antiparkinson Agents; Bromocriptine; Dopamine Agents; Dyskinesia, Drug-Induced; Humans; Levodopa; Neuroprotective Agents; Parkinson Disease; Pergolide	2000
Bromocriptine for levodopa-induced motor complications in Parkinson's disease. The Cochrane database of systematic reviews, 2000, Issue:2 Topics: Antiparkinson Agents; Bromocriptine; Dyskinesia, Drug-Induced; Dystonia; Humans; Levodopa; Parkinson Disease	2000
Lisuride versus bromocriptine for levodopa-induced complications in Parkinson's disease. The Cochrane database of systematic reviews, 2000, Issue:2 Topics: Antiparkinson Agents; Bromocriptine; Dyskinesia, Drug-Induced; Humans; Levodopa; Lisuride; Parkinson Disease	2000
Ropinirole versus bromocriptine for levodopa-induced complications in Parkinson's disease. The Cochrane database of systematic reviews, 2000, Issue:3 Topics: Antiparkinson Agents; Bromocriptine; Dopamine Agonists; Dyskinesias; Humans; Indoles; Levodopa; Parkinson Disease; Randomized Controlled Trials as Topic	2000
Pramipexole versus bromocriptine for levodopa-induced complications in Parkinson's disease. The Cochrane database of systematic reviews, 2000, Issue:3 Topics: Antiparkinson Agents; Benzothiazoles; Bromocriptine; Dopamine Agonists; Drug Tolerance; Humans; Levodopa; Parkinson Disease; Pramipexole; Randomized Controlled Trials as Topic; Thiazoles	2000
Bromocriptine versus levodopa in early Parkinson's disease. The Cochrane database of systematic reviews, 2000, Issue:3 Topics: Antiparkinson Agents; Bromocriptine; Humans; Levodopa; Parkinson Disease; Randomized Controlled Trials as Topic	2000
[The new Parkinson's disease drugs]. Nihon rinsho. Japanese journal of clinical medicine, 2000, Volume: 58, Issue:10 Topics: Antiparkinson Agents; Bromocriptine; Catechol O-Methyltransferase Inhibitors; Clinical Trials as Topic; Dopamine Agonists; Drug Therapy, Combination; Enzyme Inhibitors; Humans; Levodopa; Monoamine Oxidase Inhibitors; Parkinson Disease	2000
[Parkinson disease: diagnostic and therapeutic criteria]. Presse medicale (Paris, France : 1983), 2001, Mar-03, Volume: 30, Issue:8 Topics: Activities of Daily Living; Adult; Aged; Amantadine; Antiparkinson Agents; Bromocriptine; Diagnosis, Differential; Dopamine Agents; Dopamine Agonists; Female; Globus Pallidus; Humans; Indoles; Levodopa; Lewy Body Disease; Lisuride; Male; Mental Status Schedule; Neurosurgery; Parkinson Disease; Parkinsonian Disorders; Piribedil; Psychiatric Status Rating Scales; Serotonin Receptor Agonists; Stereotaxic Techniques; Supranuclear Palsy, Progressive; Surveys and Questionnaires; Thalamus	2001
Ropinirole versus bromocriptine for levodopa-induced complications in Parkinson's disease. The Cochrane database of systematic reviews, 2001, Issue:1 Topics: Antiparkinson Agents; Bromocriptine; Dopamine Agonists; Dyskinesias; Humans; Indoles; Levodopa; Parkinson Disease; Randomized Controlled Trials as Topic	2001
Cabergoline versus bromocriptine for levodopa-induced complications in Parkinson's disease. The Cochrane database of systematic reviews, 2001, Issue:1 Topics: Antiparkinson Agents; Bromocriptine; Cabergoline; Dopamine Agonists; Dyskinesia, Drug-Induced; Ergolines; Humans; Levodopa; Parkinson Disease; Randomized Controlled Trials as Topic	2001
Are dopamine receptor agonists neuroprotective in Parkinson's disease? Drugs & aging, 2001, Volume: 18, Issue:6 Topics: Animals; Antiparkinson Agents; Apomorphine; Benzothiazoles; Bromocriptine; Cell Culture Techniques; Clinical Trials as Topic; Dopamine Agonists; Humans; Indoles; Models, Animal; Neuroprotective Agents; Parkinson Disease; Pergolide; Pramipexole; Substantia Nigra; Thiazoles	2001
[Pleuropneumopathy caused by bromocriptine in a patient with Parkinson disease. Review of the literature apropos of a new case]. Annales de medecine interne, 1998, Volume: 149, Issue:3 Topics: Aged; Antiparkinson Agents; Bromocriptine; Diagnosis, Differential; Dose-Response Relationship, Drug; Follow-Up Studies; Humans; Male; Parkinson Disease; Pleuropneumonia; Pulmonary Fibrosis; Tomography, X-Ray Computed	1998
Bromocriptine/levodopa combined versus levodopa alone for early Parkinson's disease. The Cochrane database of systematic reviews, 2002, Issue:2 Topics: Antiparkinson Agents; Bromocriptine; Combined Modality Therapy; Humans; Levodopa; Parkinson Disease; Randomized Controlled Trials as Topic	2002
[Considerations in the drug treatment of parkinsonism (author's transl)]. Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis, 1978, Nov-07, Volume: 67, Issue:45 Topics: Amantadine; Apomorphine; Bromocriptine; Dopamine; Ergolines; Extrapyramidal Tracts; Female; Humans; Levodopa; Male; Monoamine Oxidase Inhibitors; Neurotransmitter Agents; Parkinson Disease; Phosphodiesterase Inhibitors; Piribedil; Tremor	1978
Recent advances in research on Parkinsonism. Acta neurologica Scandinavica. Supplementum, 1978, Volume: 67 Topics: Acetylcholinesterase; Adult; Apomorphine; Benserazide; Brain; Bromocriptine; Carbidopa; Dopa Decarboxylase; Dopamine; Drug Therapy, Combination; gamma-Aminobutyric Acid; Humans; Levodopa; Norepinephrine; Parkinson Disease; Selegiline; Serotonin; Substance P; Tyrosine 3-Monooxygenase	1978
Bromocriptine in the treatment of parkinsonism. Drugs, 1979, Volume: 17, Issue:5 Topics: Apomorphine; Bromocriptine; Catecholamines; Drug Interactions; Ergolines; Humans; Kinetics; Motor Activity; Movement Disorders; Parkinson Disease; Piribedil; Receptors, Drug; Stereotyped Behavior	1979
[Therapy of tparkinson's disease. Clinical and pharmacological viewpoints]. Medizinische Klinik, 1979, Jul-13, Volume: 74, Issue:28-29 Topics: Adrenergic beta-Antagonists; Amantadine; Bromocriptine; Histamine H1 Antagonists; Humans; Levodopa; Monoamine Oxidase Inhibitors; MSH Release-Inhibiting Hormone; Muscle Rigidity; Parasympatholytics; Parkinson Disease; Posture; Psychoses, Substance-Induced; Tremor	1979
Bromocriptine. Advances in drug research, 1977, Volume: 12 Topics: Acromegaly; Animals; Behavior, Animal; Biogenic Amines; Bromocriptine; Central Nervous System; Dopamine; Emetics; Female; Galactorrhea; Growth Hormone; Hallucinations; Hemodynamics; Hormones; Humans; Kinetics; Norepinephrine; Parkinson Disease; Pregnancy; Prolactin; Receptors, Dopamine; Serotonin	1977
Bromocriptine in Parkinsonism. British medical journal, 1978, May-27, Volume: 1, Issue:6124 Topics: Bromocriptine; Drug Evaluation; Drug Therapy, Combination; Humans; Levodopa; Parkinson Disease; Psychoses, Substance-Induced	1978
Pharmacology of ergot alkaloids in clinical use. The Medical journal of Australia, 1978, Nov-04, Volume: 2, Issue:3 Suppl Topics: Animals; Brain Diseases; Bromocriptine; Dihydroergotamine; Dihydroergotoxine; Dopamine Antagonists; Ergot Alkaloids; Ergotamine; Female; Humans; Methysergide; Migraine Disorders; Parkinson Disease; Pituitary Gland; Prolactin; Receptors, Adrenergic; Receptors, Dopamine; Uterus; Vasoconstriction	1978
Dopamine receptor stimulating agonists in the treatment of Parkinson's disease. Biomedicine / [publiee pour l'A.A.I.C.I.G.], 1979, Volume: 30, Issue:2 Topics: Apomorphine; Bromocriptine; Humans; Levodopa; Parkinson Disease; Piribedil; Receptors, Dopamine	1979
Drug therapy: Bromocriptine. The New England journal of medicine, 1979, Oct-18, Volume: 301, Issue:16 Topics: Acromegaly; Adenoma; Amantadine; Bromocriptine; Female; Galactorrhea; Growth Hormone; Humans; Infertility; Lactation; Levodopa; Male; Parkinson Disease; Pituitary Neoplasms; Pregnancy; Prolactin	1979
[Psychiatric manifestations induced by dopamine precursors or antagonists]. Annales medico-psychologiques, 1979, Volume: 137, Issue:9 Topics: Anxiety; Bromocriptine; Confusion; Dopamine Antagonists; Dreams; Female; Hallucinations; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Sulpiride	1979
Dopaminergic agonists in the treatment of Parkinson's disease. Neurologic clinics, 1992, Volume: 10, Issue:2 Topics: Apomorphine; Bromocriptine; Dopamine Agents; Humans; Lactose; Lisuride; Methylcellulose; Oxazines; Parkinson Disease; Pergolide; Receptors, Dopamine	1992
Drug therapy of Parkinson's disease. An overview. European neurology, 1992, Volume: 32 Suppl 1 Topics: Antiparkinson Agents; Brain; Bromocriptine; Dopamine Agents; Drug Therapy, Combination; Humans; Levodopa; Long-Term Care; Neurologic Examination; Parkinson Disease; Receptors, N-Methyl-D-Aspartate	1992
[Current therapeutic approach in Parkinson disease]. Revue medicale de Bruxelles, 1992, Volume: 13, Issue:10 Topics: Antiparkinson Agents; Apomorphine; Bromocriptine; Fetal Tissue Transplantation; Humans; Levodopa; Mesencephalon; Parkinson Disease; Selegiline; Vitamin E	1992
[New anti-parkinsonian drugs]. No to shinkei = Brain and nerve, 1991, Volume: 43, Issue:8 Topics: Antiparkinson Agents; Bromocriptine; Humans; Lisuride; Parkinson Disease; Pergolide; Picolinic Acids; Selegiline	1991
Dopaminergic agonists in the treatment of Parkinson's disease. Neurology, 1990, Volume: 40, Issue:10 Suppl 3 Topics: Bromocriptine; Dopamine Agents; Humans; Parkinson Disease; Pergolide	1990
Retroperitoneal fibrosis in two patients with Parkinson's disease treated with bromocriptine. Acta clinica Belgica, 1990, Volume: 45, Issue:5 Topics: Aged; Bromocriptine; Female; Humans; Male; Middle Aged; Parkinson Disease; Retroperitoneal Fibrosis	1990
Psychiatric disorders in parkinsonism: 2. Organic cerebral states and drug reactions. Psychosomatics, 1986, Volume: 27, Issue:3 Topics: Amantadine; Antiparkinson Agents; Atrophy; Brain; Bromocriptine; Cognition; Dementia; Dreams; Drug Interactions; Ergolines; Humans; Levodopa; Libido; Memory; Parasympatholytics; Parkinson Disease; Receptors, Dopamine; Sexual Behavior; Substance-Related Disorders; Visual Perception	1986
[Parkinson disease. The clinical picture and therapy]. Deutsche medizinische Wochenschrift (1946), 1988, Jun-16, Volume: 113, Issue:24 Topics: Adrenergic beta-Antagonists; Amantadine; Bromocriptine; Humans; Levodopa; Monoamine Oxidase Inhibitors; Parasympatholytics; Parkinson Disease	1988
Receptor changes during chronic dopaminergic stimulation. Journal of neural transmission. Supplementum, 1988, Volume: 27 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Behavior, Animal; Brain Diseases; Bromocriptine; Dopamine; Humans; Hydroxydopamines; Injections, Intraperitoneal; Levodopa; Neurotransmitter Agents; Oxidopamine; Parkinson Disease; Pergolide; Primates; Pyridines; Receptors, Dopamine; Substance Withdrawal Syndrome	1988
New perspectives in the treatment of Parkinson's disease. Clinical neuropharmacology, 1986, Volume: 9 Suppl 1 Topics: Bromocriptine; Dopamine; Drug Therapy, Combination; Humans; Levodopa; Parkinson Disease; Receptors, Dopamine; Selegiline; Sincalide	1986
'On-off' phenomenon: description, incidence and management. European neurology, 1987, Volume: 27 Suppl 1 Topics: Bromocriptine; Dose-Response Relationship, Drug; Humans; Levodopa; Monoamine Oxidase Inhibitors; Movement Disorders; Parkinson Disease; Selegiline	1987
Controversies in the management of Parkinson's disease. Movement disorders : official journal of the Movement Disorder Society, 1986, Volume: 1, Issue:3 Topics: Bromocriptine; Drug Therapy, Combination; Humans; Levodopa; Parkinson Disease; Selegiline	1986
Update on dopamine agonists in Parkinson's disease: "beyond bromocriptine". The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques, 1987, Volume: 14, Issue:3 Suppl Topics: Antiparkinson Agents; Bromocriptine; Dopamine; Ergolines; Humans; Parkinson Disease; Piperazines	1987
The safety of bromocriptine in long-term use: a review of the literature. Current medical research and opinion, 1986, Volume: 10, Issue:1 Topics: Acromegaly; Adenoma; Bromocriptine; Female; Fetus; Humans; Male; Parkinson Disease; Pituitary Hormones; Pituitary Neoplasms; Pregnancy; Pregnancy Complications; Prolactin; Time Factors	1986
Long-term use of dopamine agonists in Parkinson's disease. Clinical neuropharmacology, 1985, Volume: 8, Issue:2 Topics: Bromocriptine; Corpus Striatum; Drug Therapy, Combination; Ergolines; Humans; Levodopa; Movement Disorders; Parkinson Disease; Pergolide; Receptors, Dopamine; Time Factors	1985
The controversial role of bromocriptine in Parkinson's disease. Clinical neuropharmacology, 1985, Volume: 8, Issue:2 Topics: Apomorphine; Bromocriptine; Humans; Levodopa; Parkinson Disease; Time Factors	1985
Bromocriptine in Parkinson disease. Pharmacological reviews, 1985, Volume: 37, Issue:2 Topics: Aged; Animals; Bromocriptine; Drug Administration Schedule; Ergolines; Humans; Levodopa; Lisuride; Middle Aged; Parkinson Disease; Pergolide; Time Factors	1985
Update on the treatment of Parkinson's disease. Connecticut medicine, 1985, Volume: 49, Issue:10 Topics: Amantadine; Bromocriptine; Carbidopa; Drug Synergism; Humans; Levodopa; Parasympatholytics; Parkinson Disease; Selegiline; Time Factors	1985

Trials

139 trial(s) available for bromocriptine and Idiopathic Parkinson Disease

Article	Year
[Efficacy and safety of ropinirole in the treatment of Parkinson's disease: a multi-center, randomized, double-blind and bromocriptine-controlled trial]. Zhonghua yi xue za zhi, 2013, Jul-02, Volume: 93, Issue:25 Topics: Adult; Aged; Aged, 80 and over; Bromocriptine; Double-Blind Method; Female; Humans; Indoles; Male; Middle Aged; Parkinson Disease	2013
Fourteen-year final report of the randomized PDRG-UK trial comparing three initial treatments in PD. Neurology, 2008, Aug-12, Volume: 71, Issue:7 Topics: Antiparkinson Agents; Bromocriptine; Disability Evaluation; Female; Follow-Up Studies; Humans; Levodopa; Male; Middle Aged; Motor Skills; Parkinson Disease; Quality of Life; Selegiline	2008
Antiparkinsonian drug-induced sleepiness: a double-blind placebo-controlled study of L-dopa, bromocriptine and pramipexole in healthy subjects. British journal of clinical pharmacology, 2009, Volume: 67, Issue:3 Topics: Adolescent; Adult; Antiparkinson Agents; Benzothiazoles; Bromocriptine; Cross-Over Studies; Double-Blind Method; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Polysomnography; Pramipexole; Sleep Wake Disorders; Treatment Outcome; Young Adult	2009
Overnight switching from ergot-derived dopamine agonists to pramipexole in patients with Parkinson's disease: an open preliminary trial in Japan. Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia, 2009, Volume: 16, Issue:6 Topics: Benzothiazoles; Bromocriptine; Cabergoline; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Administration Schedule; Ergolines; Humans; Japan; Outcome Assessment, Health Care; Parkinson Disease; Pergolide; Pramipexole; Severity of Illness Index; Time Factors; Treatment Outcome	2009
Comparing bromocriptine effects with levodopa effects on bladder function in Parkinson's disease. Movement disorders : official journal of the Movement Disorder Society, 2009, Dec-15, Volume: 24, Issue:16 Topics: Aged; Antiparkinson Agents; Bromocriptine; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Parkinson Disease; Prospective Studies; Rheology; Severity of Illness Index; Statistics, Nonparametric; Urinary Bladder Diseases; Urodynamics	2009
Evaluation of the efficacy of pramipexole for treating levodopa-induced dyskinesia in patients with Parkinson's disease. Internal medicine (Tokyo, Japan), 2013, Volume: 52, Issue:3 Topics: Aged; Antiparkinson Agents; Benzothiazoles; Bromocriptine; Cabergoline; Dopamine Agonists; Dyskinesia, Drug-Induced; Ergolines; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Pergolide; Pramipexole; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, Dopamine D3	2013
Quantitative description of loss of clinical benefit following withdrawal of levodopa-carbidopa and bromocriptine in early Parkinson's disease. Movement disorders : official journal of the Movement Disorder Society, 2002, Volume: 17, Issue:5 Topics: Activities of Daily Living; Aged; Bromocriptine; Carbidopa; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Parkinson Disease; Prospective Studies; Withholding Treatment	2002
Ropinirole as an adjunct to levodopa in the treatment of Parkinson's disease: a 16-week bromocriptine controlled study. Journal of neurology, 2003, Volume: 250, Issue:1 Topics: Antiparkinson Agents; Bromocriptine; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Humans; Indoles; Levodopa; Male; Middle Aged; Motor Activity; Parkinson Disease; Treatment Outcome	2003
Piribedil and bromocriptine in Parkinson's disease: a single-blind crossover study. Acta neurologica Scandinavica, 2003, Volume: 107, Issue:3 Topics: Administration, Oral; Aged; Antiparkinson Agents; Bromocriptine; Cross-Over Studies; Female; Hallucinations; Humans; Male; Middle Aged; Nausea; Parkinson Disease; Piribedil; Psychomotor Agitation; Severity of Illness Index; Single-Blind Method; Sleep Wake Disorders; Treatment Outcome	2003
Randomized, double-blind study of pramipexole with placebo and bromocriptine in advanced Parkinson's disease. Movement disorders : official journal of the Movement Disorder Society, 2003, Volume: 18, Issue:10 Topics: Activities of Daily Living; Aged; Antiparkinson Agents; Benzothiazoles; Bromocriptine; Demography; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Tolerance; Female; Humans; Male; Middle Aged; Parkinson Disease; Pramipexole; Prospective Studies; Quality of Life; Thiazoles; Time Factors; Treatment Outcome	2003
Usefulness of switching to cabergoline from other dopamine agonists in patients with advanced Parkinson's disease. Journal of neural transmission (Vienna, Austria : 1996), 2004, Volume: 111, Issue:6 Topics: Aged; Antiparkinson Agents; Bromocriptine; Cabergoline; Ergolines; Humans; Parkinson Disease; Pergolide; Prospective Studies; Treatment Outcome	2004
The Parkinson-Control study: a 1-year randomized, double-blind trial comparing piribedil (150 mg/day) with bromocriptine (25 mg/day) in early combination with levodopa in Parkinson's disease. Movement disorders : official journal of the Movement Disorder Society, 2006, Volume: 21, Issue:4 Topics: Adult; Aged; Antiparkinson Agents; Bromocriptine; Case-Control Studies; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Middle Aged; Parkinson Disease; Piribedil; Severity of Illness Index; Time Factors; Treatment Outcome	2006
Adjuvant treatment of Parkinson's disease with dopamine agonists: open trial with bromocriptine and CU 32-085. Journal of neurology, 1982, Volume: 227, Issue:2 Topics: Aged; Bromocriptine; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Therapy, Combination; Ergolines; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Receptors, Dopamine	1982
[Neurologic indications for bromocriptine (in addition to Parkinson's disease)]. LARC medical, 1984, Volume: 4, Issue:2 Topics: Adult; Bromocriptine; Child; Clinical Trials as Topic; Dyskinesia, Drug-Induced; Dystonia; Dystonia Musculorum Deformans; Female; Humans; Huntington Disease; Male; Movement Disorders; Nervous System Diseases; Parkinson Disease; Shy-Drager Syndrome; Syndrome; Torticollis	1984
Lisuride treatment in Parkinson's disease: clinical and pharmacokinetic studies. Advances in neurology, 1983, Volume: 37 Topics: Bromocriptine; Clinical Trials as Topic; Dose-Response Relationship, Drug; Double-Blind Method; Ergolines; Female; Humans; Lisuride; Male; Middle Aged; Parkinson Disease	1983
Comparison of pergolide and bromocriptine therapy in parkinsonism. Neurology, 1983, Volume: 33, Issue:8 Topics: Aged; Bromocriptine; Clinical Trials as Topic; Double-Blind Method; Ergolines; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Pergolide	1983
[Combined treatment of the early stages of Parkinson's syndrome with bromocriptine and levodopa. The results of a multicenter study]. Deutsche medizinische Wochenschrift (1946), 1984, Aug-24, Volume: 109, Issue:34 Topics: Aged; Benserazide; Bromocriptine; Chronic Disease; Clinical Trials as Topic; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Parkinson Disease, Postencephalitic; Random Allocation; Time Factors	1984
Low-dose bromocriptine therapy in severe Parkinson's disease. Clinical neuropharmacology, 1984, Volume: 7, Issue:3 Topics: Adult; Aged; Bromocriptine; Clinical Trials as Topic; Female; Humans; Male; Middle Aged; Parkinson Disease; Time Factors	1984
Pergolide in late-stage Parkinson disease. Annals of neurology, 1982, Volume: 12, Issue:3 Topics: Bromocriptine; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Ergolines; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Pergolide; Sleep Wake Disorders	1982
Bromocriptine (ParlodelR) in the treatment of Parkinson's disease. Progress in neuro-psychopharmacology & biological psychiatry, 1982, Volume: 6, Issue:4-6 Topics: Adult; Aged; Bromocriptine; Clinical Trials as Topic; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Parkinson Disease; Parkinson Disease, Postencephalitic	1982
[Bromocriptine in the treatment of Parkinson's disease]. Neurologija, 1982, Volume: 30, Issue:1-4 Topics: Aged; Bromocriptine; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Male; Middle Aged; Parkinson Disease	1982
[Bromocriptin in the treatment of progressive stages of Parkinson's disease (author's transl)]. Deutsche medizinische Wochenschrift (1946), 1982, Feb-05, Volume: 107, Issue:5 Topics: Aged; Bromocriptine; Dihydroxyphenylalanine; Double-Blind Method; Female; Humans; Male; Middle Aged; Nausea; Parkinson Disease; Placebos	1982
Prolactin secretion in Parkinson disease. Neurology, 1981, Volume: 31, Issue:10 Topics: Adult; Aged; Blood-Brain Barrier; Bromocriptine; Carbidopa; Dopamine; Drug Combinations; Female; Humans; Hypothalamus, Anterior; Levodopa; Male; Middle Aged; Parkinson Disease; Pituitary Gland; Placebos; Prolactin; Receptors, Dopamine; Thyrotropin-Releasing Hormone	1981
Bromocriptine and Parkinson's disease: a 16-hour clinical evaluation. Acta neurologica Scandinavica, 1980, Volume: 61, Issue:2 Topics: Aged; Bromocriptine; Clinical Trials as Topic; Female; Humans; Male; Middle Aged; Parkinson Disease; Time Factors	1980
Assessment of hypokinesia in Parkinsonism. Journal of neural transmission, 1981, Volume: 51, Issue:1-2 Topics: Adult; Aged; Bromocriptine; Clinical Trials as Topic; Ergolines; Humans; Levodopa; Lisuride; Male; Middle Aged; Motor Activity; Movement; Parkinson Disease; Placebos; Posture; Time Factors	1981
Recent advances in the treatment of Parkinson's disease: the role of bromocriptine. Journal of neural transmission, 1981, Volume: 51, Issue:1-2 Topics: Bromocriptine; Carbidopa; Clinical Trials as Topic; Follow-Up Studies; Humans; Levodopa; Parkinson Disease	1981
The effect of bromocriptine (BCT) on the on-off phenomenon. Journal of neural transmission, 1981, Volume: 52, Issue:1-2 Topics: Bromocriptine; Clinical Trials as Topic; Humans; Levodopa; Parkinson Disease	1981
Weekly drug holiday in Parkinson disease. Neurology, 1981, Volume: 31, Issue:11 Topics: Adult; Aged; Amantadine; Antiparkinson Agents; Bromocriptine; Carbidopa; Clinical Trials as Topic; Drug Administration Schedule; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease	1981
Lisuride versus bromocriptine treatment in Parkinson disease: a double-blind study. Neurology, 1982, Volume: 32, Issue:1 Topics: Adult; Aged; Bromocriptine; Clinical Trials as Topic; Dose-Response Relationship, Drug; Double-Blind Method; Ergolines; Female; Humans; Lisuride; Male; Middle Aged; Parkinson Disease; Random Allocation	1982
Bromocriptine and domperidone in the treatment of Parkinson disease. Neurology, 1981, Volume: 31, Issue:6 Topics: Benzimidazoles; Bromocriptine; Domperidone; Female; Humans; Levodopa; Male; Middle Aged; Nausea; Parkinson Disease; Piperidines; Vomiting	1981
Bromocriptine: low-dose therapy in Parkinson disease. Neurology, 1982, Volume: 32, Issue:6 Topics: Aged; Bromocriptine; Double-Blind Method; Dyskinesia, Drug-Induced; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Placebos; Tremor	1982
The effect of deprenyl and levodopa on the progression of Parkinson's disease. Annals of neurology, 1995, Volume: 38, Issue:5 Topics: Aged; Analysis of Variance; Antiparkinson Agents; Bromocriptine; Carbidopa; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Female; Humans; Least-Squares Analysis; Levodopa; Male; Parkinson Disease; Prospective Studies; Selegiline; Statistics, Nonparametric; Treatment Outcome	1995
A crossover, controlled study comparing pergolide with bromocriptine as an adjunct to levodopa for the treatment of Parkinson's disease. Neurology, 1995, Volume: 45, Issue:3 Suppl 3 Topics: Aged; Bromocriptine; Cross-Over Studies; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Levodopa; Middle Aged; Parkinson Disease; Pergolide	1995
Pergolide compared with bromocriptine in Parkinson's disease: a multicenter, crossover, controlled study. Movement disorders : official journal of the Movement Disorder Society, 1994, Volume: 9, Issue:4 Topics: Aged; Bromocriptine; Cross-Over Studies; Disability Evaluation; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Infant; Levodopa; Male; Middle Aged; Neurologic Examination; Parkinson Disease; Pergolide; Single-Blind Method; Treatment Outcome	1994
Naltrexone, an opiate antagonist, fails to modify motor symptoms in patients with Parkinson's disease. Movement disorders : official journal of the Movement Disorder Society, 1994, Volume: 9, Issue:4 Topics: Aged; Bromocriptine; Cross-Over Studies; Disability Evaluation; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Humans; Levodopa; Male; Middle Aged; Motor Skills; Naltrexone; Neurologic Examination; Parkinson Disease	1994
The Sydney Multicentre Study of Parkinson's disease: a randomised, prospective five year study comparing low dose bromocriptine with low dose levodopa-carbidopa. Journal of neurology, neurosurgery, and psychiatry, 1994, Volume: 57, Issue:8 Topics: Adult; Aged; Bromocriptine; Carbidopa; Double-Blind Method; Drug Combinations; Female; Follow-Up Studies; Humans; Levodopa; Male; Middle Aged; Movement Disorders; Parkinson Disease; Prevalence; Prospective Studies; Severity of Illness Index; Survival Analysis; Treatment Failure	1994
A randomised controlled study comparing bromocriptine to which levodopa was later added, with levodopa alone in previously untreated patients with Parkinson's disease: a five year follow up. Journal of neurology, neurosurgery, and psychiatry, 1994, Volume: 57, Issue:9 Topics: Bromocriptine; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Follow-Up Studies; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Pilot Projects; Prospective Studies	1994
Visual control of arm movement in Parkinson's disease. Movement disorders : official journal of the Movement Disorder Society, 1994, Volume: 9, Issue:1 Topics: Adult; Aged; Attention; Benserazide; Bromocriptine; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Motor Skills; Orientation; Parkinson Disease; Psychomotor Performance; Reaction Time; Selegiline	1994
Progress note on Japanese multicenter bromocriptine monotherapy. European neurology, 1993, Volume: 33 Suppl 1 Topics: Bromocriptine; Dose-Response Relationship, Drug; Follow-Up Studies; Humans; Japan; Levodopa; Long-Term Care; Neurologic Examination; Parkinson Disease	1993
Comparisons of therapeutic effects of levodopa, levodopa and selegiline, and bromocriptine in patients with early, mild Parkinson's disease: three year interim report. Parkinson's Disease Research Group in the United Kingdom. BMJ (Clinical research ed.), 1993, Aug-21, Volume: 307, Issue:6902 Topics: Adult; Aged; Aged, 80 and over; Bromocriptine; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Prospective Studies; Selegiline; Treatment Outcome	1993
Early combination therapy (bromocriptine and levodopa) does not prevent motor fluctuations in Parkinson's disease. Neurology, 1993, Volume: 43, Issue:1 Topics: Activities of Daily Living; Aged; Bromocriptine; Chorea; Double-Blind Method; Drug Therapy, Combination; Dystonia; Female; Humans; Levodopa; Male; Middle Aged; Motor Skills; Parkinson Disease	1993
[L-dopa and bromocriptine in Parkinson disease. Early combination therapy has better effect]. Lakartidningen, 1993, Apr-21, Volume: 90, Issue:16 Topics: Bromocriptine; Drug Therapy, Combination; Dystonia; Female; Humans; Hyperkinesis; Levodopa; Male; Motor Activity; Parkinson Disease; Time Factors	1993
Effect of age and disease duration on parkinsonian motor scores under levodopa therapy. Journal of neural transmission. Parkinson's disease and dementia section, 1995, Volume: 9, Issue:2-3 Topics: Adult; Aged; Aging; Antiparkinson Agents; Bromocriptine; Disease Progression; Female; Gait; Humans; Levodopa; Male; Middle Aged; Muscle Rigidity; Parkinson Disease; Psychomotor Performance; Tremor	1995
A "combined" levodopa test as a useful method for evaluating the efficacy of dopamine agonists: application to pergolide and bromocriptine. Movement disorders : official journal of the Movement Disorder Society, 1995, Volume: 10, Issue:5 Topics: Aged; Antiparkinson Agents; Bromocriptine; Dopamine Agonists; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Humans; Levodopa; Middle Aged; Parkinson Disease; Pergolide	1995
Comparison of therapeutic effects and mortality data of levodopa and levodopa combined with selegiline in patients with early, mild Parkinson's disease. Parkinson's Disease Research Group of the United Kingdom. BMJ (Clinical research ed.), 1995, Dec-16, Volume: 311, Issue:7020 Topics: Antiparkinson Agents; Benserazide; Bromocriptine; Cause of Death; Disability Evaluation; Drug Administration Schedule; Drug Therapy, Combination; Follow-Up Studies; Humans; Levodopa; Monoamine Oxidase Inhibitors; Parkinson Disease; Proportional Hazards Models; Prospective Studies; Selegiline; Time Factors; Treatment Failure	1995
L-deprenyl as an adjunct to low-dose bromocriptine in early Parkinson's disease: a short-term, double-blind, and prospective follow-up study. Clinical neuropharmacology, 1995, Volume: 18, Issue:3 Topics: Aged; Antiparkinson Agents; Bromocriptine; Chemotherapy, Adjuvant; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Parkinson Disease; Placebos; Prospective Studies; Selegiline	1995
Bromocriptine therapy in early-stage Parkinson's disease. European neurology, 1996, Volume: 36, Issue:3 Topics: Antiparkinson Agents; Bromocriptine; Disease Progression; Drug Therapy, Combination; Evaluation Studies as Topic; Follow-Up Studies; Humans; Levodopa; Neuroprotective Agents; Parkinson Disease; Time Factors; Treatment Outcome	1996
The response of "de novo" Parkinson's disease patients to bromocriptine in a "low and slow" regimen is predictive for prognosis. Journal of neural transmission. Supplementum, 1995, Volume: 45 Topics: Adult; Aged; Antiparkinson Agents; Bromocriptine; Dopamine Agonists; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Parkinson Disease; Predictive Value of Tests; Prognosis; Regression Analysis; Sensitivity and Specificity	1995
Age at onset: the major determinant of outcome in Parkinson's disease. Acta neurologica Scandinavica, 1995, Volume: 92, Issue:6 Topics: Adult; Age of Onset; Aged; Antiparkinson Agents; Bromocriptine; Dose-Response Relationship, Drug; Female; Humans; Levodopa; Male; Middle Aged; Movement Disorders; Parkinson Disease; Postural Balance; Treatment Outcome; Tremor	1995
Eight-year follow-up study of bromocriptine monotherapy for Parkinson's disease. European neurology, 1996, Volume: 36 Suppl 1 Topics: Aged; Antiparkinson Agents; Bromocriptine; Disease Progression; Dopamine Agonists; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Follow-Up Studies; Humans; Japan; Levodopa; Male; Middle Aged; Parkinson Disease	1996
Double-blind comparison of cabergoline and bromocriptine in Parkinson's disease patients with motor fluctuations. Neurology, 1996, Volume: 47, Issue:3 Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Bromocriptine; Cabergoline; Double-Blind Method; Ergolines; Female; Humans; Male; Middle Aged; Movement Disorders; Parkinson Disease	1996
Early institution of bromocriptine in Parkinson's disease inhibits the emergence of levodopa-associated motor side effects. Long-term results of the PRADO study. Journal of neural transmission (Vienna, Austria : 1996), 1996, Volume: 103, Issue:6 Topics: Aged; Antiparkinson Agents; Bromocriptine; Drug Combinations; Dyskinesia, Drug-Induced; Female; Humans; Incidence; Levodopa; Longitudinal Studies; Male; Middle Aged; Motor Neurons; Parkinson Disease; Prospective Studies; Time Factors	1996
Early combination of bromocriptine and levodopa in Parkinson's disease: a prospective randomized study of two parallel groups over a total follow-up period of 44 months including an initial 8-month double-blind stage. Clinical neuropharmacology, 1997, Volume: 20, Issue:1 Topics: Aged; Antiparkinson Agents; Bromocriptine; Dopamine Agonists; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Motor Activity; Movement Disorders; Parkinson Disease; Placebos; Prospective Studies	1997
Nine-year follow-up study of bromocriptine monotherapy for Parkinson's disease. European neurology, 1997, Volume: 38 Suppl 1 Topics: Aged; Antiparkinson Agents; Bromocriptine; Dyskinesia, Drug-Induced; Female; Follow-Up Studies; Humans; Levodopa; Male; Middle Aged; Parkinson Disease	1997
Tolcapone, bromocriptine, and Parkinson's disease. French Tolcapone Study Group. Lancet (London, England), 1997, Sep-06, Volume: 350, Issue:9079 Topics: Antiparkinson Agents; Benzophenones; Bromocriptine; Drug Therapy, Combination; Drug Tolerance; Humans; Levodopa; Nitrophenols; Parkinson Disease; Tolcapone	1997
Discontinuation of prolonged bromocriptine therapy in Parkinson's disease patients with uncontrolled motor oscillations. Clinical neuropharmacology, 1994, Volume: 17, Issue:5 Topics: Aged; Antiparkinson Agents; Bromocriptine; Dopamine Agonists; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Motor Activity; Parkinson Disease; Prospective Studies	1994
Double-blind comparison of pramipexole and bromocriptine treatment with placebo in advanced Parkinson's disease. International Pramipexole-Bromocriptine Study Group. Neurology, 1997, Volume: 49, Issue:4 Topics: Adult; Aged; Antiparkinson Agents; Benzothiazoles; Bromocriptine; Double-Blind Method; Female; Humans; Male; Middle Aged; Parkinson Disease; Placebos; Pramipexole; Quality of Life; Severity of Illness Index; Thiazoles; Treatment Outcome	1997
Nationwide multicenter prospective study on the long-term effects of bromocriptine for Parkinson's disease. Final report of a ten-year follow-up. European neurology, 1997, Volume: 38 Suppl 2 Topics: Aged; Antiparkinson Agents; Bromocriptine; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Japan; Levodopa; Long-Term Care; Male; Middle Aged; Neurologic Examination; Parkinson Disease	1997
Effect of chronic oral domperidone therapy on gastrointestinal symptoms and gastric emptying in patients with Parkinson's disease. Movement disorders : official journal of the Movement Disorder Society, 1997, Volume: 12, Issue:6 Topics: Aged; Antiparkinson Agents; Bromocriptine; Carbidopa; Domperidone; Dopamine Antagonists; Drug Therapy, Combination; Female; Follow-Up Studies; Gastric Emptying; Gastrointestinal Diseases; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Selegiline; Severity of Illness Index	1997
Ropinirole versus bromocriptine in the treatment of early Parkinson's disease: a 6-month interim report of a 3-year study. 053 Study Group. Movement disorders : official journal of the Movement Disorder Society, 1998, Volume: 13, Issue:1 Topics: Adult; Aged; Antiparkinson Agents; Bromocriptine; Confidence Intervals; Disease Progression; Dopamine Agonists; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Indoles; Longitudinal Studies; Male; Middle Aged; Odds Ratio; Parkinson Disease; Regression Analysis; Selegiline; Severity of Illness Index; Treatment Outcome	1998
Investigation by Parkinson's Disease Research Group of United Kingdom into excess mortality seen with combined levodopa and selegiline treatment in patients with early, mild Parkinson's disease: further results of randomised trial and confidential inquiry BMJ (Clinical research ed.), 1998, Apr-18, Volume: 316, Issue:7139 Topics: Antiparkinson Agents; Bromocriptine; Cause of Death; Disabled Persons; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Levodopa; Male; Parkinson Disease; Proportional Hazards Models; Selegiline; Survival Rate; Treatment Failure	1998
Is stereotactic surgical treatment still necessary for Parkinson's disease in the contemporary trend of medical therapy with dopamine receptor agonist? Stereotactic and functional neurosurgery, 1997, Volume: 69, Issue:1-4 Pt 2 Topics: Aged; Aged, 80 and over; Bromocriptine; Carbidopa; Dopamine Agonists; Drug Administration Schedule; Drug Therapy, Combination; Female; Globus Pallidus; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Pergolide; Stereotaxic Techniques; Treatment Outcome	1997
Efficacy and tolerability of tolcapone compared with bromocriptine in levodopa-treated parkinsonian patients. Tolcapone Study Group. Movement disorders : official journal of the Movement Disorder Society, 1999, Volume: 14, Issue:1 Topics: Aged; Antiparkinson Agents; Benzophenones; Bromocriptine; Catechol O-Methyltransferase Inhibitors; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Drug Tolerance; Female; Humans; Levodopa; Male; Middle Aged; Neurologic Examination; Nitrophenols; Parkinson Disease; Tolcapone; Treatment Outcome	1999
A 3-year randomized trial of ropinirole and bromocriptine in early Parkinson's disease. The 053 Study Group. Neurology, 1999, Jul-22, Volume: 53, Issue:2 Topics: Activities of Daily Living; Aged; Antiparkinson Agents; Bromocriptine; Double-Blind Method; Female; Humans; Indoles; Levodopa; Male; Middle Aged; Parkinson Disease; Time Factors	1999
Time course of loss of clinical benefit following withdrawal of levodopa/carbidopa and bromocriptine in early Parkinson' s disease. Movement disorders : official journal of the Movement Disorder Society, 2000, Volume: 15, Issue:3 Topics: Aged; Antiparkinson Agents; Bromocriptine; Carbidopa; Disability Evaluation; Disease Progression; Double-Blind Method; Female; Humans; Levodopa; Male; Middle Aged; Neurologic Examination; Parkinson Disease; Prospective Studies; Selegiline; Substance Withdrawal Syndrome	2000
Levodopa, bromocriptine and selegiline modify cardiovascular responses in Parkinson's disease. Journal of neurology, 2000, Volume: 247, Issue:11 Topics: Aged; Blood Pressure; Bromocriptine; Cardiovascular System; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Selegiline	2000
Long-term persistence of symptomatic effect of selegiline in Parkinson's disease. A two-months placebo-controlled withdrawal study. Journal of neural transmission (Vienna, Austria : 1996), 2001, Volume: 108, Issue:2 Topics: Aged; Antiparkinson Agents; Bromocriptine; Female; Humans; Male; Middle Aged; Motor Activity; Parkinson Disease; Selegiline; Severity of Illness Index; Single-Blind Method; Substance Withdrawal Syndrome	2001
Suppressed sympathetic skin response in Parkinson disease. Clinical autonomic research : official journal of the Clinical Autonomic Research Society, 2000, Volume: 10, Issue:6 Topics: Acoustic Stimulation; Aged; Antiparkinson Agents; Bromocriptine; Carbidopa; Electric Stimulation; Evoked Potentials; Evoked Potentials, Auditory; Female; Foot; Hand; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Reaction Time; Reference Values; Selegiline; Skin; Sympathetic Nervous System	2000
Long-term mortality results of the randomized controlled study comparing bromocriptine to which levodopa was later added with levodopa alone in previously untreated patients with Parkinson's disease. Movement disorders : official journal of the Movement Disorder Society, 2001, Volume: 16, Issue:3 Topics: Aged; Antiparkinson Agents; Bromocriptine; Drug Therapy, Combination; Female; Follow-Up Studies; France; Humans; Levodopa; Male; Middle Aged; Mortality; Parkinson Disease; Prospective Studies; Treatment Outcome	2001
Ten-year follow-up of three different initial treatments in de-novo PD: a randomized trial. Neurology, 2001, Nov-13, Volume: 57, Issue:9 Topics: Antiparkinson Agents; Aromatic Amino Acid Decarboxylase Inhibitors; Bromocriptine; Disability Evaluation; Dyskinesia, Drug-Induced; Female; Follow-Up Studies; Humans; Incidence; Levodopa; Male; Parkinson Disease; Selegiline; Treatment Outcome	2001
A six-month multicentre, double-blind, bromocriptine-controlled study of the safety and efficacy of ropinirole in the treatment of patients with Parkinson's disease not optimally controlled by L-dopa. Journal of neural transmission (Vienna, Austria : 1996), 2002, Volume: 109, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Antiparkinson Agents; Bromocriptine; Double-Blind Method; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Hallucinations; Humans; Indoles; Levodopa; Logistic Models; Male; Middle Aged; Odds Ratio; Parkinson Disease	2002
Ropinirole for the treatment of tremor in early Parkinson's disease. European journal of neurology, 2002, Volume: 9, Issue:3 Topics: Aged; Antiparkinson Agents; Bromocriptine; Double-Blind Method; Female; Humans; Indoles; Levodopa; Male; Middle Aged; Parkinson Disease; Treatment Outcome; Tremor	2002
Budipine provides additional benefit in patients with Parkinson disease receiving a stable optimum dopaminergic drug regimen. Archives of neurology, 2002, Volume: 59, Issue:5 Topics: Adult; Aged; Antiparkinson Agents; Bromocriptine; Dopamine Agents; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Piperidines; Treatment Outcome	2002
Editorial: Bromocriptine. Lancet (London, England), 1975, May-10, Volume: 1, Issue:7915 Topics: Acromegaly; Bromocriptine; Clinical Trials as Topic; Ergolines; Female; Galactorrhea; Humans; Lactation; Parkinson Disease; Pregnancy	1975
Letter: Bromocriptine in parkinsonism. Lancet (London, England), 1975, Oct-11, Volume: 2, Issue:7937 Topics: Bromocriptine; Clinical Trials as Topic; Drug Evaluation; Ergolines; Humans; Parkinson Disease	1975
Letter: Bromocriptine in parkinsonism. Lancet (London, England), 1975, Nov-15, Volume: 2, Issue:7942 Topics: Bromocriptine; Drug Evaluation; Ergolines; Humans; Levodopa; Parkinson Disease	1975
Bromocriptine and levodopa (with or without carbidopa) in parkinsonism. Lancet (London, England), 1976, Aug-07, Volume: 2, Issue:7980 Topics: Aged; Bromocriptine; Carbidopa; Clinical Trials as Topic; Disability Evaluation; Dose-Response Relationship, Drug; Drug Combinations; Drug Evaluation; Ergolines; Female; Follow-Up Studies; Humans; Hydrazines; Levodopa; Male; Middle Aged; Parkinson Disease; Placebos; Time Factors	1976
Bromocriptine in Parkinson's disease. Lancet (London, England), 1978, Sep-09, Volume: 2, Issue:8089 Topics: Antiparkinson Agents; Bromocriptine; Clinical Trials as Topic; Drug Therapy, Combination; Humans; Levodopa; Parasympatholytics; Parkinson Disease; Piperidines; Thioxanthenes; Trihexyphenidyl	1978
Bromocriptine associated with a peripheral dopamine blocking agent in treatment of Parkinson's disease. Lancet (London, England), 1979, Mar-17, Volume: 1, Issue:8116 Topics: Adult; Antiparkinson Agents; Benzimidazoles; Bromocriptine; Clinical Trials as Topic; Disability Evaluation; Dopamine Antagonists; Double-Blind Method; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Parkinson Disease; Piperidines; Placebos; Receptors, Dopamine	1979
Lisuride in Parkinson's disease. Lancet (London, England), 1979, Nov-24, Volume: 2, Issue:8152 Topics: Administration, Oral; Antiparkinson Agents; Bromocriptine; Clinical Trials as Topic; Drug Therapy, Combination; Ergolines; Humans; Lisuride; Parkinson Disease	1979
Studies with bromocriptine: III. Concomitant administration of caffeine to patients with idiopathic parkinsonism. Neurology, 1976, Volume: 26, Issue:8 Topics: Bromocriptine; Caffeine; Clinical Trials as Topic; Drug Synergism; Drug Therapy, Combination; Ergolines; Female; Humans; Male; Middle Aged; Parkinson Disease; Phosphodiesterase Inhibitors	1976
An ergot derivative in the treatment of Parkinson's disease. Postgraduate medical journal, 1976, Volume: 52suppl 1 Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Bromocriptine; Clinical Trials as Topic; Ergolines; Humans; Levodopa; Parkinson Disease	1976
Comparison of the effects of bromocriptine and levodopa in Parkinson's disease. Journal of neurology, neurosurgery, and psychiatry, 1977, Volume: 40, Issue:5 Topics: Aged; Bromocriptine; Clinical Trials as Topic; Drug Evaluation; Ergolines; Humans; Individuality; Levodopa; Male; Middle Aged; Parkinson Disease	1977
Bromocriptine versus placebo in levodopa treated patients with Parkinson's disease. Acta neurologica Scandinavica, 1977, Volume: 56, Issue:3 Topics: Aged; Bromocriptine; Clinical Trials as Topic; Double-Blind Method; Drug Evaluation; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Placebos	1977
Bromocriptine in the treatment of advanced Parkinsonism. Acta neurologica Scandinavica, 1977, Volume: 56, Issue:3 Topics: Aged; Bromocriptine; Clinical Trials as Topic; Double-Blind Method; Drug Evaluation; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Placebos	1977
Treatment of Parkinson's disease with lergotrile mesylate. JAMA, 1977, Nov-28, Volume: 238, Issue:22 Topics: Acetonitriles; Antiparkinson Agents; Bromocriptine; Carbidopa; Carboxy-Lyases; Clinical Trials as Topic; Drug Evaluation; Drug Therapy, Combination; Ergolines; Ergot Alkaloids; Female; Humans; Hypotension, Orthostatic; Levodopa; Male; Parkinson Disease	1977
Bromocryptine in levodopa response-losing parkinsonism. A double blind study. European neurology, 1978, Volume: 17, Issue:2 Topics: Bromocriptine; Clinical Trials as Topic; Double-Blind Method; Drug Evaluation; Drug Therapy, Combination; Drug Tolerance; Humans; Levodopa; Parkinson Disease; Placebos; Psychiatric Status Rating Scales	1978
Restatement and prospectives of ergot alkaloids in clinical neurology and psychiatry. Pharmacology, 1978, Volume: 16 Suppl 1 Topics: Aged; Amantadine; Basal Ganglia Diseases; Bromocriptine; Chorea; Clinical Trials as Topic; Depression; Drug Evaluation; Humans; Levodopa; Parkinson Disease; Tranquilizing Agents	1978
Plasma bromocriptine levels, clinical and growth hormone responses in Parkinsonism. British journal of clinical pharmacology, 1978, Volume: 6, Issue:4 Topics: Aged; Blood Pressure; Bromocriptine; Clinical Trials as Topic; Female; Growth Hormone; Humans; Male; Metoclopramide; Middle Aged; Nausea; Parkinson Disease; Time Factors; Vomiting	1978
Treatment of the on-off syndrome in Parkinsonism with low dose bromocriptine in combination with levodopa. Journal of neurology, neurosurgery, and psychiatry, 1978, Volume: 41, Issue:12 Topics: Antiparkinson Agents; Bromocriptine; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Humans; Levodopa; Parkinson Disease; Syndrome	1978
A double-blind trial of bromocriptine in Parkinson's disease. The Medical journal of Australia, 1978, Nov-04, Volume: 2, Issue:3 Suppl Topics: Bromocriptine; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Humans; Levodopa; Parkinson Disease	1978
An evaluation of bromocriptine in the treatment of Parkinson's disease. Clinical and experimental neurology, 1978, Volume: 15 Topics: Aged; Bromocriptine; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Hallucinations; Humans; Levodopa; Male; Middle Aged; Nausea; Parkinson Disease	1978
Effect of CB 154 (2-bromo-alpha-ergocryptine) on paralysis agitans compared with Madopar in a double-blind, cross-over trial. Acta neurologica Scandinavica, 1976, Volume: 53, Issue:3 Topics: Aged; Azides; Benserazide; Bromocriptine; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Combinations; Ergolines; Female; Humans; Hydrazines; Hyperkinesis; Levodopa; Male; Middle Aged; Nausea; Parkinson Disease; Psychoses, Substance-Induced	1976
Studies with bromocriptine. Part 2. Double-blind comparison with levodopa in idiopathic parkinsonism. Neurology, 1976, Volume: 26, Issue:6 PT 1 Topics: Aged; Bromocriptine; Clinical Trials as Topic; Drug Evaluation; Ergolines; Female; Humans; Levodopa; Male; Middle Aged; Muscle Rigidity; Parkinson Disease; Tremor	1976
[Clinical experience with bromocriptine, a central dopaminergic stimulator]. Der Nervenarzt, 1976, Volume: 47, Issue:11 Topics: Aged; Amantadine; Bromocriptine; Chemical Phenomena; Chemistry; Clinical Trials as Topic; Dose-Response Relationship, Drug; Ergolines; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Placebos; Trihexyphenidyl	1976
Dopaminergic agonists in Parkinsonism. Advances in neurology, 1975, Volume: 9 Topics: Aged; Bromocriptine; Clinical Trials as Topic; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Placebos	1975
The evolution of dementia in idiopathic Parkinson's disease: neuropsychological and clinical evidence in support of subtypes. International psychogeriatrics, 1992, Volume: 4 Suppl 2 Topics: Age Factors; Aged; Bromocriptine; Carbidopa; Dementia; Drug Therapy, Combination; Female; Humans; Levodopa; Longitudinal Studies; Male; Middle Aged; Neurologic Examination; Neuropsychological Tests; Parkinson Disease	1992
Primary combination therapy of early Parkinson's disease. A long-term comparison between the combined regimen bromocriptine/levodopa and levodopa monotherapy--first interim report. European neurology, 1992, Volume: 32 Suppl 1 Topics: Benserazide; Bromocriptine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Levodopa; Long-Term Care; Motor Skills; Neurologic Examination; Parkinson Disease; Prospective Studies; Psychomotor Performance	1992
Nation-wide collaborative study on the long-term effects of bromocriptine in the treatment of parkinsonian patients: analysis on the maintenance and the change of the original mode of treatment. European neurology, 1992, Volume: 32 Suppl 1 Topics: Activities of Daily Living; Adult; Aged; Bromocriptine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Gait; Humans; Levodopa; Long-Term Care; Male; Middle Aged; Neurologic Examination; Parkinson Disease	1992
Nation-wide collaborative study on the long-term effects of bromocriptine in the treatment of parkinsonian patients. Final report. European neurology, 1992, Volume: 32 Suppl 1 Topics: Activities of Daily Living; Adult; Aged; Bromocriptine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Gait; Humans; Levodopa; Long-Term Care; Male; Middle Aged; Neurologic Examination; Parkinson Disease; Prospective Studies	1992
Bromocriptine lessens the incidence of mortality in L-dopa-treated parkinsonian patients: prado-study discontinued. European journal of clinical pharmacology, 1992, Volume: 43, Issue:4 Topics: Aged; Aged, 80 and over; Bromocriptine; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Prospective Studies; Psychomotor Performance	1992
Comparison of lisuride and bromocriptine in the treatment of advanced Parkinson's disease. Acta neurologica Scandinavica, 1992, Volume: 86, Issue:6 Topics: Aged; Bromocriptine; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Levodopa; Lisuride; Male; Middle Aged; Neurologic Examination; Parkinson Disease	1992
Different effects of dopaminergic and anticholinergic therapies on cognitive and motor function in Parkinson's disease. A follow-up study of untreated patients. Brain : a journal of neurology, 1992, Volume: 115 ( Pt 6) Topics: Adult; Aged; Bromocriptine; Cognition Disorders; Female; Follow-Up Studies; Frontal Lobe; Humans; Levodopa; Male; Memory Disorders; Middle Aged; Motor Activity; Movement; Parasympatholytics; Parkinson Disease; Psychomotor Performance; Visual Perception	1992
Parlodel SRO in Parkinson's disease: a double-blind randomized comparison of Parlodel standard and Parlodel SRO. European neurology, 1992, Volume: 32, Issue:6 Topics: Administration, Oral; Aged; Bromocriptine; Delayed-Action Preparations; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Neurologic Examination; Parkinson Disease	1992
Effects of a selective partial D1 agonist, CY 208-243, in de novo patients with Parkinson disease. Movement disorders : official journal of the Movement Disorder Society, 1992, Volume: 7, Issue:3 Topics: Adult; Aged; Antiparkinson Agents; Bromocriptine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Indoles; Male; Middle Aged; Neurologic Examination; Parkinson Disease; Phenanthridines; Receptors, Dopamine; Receptors, Dopamine D1	1992
Comparison of three regimens of Parlodel-SRO in levodopa-treated parkinsonians: a randomized double-blind crossover study. International journal of clinical pharmacology, therapy, and toxicology, 1991, Volume: 29, Issue:8 Topics: Adult; Aged; Aged, 80 and over; Behavior; Bromocriptine; Delayed-Action Preparations; Double-Blind Method; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease	1991
A nationwide collaborative study on the long-term effects of bromocriptine in patients with Parkinson's disease. The fourth interim report. European neurology, 1991, Volume: 31 Suppl 1 Topics: Bromocriptine; Dose-Response Relationship, Drug; Drug Administration Schedule; Follow-Up Studies; Humans; Levodopa; Long-Term Care; Motor Skills; Neurologic Examination; Parkinson Disease	1991
A multi-center, double-blind study on slow-release bromocriptine in the treatment of Parkinson's disease. Neurology, 1991, Volume: 41, Issue:10 Topics: Aged; Bromocriptine; Delayed-Action Preparations; Double-Blind Method; Drug Evaluation; Humans; Middle Aged; Parkinson Disease	1991
Simplification of the initiation of bromocriptine in elderly patients with advanced Parkinson's disease. Age and ageing, 1991, Volume: 20, Issue:2 Topics: Aged; Aged, 80 and over; Bromocriptine; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease	1991
Randomized double-blind trial of injectable heptaminol for controlling spontaneous or bromocriptine-induced orthostatic hypotension in parkinsonians. Fundamental & clinical pharmacology, 1990, Volume: 4, Issue:6 Topics: Blood Pressure; Bromocriptine; Double-Blind Method; Female; Heart Rate; Heptaminol; Humans; Hypotension, Orthostatic; Injections, Intravenous; Male; Middle Aged; Parkinson Disease; Renin	1990
Third interim report of the nationwide collaborative study on the long-term effects of bromocriptine in the treatment of parkinsonian patients. European neurology, 1990, Volume: 30 Suppl 1 Topics: Adult; Aged; Aged, 80 and over; Bromocriptine; Drug Evaluation; Drug Therapy, Combination; Humans; Japan; Levodopa; Middle Aged; Multicenter Studies as Topic; Parkinson Disease	1990
Bromocriptine as initial therapy in elderly parkinsonian patients. The Bromocriptine Multicentre Trial Group. Age and ageing, 1990, Volume: 19, Issue:1 Topics: Aged; Aged, 80 and over; Bromocriptine; Double-Blind Method; Drug Evaluation; Female; Humans; Male; Middle Aged; Multicenter Studies as Topic; Parkinson Disease	1990
[Comparison of bromocriptine and levodopa as first line treatment of Parkinson's disease: results of a 3-year prospective randomized study]. Revue neurologique, 1990, Volume: 146, Issue:2 Topics: Bromocriptine; Dose-Response Relationship, Drug; Drug Evaluation; Dyskinesia, Drug-Induced; Female; Humans; Levodopa; Male; Mental Disorders; Middle Aged; Parkinson Disease; Prospective Studies; Psychomotor Disorders; Randomized Controlled Trials as Topic	1990
Bromocriptine and levodopa in early combination in Parkinson's disease: first results of the Collaborative European Multicentric Trial. Advances in neurology, 1990, Volume: 53 Topics: Bromocriptine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Europe; Female; Humans; Levodopa; Male; Middle Aged; Motor Skills; Neurologic Examination; Parkinson Disease	1990
Adjunctive therapy with bromocriptine in Parkinson's disease. South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 1990, Dec-01, Volume: 78, Issue:11 Topics: Adult; Aged; Bromocriptine; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Time Factors	1990
The effect of dietary protein on the efficacy of L-dopa: a double-blind study. Neurology, 1989, Volume: 39, Issue:4 Topics: Antiparkinson Agents; Bromocriptine; Carbidopa; Clinical Trials as Topic; Dietary Proteins; Double-Blind Method; Drug Combinations; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Random Allocation; Selegiline	1989
The Sydney Multicentre Study of Parkinson's disease: a report on the first 3 years. Journal of neurology, neurosurgery, and psychiatry, 1989, Volume: 52, Issue:3 Topics: Adult; Aged; Bromocriptine; Carbidopa; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Random Allocation	1989
Bromocriptine in Parkinson's disease: a double-blind study comparing "low-slow" and "high-fast" introductory dosage regimens in de novo patients. UK Bromocriptine Research Group. Journal of neurology, neurosurgery, and psychiatry, 1989, Volume: 52, Issue:1 Topics: Bromocriptine; Clinical Trials as Topic; Disability Evaluation; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Motor Skills; Parkinson Disease; Random Allocation	1989
A randomised controlled study of bromocriptine versus levodopa in previously untreated Parkinsonian patients: a 3 year follow-up. Journal of neurology, neurosurgery, and psychiatry, 1989, Volume: 52, Issue:6 Topics: Bromocriptine; Clinical Trials as Topic; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Levodopa; Male; Middle Aged; Motor Skills; Parkinson Disease; Random Allocation	1989
The addition of bromocriptine to long-term dopa therapy in Parkinson's disease. Clinical and experimental neurology, 1989, Volume: 26 Topics: Adult; Aged; Aged, 80 and over; Bromocriptine; Clinical Trials as Topic; Drug Therapy, Combination; Gait; Humans; Levodopa; Middle Aged; Parkinson Disease	1989
Long term bromocriptine treatment in de novo parkinsonian patients. Medicina, 1988, Volume: 48, Issue:4 Topics: Adult; Aged; Bromocriptine; Carbidopa; Clinical Trials as Topic; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Random Allocation	1988
[Parlodel: a new therapeutic possibility in the management of Parkinson disease]. Orvosi hetilap, 1988, Feb-21, Volume: 129, Issue:8 Topics: Adult; Aged; Bromocriptine; Clinical Trials as Topic; Drug Evaluation; Female; Humans; Hungary; Male; Middle Aged; Parkinson Disease	1988
A double-blind study of bromocriptine and L-dopa in de novo Parkinson's disease. Short-term results. European neurology, 1988, Volume: 28 Suppl 1 Topics: Aged; Bromocriptine; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Levodopa; Male; Parkinson Disease; Random Allocation	1988
A progress report on the New Zealand Multicentre Parkinson's disease trial. A comparison of low-dose treatment with bromocriptine or L-dopa. European neurology, 1988, Volume: 28 Suppl 1 Topics: Bromocriptine; Clinical Trials as Topic; Humans; Levodopa; Parkinson Disease; Prospective Studies	1988
Parkinson's disease: an open label trial of pergolide in patients failing bromocriptine therapy. Journal of neurology, neurosurgery, and psychiatry, 1988, Volume: 51, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Bromocriptine; Clinical Trials as Topic; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Parkinson Disease; Pergolide	1988
A comparison of bromocriptine (Parlodel) and levodopa-carbidopa (Sinemet) for treatment of "de novo" Parkinson's disease patients. The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques, 1987, Volume: 14, Issue:4 Topics: Antiparkinson Agents; Bromocriptine; Carbidopa; Clinical Trials as Topic; Double-Blind Method; Drug Combinations; Follow-Up Studies; Humans; Levodopa; Neurologic Examination; Parkinson Disease	1987
Low-dose bromocriptine in the early phases of Parkinson's disease. Clinical neuropharmacology, 1987, Volume: 10, Issue:2 Topics: Adult; Aged; Bromocriptine; Clinical Trials as Topic; Drug Administration Schedule; Drug Evaluation; Female; Humans; Male; Middle Aged; Parkinson Disease; Time Factors	1987
A nation-wide collaborative study on the long-term effects of bromocriptine in patients with Parkinson's disease. First interim report in Japan. European neurology, 1988, Volume: 28 Suppl 1 Topics: Adult; Aged; Bromocriptine; Drug Therapy, Combination; Humans; Levodopa; Middle Aged; Parkinson Disease; Prospective Studies	1988
Low-dose bromocriptine therapy in Parkinson's disease: double-blind, placebo-controlled study. Neurology, 1986, Volume: 36, Issue:2 Topics: Adult; Aged; Bromocriptine; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Male; Middle Aged; Muscle Rigidity; Parkinson Disease; Random Allocation; Tremor	1986
Patients sought for New Zealand multi-centre Parkinson's disease trial. The New Zealand medical journal, 1987, Jan-28, Volume: 100, Issue:816 Topics: Bromocriptine; Clinical Trials as Topic; Humans; Levodopa; New Zealand; Parkinson Disease	1987
Bromocriptine in the treatment of Parkinson's disease: a double-blind study against L-dopa/carbidopa. Advances in neurology, 1987, Volume: 45 Topics: Aged; Bromocriptine; Carbidopa; Clinical Trials as Topic; Double-Blind Method; Drug Combinations; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Random Allocation	1987
Treatment of early morning akinesia with low-dose bromocriptine. Advances in neurology, 1987, Volume: 45 Topics: Aged; Aged, 80 and over; Bromocriptine; Clinical Trials as Topic; Disability Evaluation; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Motor Skills; Parkinson Disease	1987
The Sydney multicentre study of Parkinson's disease. The first 18 months. The Medical journal of Australia, 1987, Feb-16, Volume: 146, Issue:4 Topics: Australia; Bromocriptine; Carbidopa; Clinical Trials as Topic; Double-Blind Method; Drug Combinations; Humans; Levodopa; Parkinson Disease	1987
Bromocriptine and the clinical spectrum of Parkinson's disease. The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques, 1987, Volume: 14, Issue:3 Suppl Topics: Aged; Bromocriptine; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Time Factors	1987
Parkinson's disease: a comparison of mesulergine and bromocriptine. Neurology, 1985, Volume: 35, Issue:8 Topics: Adult; Aged; Bromocriptine; Clinical Trials as Topic; Ergolines; Female; Humans; Male; Middle Aged; Movement; Nervous System; Parkinson Disease	1985
Effects of bromocriptine on parkinsonism. A nation-wide collaborative double-blind study. Acta neurologica Scandinavica, 1985, Volume: 72, Issue:2 Topics: Bromocriptine; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Male; Middle Aged; Parkinson Disease; Parkinson Disease, Secondary	1985
Low dosages of bromocriptine added to levodopa in Parkinson's disease. Neurology, 1985, Volume: 35, Issue:2 Topics: Adult; Aged; Bromocriptine; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Neurologic Examination; Parkinson Disease	1985
Low-dose bromocriptine therapy in Parkinson's disease. Archives of neurology, 1985, Volume: 42, Issue:6 Topics: Aged; Bromocriptine; Humans; Middle Aged; Parkinson Disease	1985
Mesulergine and bromocriptine in long-term treatment of advanced parkinsonism. Journal of neural transmission, 1985, Volume: 64, Issue:1 Topics: Adult; Aged; Blood Pressure; Bromocriptine; Drug Administration Schedule; Ergolines; Female; Heart Rate; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Time Factors	1985

Other Studies

388 other study(ies) available for bromocriptine and Idiopathic Parkinson Disease

Article	Year
Troponoids. 6. Troponylpiperazines: a new class of dopamine agonists. Journal of medicinal chemistry, 1984, Volume: 27, Issue:7 Topics: Animals; Bromocriptine; Cycloheptanes; Disease Models, Animal; Hydroxydopamines; Male; Oxidopamine; Parkinson Disease; Piperazines; Rats; Rats, Inbred Strains; Receptors, Dopamine; Structure-Activity Relationship; Tropolone	1984
Amelioration of oxidative stress utilizing nanoemulsion loaded with bromocriptine and glutathione for the management of Parkinson's disease. International journal of pharmaceutics, 2022, Apr-25, Volume: 618 Topics: Animals; Antioxidants; Bromocriptine; Catalase; Emulsions; Glutathione; Oxidative Stress; Parkinson Disease; Rats; Rats, Wistar; Superoxide Dismutase; Thiobarbituric Acid Reactive Substances	2022
CCRD based development of bromocriptine and glutathione nanoemulsion tailored ultrasonically for the combined anti-parkinson effect. Chemistry and physics of lipids, 2021, Volume: 235 Topics: Animals; Behavior, Animal; Bromocriptine; Cell Line, Tumor; Cell Survival; Drug Development; Emulsions; Glutathione; Goats; Humans; Hydrogen-Ion Concentration; Nanoparticles; Neuroprotective Agents; Parkinson Disease; Particle Size; Rats; Rats, Wistar	2021
Multiple valvular regurgitation associated with bromocriptine therapy. Archives of cardiovascular diseases, 2014, Volume: 107, Issue:10 Topics: Aged; Aortic Valve Insufficiency; Bromocriptine; Dopamine Agonists; Echocardiography, Doppler, Color; Humans; Male; Mitral Valve Insufficiency; Parkinson Disease	2014
An exploratory evaluation of tyrosine hydroxylase inhibition in planaria as a model for parkinsonism. International journal of molecular sciences, 2013, Nov-26, Volume: 14, Issue:12 Topics: Animals; Bromocriptine; Humans; Light; Locomotion; Models, Animal; Monoiodotyrosine; Parkinson Disease; Planarians; Protein Binding; Receptors, Dopamine; Tyrosine 3-Monooxygenase	2013
Occlusal treatment with bite splint improves dyskinesia in Parkinson's disease patient: a case report. The Bulletin of Tokyo Dental College, 2013, Volume: 54, Issue:3 Topics: Activities of Daily Living; Antiparkinson Agents; Bromocriptine; Cabergoline; Clonidine; Dyskinesias; Ergolines; Female; Hand Strength; Humans; Levodopa; Middle Aged; Motor Skills; Occlusal Splints; Parkinson Disease; Posture	2013
Optimised nanoformulation of bromocriptine for direct nose-to-brain delivery: biodistribution, pharmacokinetic and dopamine estimation by ultra-HPLC/mass spectrometry method. Expert opinion on drug delivery, 2014, Volume: 11, Issue:6 Topics: Administration, Intranasal; Animals; Antiparkinson Agents; Biological Availability; Biological Transport; Blood-Brain Barrier; Brain; Bromocriptine; Chitosan; Chromatography, High Pressure Liquid; Disease Models, Animal; Dopamine; Drug Delivery Systems; Female; Male; Mass Spectrometry; Mice; Nanoparticles; Nasal Mucosa; Parkinson Disease; Radiopharmaceuticals; Sodium Pertechnetate Tc 99m; Tissue Distribution	2014
Effect of bromocriptine alginate nanocomposite (BANC) on a transgenic Drosophila model of Parkinson's disease. Disease models & mechanisms, 2016, Volume: 9, Issue:1 Topics: Alginates; Animals; Animals, Genetically Modified; Brain; Bromocriptine; Crosses, Genetic; Disease Models, Animal; Dose-Response Relationship, Drug; Drosophila melanogaster; Female; Glutathione; Glutathione Transferase; Lipid Peroxidation; Male; Nanocomposites; Parkinson Disease; Permeability; Solubility; Spectrophotometry, Ultraviolet; Spectroscopy, Fourier Transform Infrared	2016
Neuromolecular imaging, a nanobiotechnology for Parkinson's disease: advancing pharmacotherapy for personalized medicine. Journal of neural transmission (Vienna, Austria : 1996), 2017, Volume: 124, Issue:1 Topics: Animals; Antiparkinson Agents; Biosensing Techniques; Bromocriptine; Catecholamines; Dopamine Agonists; Dopaminergic Neurons; Equipment Design; Levodopa; Mice; Molecular Imaging; Nanotechnology; Neuroimaging; Parkinson Disease; Precision Medicine; Substantia Nigra	2017
Bromocriptine use and the risk of valvular heart disease. Movement disorders : official journal of the Movement Disorder Society, 2009, Feb-15, Volume: 24, Issue:3 Topics: Aged; Aortic Valve Insufficiency; Bromocriptine; Dopamine Agonists; Dose-Response Relationship, Drug; Echocardiography, Doppler; Female; Heart Valve Diseases; Humans; Male; Mitral Valve Insufficiency; Parkinson Disease; Receptor, Serotonin, 5-HT2B; Risk Factors; Severity of Illness Index; Tricuspid Valve Insufficiency	2009
High risk factors for valvular heart disease from dopamine agonists in patients with Parkinson's disease. Journal of neural transmission (Vienna, Austria : 1996), 2009, Volume: 116, Issue:2 Topics: Age Factors; Aged; Benzothiazoles; Bromocriptine; Cabergoline; Case-Control Studies; Dopamine Agonists; Echocardiography; Ergolines; Female; Heart Valve Diseases; Humans; Hypertension; Male; Parkinson Disease; Pergolide; Pramipexole; Risk Factors	2009
Protective effect of bromocriptine against BH4-induced Cath.a cell death involving up-regulation of antioxidant enzymes. Neuroscience letters, 2009, Feb-27, Volume: 451, Issue:3 Topics: Animals; Antioxidants; Biopterins; Bromocriptine; Cell Death; Cell Line; Cytochromes c; Dopamine; Dopamine Agonists; Enzymes; L-Lactate Dehydrogenase; Mice; Neurons; Neuroprotective Agents; NF-E2-Related Factor 2; Oxidative Stress; Parkinson Disease; Phosphatidylinositol 3-Kinases; Receptors, Dopamine; Signal Transduction; Up-Regulation	2009
Dopamine agonists, Dopplers and doubt: cabergoline-associated cardiac valvulopathy. Internal medicine journal, 2009, Volume: 39, Issue:4 Topics: Antiparkinson Agents; Bromocriptine; Cabergoline; Case-Control Studies; Cross-Sectional Studies; Dopamine Agonists; Ergolines; Female; Heart Valve Diseases; Humans; Hyperprolactinemia; Male; Parkinson Disease; Pergolide; Prolactin; Serotonin 5-HT2 Receptor Agonists; Ultrasonography	2009
Agonist or levodopa for Parkinson disease? Ultimately, it doesn't matter; neither is good enough. Neurology, 2009, Jun-16, Volume: 72, Issue:24 Topics: Bromocriptine; Dopamine Agents; Dopamine Agonists; Dyskinesia, Drug-Induced; Follow-Up Studies; Humans; Indoles; Levodopa; Parkinson Disease; Practice Patterns, Physicians'; Prevalence; Randomized Controlled Trials as Topic; Time; Treatment Outcome	2009
Role of two efflux proteins, ABCB1 and ABCG2 in blood-brain barrier transport of bromocriptine in a murine model of MPTP-induced dopaminergic degeneration. Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques, 2009, Volume: 12, Issue:2 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Antiparkinson Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Blood-Brain Barrier; Blotting, Western; Brain; Bromocriptine; Disease Models, Animal; Gene Expression Regulation; Injections, Intraperitoneal; Male; Mice; Mice, Inbred C57BL; MPTP Poisoning; Parkinson Disease; Tissue Distribution	2009
[General anaesthesia for neurological diseases]. Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS, 2010, Volume: 45, Issue:5 Topics: Anesthesia, General; Anesthetics, Inhalation; Anesthetics, Intravenous; Autonomic Nervous System; Brain; Bromocriptine; Dopamine Agonists; Humans; Intubation; Levodopa; Monoamine Oxidase Inhibitors; Muscle Relaxants, Central; Nervous System Diseases; Neurodegenerative Diseases; Neurosurgery; Parkinson Disease; Piperidines; Premedication; Preoperative Care; Propofol; Remifentanil; Selegiline; Stereotaxic Techniques; Syndrome	2010
The history of ergot of rye (Claviceps purpurea) III: 1940-80. The journal of the Royal College of Physicians of Edinburgh, 2010, Volume: 40, Issue:1 Topics: Bromocriptine; Claviceps; Dihydroergocryptine; Ergot Alkaloids; History, 20th Century; Humans; Lysergic Acid Diethylamide; Parkinson Disease; Prolactinoma; Receptors, Dopamine; Schizophrenia; Scotland; Secale	2010
Dementia in Parkinson's disease: a 20-year neuropsychological study (Sydney Multicentre Study). Journal of neurology, neurosurgery, and psychiatry, 2011, Volume: 82, Issue:9 Topics: Age Factors; Age of Onset; Aged; Antiparkinson Agents; Bromocriptine; Cognition; Cohort Studies; Dementia; Disease Progression; Female; Humans; Levodopa; Longitudinal Studies; Male; Memory; Middle Aged; Neurologic Examination; Neuropsychological Tests; New South Wales; Parkinson Disease; Survival Analysis	2011
Bromocriptine use and myocardial function. Movement disorders : official journal of the Movement Disorder Society, 2011, Volume: 26, Issue:5 Topics: Bromocriptine; Dopamine Agonists; Echocardiography; Follow-Up Studies; Heart; Humans; Myocardial Infarction; Parkinson Disease; Ultrasonography	2011
Impulse control disorders in Chinese Parkinson's disease patients: the effect of ergot derived dopamine agonist. Parkinsonism & related disorders, 2011, Volume: 17, Issue:8 Topics: Aged; Antiparkinson Agents; Asian People; Bromocriptine; China; Cross-Sectional Studies; Disruptive, Impulse Control, and Conduct Disorders; Dopamine Agonists; Drug Therapy, Combination; Ergot Alkaloids; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Prospective Studies	2011
Bromocriptine and dopamine receptor stimulation. British journal of clinical pharmacology, 1976, Volume: 3, Issue:6 Topics: Aged; Blood Pressure; Bromocriptine; Dopamine Agonists; Female; Human Growth Hormone; Humans; Male; Middle Aged; Parkinson Disease; Receptors, Dopamine	1976
Some consequences of assuming simple patterns for the treatment effect over time in a linear mixed model. Statistics in medicine, 2013, Jul-10, Volume: 32, Issue:15 Topics: Activities of Daily Living; Antiparkinson Agents; Biostatistics; Bromocriptine; Clinical Trials as Topic; Data Interpretation, Statistical; Humans; Indoles; Linear Models; Models, Statistical; Parkinson Disease; Randomized Controlled Trials as Topic	2013
Bromocriptine loaded chitosan nanoparticles intended for direct nose to brain delivery: pharmacodynamic, pharmacokinetic and scintigraphy study in mice model. European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 2013, Feb-14, Volume: 48, Issue:3 Topics: Administration, Intranasal; Animals; Antiparkinson Agents; Behavior, Animal; Blood-Brain Barrier; Brain; Bromocriptine; Catalepsy; Chitosan; Disease Models, Animal; Drug Compounding; Drug Delivery Systems; Hypokinesia; Injections, Intravenous; Male; Mice; Nanoparticles; Neurons; Parkinson Disease; Radionuclide Imaging; Random Allocation; Sodium Pertechnetate Tc 99m; Tissue Distribution	2013
Neuroleptic malignant-like syndrome after rapid switch from bromocriptine to pergolide. Parkinsonism & related disorders, 2002, Volume: 9, Issue:2 Topics: Bromocriptine; Dopamine Agonists; Humans; Male; Middle Aged; Neuroleptic Malignant Syndrome; Parkinson Disease; Pergolide	2002
Ropinirole as an adjunct to levodopa in the treatment of Parkinson's disease A short commentary. Journal of neurology, 2003, Volume: 250, Issue:1 Topics: Antiparkinson Agents; Bromocriptine; Drug Therapy, Combination; Humans; Indoles; Levodopa; Parkinson Disease	2003
The prevalence of Parkinson's disease in British Columbia, Canada, estimated by using drug tracer methodology. Parkinsonism & related disorders, 2003, Volume: 9, Issue:4 Topics: Adult; Aged; Antiparkinson Agents; British Columbia; Bromocriptine; Data Interpretation, Statistical; Databases, Factual; Drug Prescriptions; Drug Utilization; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Sex Factors	2003
[Sexual delinquency and Parkinson's disease]. Der Nervenarzt, 2003, Volume: 74, Issue:4 Topics: Antiparkinson Agents; Awareness; Bromocriptine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Exhibitionism; Expert Testimony; Humans; Impulsive Behavior; Indoles; Levodopa; Libido; Male; Middle Aged; Parkinson Disease; Pedophilia; Sex Offenses	2003
Pharmacokinetic and pharmacodynamic analyses, based on dopamine D2-receptor occupancy of bromocriptine, of bromocriptine-induced contralateral rotations in unilaterally 6-OHDA-lesioned rats. Synapse (New York, N.Y.), 2003, Volume: 50, Issue:2 Topics: Animals; Bromocriptine; Denervation; Disease Models, Animal; Dopamine Agonists; Dose-Response Relationship, Drug; Male; Neostriatum; Neural Pathways; Neurons; Oxidopamine; Parkinson Disease; Rats; Rats, Sprague-Dawley; Reaction Time; Receptors, Dopamine D2; Rotation; Substantia Nigra	2003
[Therapy for patients with early-stage Parkinson's disease]. Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 2003, Aug-10, Volume: 92, Issue:8 Topics: Amantadine; Animals; Antiparkinson Agents; Bromocriptine; Dopamine Agonists; Drug Therapy, Combination; Humans; Levodopa; Monoamine Oxidase Inhibitors; Parkinson Disease; Practice Guidelines as Topic; Selegiline; Trihexyphenidyl	2003
Predictors of impaired daytime sleep and wakefulness in patients with Parkinson disease treated with older (ergot) vs newer (nonergot) dopamine agonists. Archives of neurology, 2004, Volume: 61, Issue:1 Topics: Aged; Benzothiazoles; Bromocriptine; Disorders of Excessive Somnolence; Dopamine Agonists; Dose-Response Relationship, Drug; Ergot Alkaloids; Female; Humans; Indoles; Male; Middle Aged; Parkinson Disease; Pergolide; Polysomnography; Pramipexole; Prospective Studies; Sleep; Thiazoles; Wakefulness	2004
Effects of pergolide on nocturia in Parkinson's disease: three female cases selected from over 400 patients. Parkinsonism & related disorders, 2004, Volume: 10, Issue:3 Topics: Aged; Bromocriptine; Female; Humans; Middle Aged; Parkinson Disease; Patient Selection; Pergolide; Urination Disorders	2004
[Two cases of Parkinson's disease in which visual hallucinations disappeared after cataract surgery]. No to shinkei = Brain and nerve, 2004, Volume: 56, Issue:4 Topics: Aged; Antiparkinson Agents; Bromocriptine; Cataract Extraction; Female; Hallucinations; Humans; Levodopa; Parkinson Disease; Remission Induction; Risperidone; Visual Perception	2004
Switching from ergot to nonergot dopamine agonists in Parkinson's disease: a clinical series and five-drug dose conversion table. Movement disorders : official journal of the Movement Disorder Society, 2004, Volume: 19, Issue:11 Topics: Adult; Adverse Drug Reaction Reporting Systems; Antiparkinson Agents; Benzothiazoles; Bromocriptine; Cabergoline; Domperidone; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Ergolines; Ergot Alkaloids; Feasibility Studies; Female; Follow-Up Studies; Humans; Indoles; Levodopa; Male; Middle Aged; Parkinson Disease; Pergolide; Pramipexole; Therapeutic Equivalency; Thiazoles	2004
Valvular heart disease and fibrotic reactions may be related to ergot dopamine agonists, but non-ergot agonists may also not be spared. Movement disorders : official journal of the Movement Disorder Society, 2004, Volume: 19, Issue:12 Topics: Aortic Valve; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Fibrosis; Heart Valve Diseases; Humans; Parkinson Disease; Pergolide	2004
Sydney Multicenter Study of Parkinson's disease: non-L-dopa-responsive problems dominate at 15 years. Movement disorders : official journal of the Movement Disorder Society, 2005, Volume: 20, Issue:2 Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Bromocriptine; Dementia; Disease Progression; Dose-Response Relationship, Drug; Employment; Female; Follow-Up Studies; Humans; Levodopa; Male; Middle Aged; Mortality; Movement Disorders; Multicenter Studies as Topic; Neurologic Examination; Neuropsychological Tests; Parkinson Disease; Time Factors	2005
Analysis of the course of Parkinson's disease under dopaminergic therapy: performance of "fast tapping" is not a suitable parameter. Movement disorders : official journal of the Movement Disorder Society, 2005, Volume: 20, Issue:3 Topics: Bromocriptine; Cross-Sectional Studies; Disease Progression; Dopamine Agonists; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease	2005
Levodopa + carbidopa + entacapone. Entacapone: a second look: new preparations. Parkinson's disease: a modest effect. Prescrire international, 2005, Volume: 14, Issue:76 Topics: Antiparkinson Agents; Bromocriptine; Carbidopa; Catechols; Clinical Trials as Topic; Dopamine Agonists; Double-Blind Method; Drug Therapy, Combination; Dyskinesias; France; Gastrointestinal Diseases; Humans; Levodopa; Parkinson Disease	2005
Bromocriptine treatment in a murine Parkinson's model: ultrastructural evaluation after dopaminergic deafferentation. The International journal of neuroscience, 2005, Volume: 115, Issue:6 Topics: Animals; Antiparkinson Agents; Bromocriptine; Caudate Nucleus; Disease Models, Animal; Dopamine; Male; Motor Endplate; Oxidative Stress; Parkinson Disease; Rats; Rats, Wistar	2005
Bromocriptine in traumatic brain injury. Brain injury, 2006, Volume: 20, Issue:1 Topics: Brain Injuries; Bromocriptine; Cognition; Dopamine Agonists; Head Injuries, Closed; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Psychomotor Performance	2006
Long-term clinical evaluation in patients with Parkinson's disease and early autonomic involvement. Parkinsonism & related disorders, 2006, Volume: 12, Issue:5 Topics: Aged; Antiparkinson Agents; Autonomic Nervous System; Bromocriptine; Disability Evaluation; Disease Progression; Dopamine Agonists; Drug Therapy, Combination; Female; Follow-Up Studies; Hemodynamics; Humans; Levodopa; Longitudinal Studies; Male; Middle Aged; Parkinson Disease; Pergolide; Prognosis; Survival Analysis	2006
Tolcapone: new drug. In Parkinson's disease: unacceptable risk of severe hepatitis. Prescrire international, 2006, Volume: 15, Issue:82 Topics: Antiparkinson Agents; Benzophenones; Bromocriptine; Clinical Trials as Topic; Cost-Benefit Analysis; Dopamine Agonists; Hepatitis; Humans; Nitrophenols; Parkinson Disease; Treatment Outcome	2006
Disease progression and pharmacodynamics in Parkinson disease - evidence for functional protection with levodopa and other treatments. Journal of pharmacokinetics and pharmacodynamics, 2006, Volume: 33, Issue:3 Topics: Algorithms; Antiparkinson Agents; Bayes Theorem; Bromocriptine; Disease Progression; Dopamine Agonists; Drug Therapy, Combination; Humans; Levodopa; Models, Biological; Parkinson Disease; Pergolide; Randomized Controlled Trials as Topic; Selegiline; Treatment Outcome	2006
Valvular heart disease in Parkinson's disease treated with ergot derivative dopamine agonists. Movement disorders : official journal of the Movement Disorder Society, 2006, Volume: 21, Issue:8 Topics: Adult; Aged; Aged, 80 and over; Bromocriptine; Dopamine Agonists; Echocardiography; Ergot Alkaloids; Heart Valve Diseases; Humans; Middle Aged; Parkinson Disease; Pergolide; Reference Values	2006
Changes in gait and symptoms after bilateral pallidotomy: a client with Parkinson's disease. Physiotherapy research international : the journal for researchers and clinicians in physical therapy, 2006, Volume: 11, Issue:3 Topics: Antiparkinson Agents; Bromocriptine; Combined Modality Therapy; Disease Progression; Female; Gait; Globus Pallidus; Humans; Levodopa; Middle Aged; Pallidotomy; Parkinson Disease; Severity of Illness Index; Time Factors; Treatment Outcome	2006
Identification of neuroprotective compounds of caenorhabditis elegans dopaminergic neurons against 6-OHDA. Journal of molecular neuroscience : MN, 2007, Volume: 31, Issue:2 Topics: Animals; Bromocriptine; Caenorhabditis elegans; Caenorhabditis elegans Proteins; Cell Line; Dopamine; Dopamine Agonists; Dopamine Plasma Membrane Transport Proteins; Dose-Response Relationship, Drug; Humans; Neurons; Neuroprotective Agents; Oxidopamine; Parkinson Disease; Quinpirole	2007
Short episode of seizures in a newborn of a mother treated with levodopa/carbidopa/entacapone and bromocriptine. Movement disorders : official journal of the Movement Disorder Society, 2007, Jul-30, Volume: 22, Issue:10 Topics: Adolescent; Antiparkinson Agents; Bromocriptine; Catechols; Drug Therapy, Combination; Epilepsy; Female; Humans; Levodopa; Nitriles; Parkinson Disease; Pregnancy; Prenatal Exposure Delayed Effects	2007
The frequency of cardiac valvular regurgitation in Parkinson's disease. Movement disorders : official journal of the Movement Disorder Society, 2008, May-15, Volume: 23, Issue:7 Topics: Aged; Aortic Valve Insufficiency; Azepines; Benzothiazoles; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Female; Humans; Male; Mitral Valve Insufficiency; Parkinson Disease; Pergolide; Pramipexole; Prevalence	2008
Bromocriptine activates NQO1 via Nrf2-PI3K/Akt signaling: novel cytoprotective mechanism against oxidative damage. Pharmacological research, 2008, Volume: 57, Issue:5 Topics: Active Transport, Cell Nucleus; Animals; Antiparkinson Agents; Bromocriptine; Cytoprotection; Dopamine Agonists; Hydrogen Peroxide; NAD(P)H Dehydrogenase (Quinone); Neurons; NF-E2-Related Factor 2; Oxidative Stress; Parkinson Disease; PC12 Cells; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Rats; Receptors, Dopamine D2; Signal Transduction; Up-Regulation	2008
Dopamine agonists and Parkinson's disease. Clinical neurology and neurosurgery, 1984, Volume: 86, Issue:3 Topics: Antiparkinson Agents; Apomorphine; Brain; Bromocriptine; Ergolines; Ergot Alkaloids; Humans; Levodopa; Lisuride; Neurons; Parkinson Disease; Pergolide; Piribedil; Receptors, Dopamine	1984
Cross tolerance between two dopaminergic ergot derivatives--bromocriptine and lergotrile. British journal of clinical pharmacology, 1980, Volume: 9, Issue:1 Topics: Aged; Blood Pressure; Bromocriptine; Drug Tolerance; Ergolines; Heart Rate; Humans; Levodopa; Male; Middle Aged; Parkinson Disease	1980
Psychiatric effects of bromocriptine and lergotrile in Parkinsonian patients. Advances in biochemical psychopharmacology, 1980, Volume: 23 Topics: Aged; Bromocriptine; Cognition Disorders; Confusion; Dose-Response Relationship, Drug; Electroencephalography; Ergolines; Female; Humans; Male; Mental Disorders; Middle Aged; Parkinson Disease; Personality Disorders; Psychoses, Substance-Induced; Schizophrenia	1980
Progress in the pharmacotherapy of Parkinsonism. Advances in biochemical psychopharmacology, 1980, Volume: 23 Topics: Aromatic Amino Acid Decarboxylase Inhibitors; Bromocriptine; Dopamine Antagonists; Ergolines; Humans; Monoamine Oxidase Inhibitors; Parkinson Disease; Receptors, Dopamine	1980
Bromocriptine in treatment of levodopa-induced end-of-dose dystonia. Lancet (London, England), 1980, Jul-26, Volume: 2, Issue:8187 Topics: Bromocriptine; Dystonia; Female; Humans; Levodopa; Middle Aged; Parkinson Disease	1980
Pleuropulmonary changes during long-term bromocriptine treatment for Parkinson's disease. Lancet (London, England), 1981, Jan-03, Volume: 1, Issue:8210 Topics: Bromocriptine; Dyspnea; Humans; Male; Middle Aged; Parkinson Disease; Pleural Effusion; Time Factors	1981
Pleuropulmonary shadows on bromocriptine. Lancet (London, England), 1981, Feb-07, Volume: 1, Issue:8215 Topics: Adult; Aged; Bromocriptine; Female; Humans; Lung; Male; Middle Aged; Parkinson Disease; Pleura; Radiography	1981
Bromocriptine for levodopa-induced end-of-dose dystonia. Lancet (London, England), 1981, Mar-14, Volume: 1, Issue:8220 Pt 1 Topics: Aged; Bromocriptine; Dystonia; Female; Humans; Levodopa; Parkinson Disease	1981
[Bromocriptine therapy]. Schweizerische medizinische Wochenschrift, 1981, Feb-28, Volume: 111, Issue:9 Topics: Acromegaly; Bromocriptine; Female; Humans; Lactation; Neurotransmitter Agents; Parkinson Disease; Pregnancy; Prolactin	1981
Low CSF GABA in Parkinsonian patients who respond poorly to therapy or suffer from the "on-off" phenomenon. Annals of neurology, 1982, Volume: 11, Issue:1 Topics: Antiparkinson Agents; Bromocriptine; Carbidopa; Ergolines; Female; gamma-Aminobutyric Acid; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Prognosis; Radioligand Assay	1982
Bromocriptine induced collagenosis-like symptomatology in Parkinson's disease. Lancet (London, England), 1982, Apr-10, Volume: 1, Issue:8276 Topics: Bromocriptine; Collagen Diseases; Female; Humans; Middle Aged; Parkinson Disease	1982
[Drug therapy of parkinsonism]. Duodecim; laaketieteellinen aikakauskirja, 1982, Volume: 98, Issue:11 Topics: Amantadine; Bromocriptine; Dopamine Antagonists; Humans; Levodopa; Neurotransmitter Agents; Parasympatholytics; Parkinson Disease	1982
Pergolide-induced circling in rats with 6-hydroxydopamine lesions in the nigrostriatal pathway. Neurology, 1982, Volume: 32, Issue:12 Topics: Animals; Behavior, Animal; Brain Diseases; Bromocriptine; Ergolines; Female; Hydroxydopamines; Oxidopamine; Parkinson Disease; Pergolide; Rats; Rats, Inbred Strains	1982
[How do we explain the antihypertensive effect of bromocriptine? Clinical and experimental contribution]. Archives des maladies du coeur et des vaisseaux, 1984, Volume: 77, Issue:11 Topics: Adrenergic alpha-Antagonists; Aged; Animals; Antihypertensive Agents; Bromocriptine; Dogs; Domperidone; Drug Therapy, Combination; Epinephrine; Female; Humans; Hypertension; Male; Middle Aged; Parkinson Disease; Receptors, Dopamine	1984
Long-term experience with bromocriptine in advanced parkinsonism. Results after one year's treatment. Journal of neurology, 1982, Volume: 228, Issue:4 Topics: Adult; Aged; Bromocriptine; Drug Therapy, Combination; Female; Humans; Levodopa; Long-Term Care; Male; Middle Aged; Parkinson Disease	1982
[Therapeutic concept in Parkinson disease]. Deutsche medizinische Wochenschrift (1946), 1983, Jul-15, Volume: 108, Issue:28-29 Topics: Adrenergic beta-Antagonists; Amantadine; Antidepressive Agents, Tricyclic; Benzodiazepines; Bromocriptine; Depression; Fludrocortisone; Humans; Hypotension, Orthostatic; Levodopa; Midodrine; Parasympatholytics; Parkinson Disease; Physical Therapy Modalities; Thalamus; Tremor	1983
Therapeutic experience with the new dopamine agonist CU 32-085 in advanced Parkinson's disease. Journal of neurology, 1983, Volume: 230, Issue:1 Topics: Adult; Aged; Amantadine; Antiparkinson Agents; Bromocriptine; Carboxy-Lyases; Drug Therapy, Combination; Ergolines; Female; Humans; Levodopa; Male; Middle Aged; Parasympatholytics; Parkinson Disease	1983
Erythromelalgia-like eruption in parkinsonian patients treated with bromocriptine. Neurology, 1981, Volume: 31, Issue:10 Topics: Aged; Bromocriptine; Drug Eruptions; Erythromelalgia; Female; Humans; Male; Middle Aged; Parkinson Disease	1981
Antiparkinsonian and antidepressant effects of high doses of bromocriptine. An independent comparison. Journal of affective disorders, 1983, Volume: 5, Issue:2 Topics: Adult; Aged; Bromocriptine; Depressive Disorder; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Parkinson Disease	1983
Dopamine agonists in Parkinson's disease. The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques, 1984, Volume: 11, Issue:1 Suppl Topics: Bromocriptine; Dopamine; Drug Therapy, Combination; Ergolines; Ergot Alkaloids; Humans; Levodopa; Lisuride; Parkinson Disease; Pergolide; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2	1984
[Treatment of Parkinson's disease with high doses of bromocriptine. Possible interaction with josamycin]. Presse medicale (Paris, France : 1983), 1984, Oct-20, Volume: 13, Issue:37 Topics: Aged; Bromocriptine; Drug Interactions; Humans; Leucomycins; Male; Parkinson Disease	1984
Dopamine agonists in the treatment of Parkinson's disease. Advances in neurology, 1983, Volume: 37 Topics: Blood Pressure; Bromocriptine; Disability Evaluation; Domperidone; Dopamine; Ergolines; Follow-Up Studies; Humans; Levodopa; Parkinson Disease; Pleural Effusion; Receptors, Neurotransmitter; Time Factors	1983
Brain receptor changes in Parkinson's disease in relation to the disease process and treatment. Journal of neural transmission. Supplementum, 1983, Volume: 18 Topics: Apomorphine; Brain; Bromocriptine; Humans; Levodopa; Parkinson Disease; Prolactin; Receptors, Dopamine; Receptors, Opioid; Thyrotropin-Releasing Hormone	1983
Vitamin D metabolites and analogues, diphosphonates, danazol, and bromocriptine. British medical journal (Clinical research ed.), 1983, May-21, Volume: 286, Issue:6378 Topics: Acromegaly; Bromocriptine; Calcitriol; Danazol; Endometriosis; Etidronic Acid; Female; Fibrocystic Breast Disease; Humans; Hydroxycholecalciferols; Hypoparathyroidism; Kidney Failure, Chronic; Lactation; Menorrhagia; Osteomalacia; Parkinson Disease; Pregnadienes; Pregnancy; Prolactin; Rickets; Vitamin D	1983
Combination treatment with selective monoamine oxidase inhibitors and dopaminergic agonists in Parkinson's disease: biochemical and clinical observations. Advances in neurology, 1983, Volume: 37 Topics: Bromocriptine; Dopamine; Drug Therapy, Combination; Humans; Lisuride; Monoamine Oxidase Inhibitors; Parkinson Disease; Selegiline; Tranylcypromine	1983
[Dopaminergic ergot combinations. A new therapeutic principle]. MMW, Munchener medizinische Wochenschrift, 1983, Jun-10, Volume: 125, Issue:23 Topics: Bromocriptine; Dopamine Antagonists; Drug Combinations; Ergot Alkaloids; Female; Humans; Lisuride; Male; Parkinson Disease; Pituitary Neoplasms; Prolactin	1983
Adjuvant drugs in the treatment of on-off phenomena in Parkinson's disease. Advances in neurology, 1984, Volume: 40 Topics: Benzamides; Bromocriptine; Carboxy-Lyases; Drug Therapy, Combination; Humans; Levodopa; Parkinson Disease; Phenethylamines; Selegiline; Tiapamil Hydrochloride	1984
Therapy of neurologic disorders in the elderly. Hospital practice (Office ed.), 1984, Volume: 19, Issue:10 Topics: Aged; Amantadine; Anticoagulants; Brain Ischemia; Bromocriptine; Carbidopa; Dexamethasone; Drug Interactions; Heparin; Humans; Levodopa; Parasympatholytics; Parkinson Disease; Trihexyphenidyl	1984
Dopamine receptors: effects of chronic L-dopa and bromocriptine treatment in an animal model of Parkinson's disease. Clinical neuropharmacology, 1984, Volume: 7, Issue:3 Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Bromocriptine; Corpus Striatum; Disease Models, Animal; Dopamine; Humans; Hydroxydopamines; Kinetics; Levodopa; Male; Membranes; Oxidopamine; Parkinson Disease; Rats; Rats, Inbred Strains; Receptors, Dopamine; Spiperone; Stereotyped Behavior; Substantia Nigra	1984
Bromocriptine update. American family physician, 1984, Volume: 30, Issue:2 Topics: Acromegaly; Bromocriptine; Female; Humans; Hypotension, Orthostatic; Lactation; Male; Nausea; Parkinson Disease; Pituitary Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Prolactin	1984
The drug treatment of Parkinson's disease. Australian family physician, 1984, Volume: 13, Issue:5 Suppl Topics: Amantadine; Bromocriptine; Cardiovascular Diseases; Chemical Phenomena; Chemistry; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Humans; Levodopa; Nausea; Parasympatholytics; Parkinson Disease	1984
Bromocriptine in the management of end of dose deterioration in Parkinson's disease. The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques, 1984, Volume: 11, Issue:4 Topics: Adult; Aged; Bromocriptine; Drug Therapy, Combination; Humans; Levodopa; Middle Aged; Nausea; Parkinson Disease	1984
Pergolide versus bromocriptine. Neurology, 1984, Volume: 34, Issue:2 Topics: Bromocriptine; Ergolines; Humans; Parkinson Disease; Pergolide	1984
Severity of Parkinson's disease and the dosage of bromocriptine. Neurology, 1984, Volume: 34, Issue:6 Topics: Adult; Aged; Bromocriptine; Carbidopa; Drug Combinations; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Retrospective Studies	1984
[Does bromocriptine enhance the effect of drugs that reduce intraocular pressure?]. Deutsche medizinische Wochenschrift (1946), 1983, Oct-28, Volume: 108, Issue:43 Topics: Bromocriptine; Drug Synergism; Humans; Intraocular Pressure; Parkinson Disease	1983
Treatment of Parkinson's disease with 8-alpha-amino-ergoline, CU 32-085. Neurology, 1983, Volume: 33, Issue:4 Topics: Activities of Daily Living; Adult; Aged; Antiparkinson Agents; Bromocriptine; Drug Therapy, Combination; Ergolines; Female; Humans; Hypotension, Orthostatic; Levodopa; Male; Middle Aged; Nausea; Parkinson Disease; Psychomotor Performance; Receptors, Dopamine	1983
Hypersexuality--a complication of dopaminergic therapy in Parkinson's disease. Pharmacopsychiatria, 1983, Volume: 16, Issue:4 Topics: Benserazide; Bromocriptine; Dopamine; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Sexual Dysfunction, Physiological	1983
Therapeutic results with a new ergoline derivate (8-alpha-amino-ergoline, CU 32-085) in parkinsonian patients. Advances in neurology, 1984, Volume: 40 Topics: Aged; Antiparkinson Agents; Bromocriptine; Drug Therapy, Combination; Ergolines; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease	1984
Bromocriptine and lisuride in Parkinson's disease. Advances in neurology, 1984, Volume: 40 Topics: Adult; Aged; Bromocriptine; Carboxy-Lyases; Drug Therapy, Combination; Ergolines; Female; Humans; Levodopa; Lisuride; Male; Middle Aged; Parkinson Disease	1984
Clinical administration of parlodel in low doses. Advances in neurology, 1984, Volume: 40 Topics: Adult; Aged; Bromocriptine; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease	1984
Bromocriptine in Parkinson's disease: results obtained with high and low dose therapy. The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques, 1984, Volume: 11, Issue:1 Suppl Topics: Bromocriptine; Dose-Response Relationship, Drug; Humans; Parkinson Disease	1984
Should dopamine agonists be given early or late in the treatment of Parkinson's disease? The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques, 1984, Volume: 11, Issue:1 Suppl Topics: Adult; Aged; Bromocriptine; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Time Factors	1984
Should dopamine agonists be given early or late? A review of nine years experience with bromocriptine. The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques, 1984, Volume: 11, Issue:1 Suppl Topics: Aged; Bromocriptine; Drug Evaluation; Humans; Levodopa; Middle Aged; Parkinson Disease; Retrospective Studies; Time Factors	1984
Diagnosis and management of Parkinson's disease. Geriatrics, 1984, Volume: 39, Issue:5 Topics: Bromocriptine; Diagnosis, Differential; Humans; Levodopa; Muscle Rigidity; Parasympatholytics; Parkinson Disease; Tremor	1984
Long-term efficacy of bromocriptine in Parkinson disease. Neurology, 1980, Volume: 30, Issue:5 Topics: Bromocriptine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Levodopa; Long-Term Care; Middle Aged; Parkinson Disease; Substance Withdrawal Syndrome	1980
Presynaptic neuron and postsynaptic dopamine receptor function in long term treatment of Parkinson's disease: a neuroendocrine study. Progress in clinical and biological research, 1980, Volume: 39 Topics: Aged; Apomorphine; Benserazide; Bromocriptine; Carbidopa; Female; Humans; Levodopa; Male; Middle Aged; Nomifensine; Parkinson Disease; Prolactin; Receptors, Dopamine; Selegiline; Tremor	1980
Incontinence of urine with long-term bromocriptine therapy. Annals of neurology, 1980, Volume: 8, Issue:2 Topics: Bromocriptine; Humans; Long-Term Care; Male; Middle Aged; Parkinson Disease; Urinary Incontinence	1980
The use of bromocriptine for testing central dopaminergic reactivity. Psychopharmacology, 1980, Volume: 70, Issue:3 Topics: Blood Pressure; Brain; Bromocriptine; Drug Resistance; Humans; Levodopa; Movement Disorders; Parkinson Disease; Receptors, Dopamine; Renin	1980
Bromocriptine and lisuride in Parkinson disease. Annals of neurology, 1983, Volume: 13, Issue:1 Topics: Aged; Bromocriptine; Carbidopa; Drug Therapy, Combination; Ergolines; Humans; Levodopa; Lisuride; Middle Aged; Parkinson Disease	1983
Progressive supranuclear palsy: clinical features and response to treatment in 16 patients. Annals of neurology, 1983, Volume: 13, Issue:3 Topics: Aged; Bromocriptine; Bulbar Palsy, Progressive; Ergolines; Female; Follow-Up Studies; Humans; Male; Middle Aged; Parkinson Disease; Pergolide	1983
Sustained bromocriptine therapy in 50 previously untreated patients with Parkinson's disease. Advances in neurology, 1983, Volume: 37 Topics: Bromocriptine; Disability Evaluation; Female; Humans; Male; Middle Aged; Parkinson Disease; Time Factors	1983
Comparative efficacy of pergolide and bromocriptine in patients with advanced Parkinson's disease. Advances in neurology, 1983, Volume: 37 Topics: Aged; Bromocriptine; Disability Evaluation; Drug Evaluation; Ergolines; Humans; Levodopa; Middle Aged; Parkinson Disease; Pergolide; Time Factors	1983
Dopa dose-dependent sexual deviation. The British journal of psychiatry : the journal of mental science, 1983, Volume: 142 Topics: Antiparkinson Agents; Bromocriptine; Carbidopa; Ergolines; Humans; Male; Middle Aged; Paraphilic Disorders; Parkinson Disease; Pergolide	1983
Bromocriptine in the long-term management of advanced Parkinson's disease. The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques, 1983, Volume: 10, Issue:2 Topics: Aged; Bromocriptine; Drug Evaluation; Follow-Up Studies; Humans; Parkinson Disease; Time Factors	1983
Bromocriptine--lisuride cross tolerance. Italian journal of neurological sciences, 1983, Volume: 4, Issue:1 Topics: Aged; Bromocriptine; Drug Tolerance; Ergolines; Humans; Lisuride; Male; Middle Aged; Parkinson Disease	1983
[Bromocriptine (Parlodel) in the treatment of Parkinson's disease. Summary of 7 years' experience]. Revue medicale de Liege, 1983, May-01, Volume: 38, Issue:9 Topics: Bromocriptine; Double-Blind Method; Drug Evaluation; Drug Therapy, Combination; Humans; Levodopa; Male; Middle Aged; Parkinson Disease	1983
Bromocriptine and endocrine imbalance. Nursing mirror, 1981, Mar-19, Volume: 152, Issue:12 Topics: Bromocriptine; Humans; Parkinson Disease; Pituitary Hormones	1981
Recent advances in the treatment of Parkinson's disease. Acta neurologica Scandinavica. Supplementum, 1980, Volume: 78 Topics: Brain; Bromocriptine; Drug Therapy, Combination; Endorphins; Enkephalins; Humans; Levodopa; Mental Disorders; Parkinson Disease; Receptors, Dopamine	1980
[Sleep-waking cycle and the nyctohemeral secretion of prolactin and somatotropin in Parkinson patients. Effect of bromocriptine]. Bulletin de l'Academie nationale de medecine, 1980, Volume: 164, Issue:2 Topics: Bromocriptine; Circadian Rhythm; Female; Growth Hormone; Humans; Male; Middle Aged; Parkinson Disease; Prolactin; Sleep	1980
[Dopamine-receptor stimulants in the treatment of Parkinson's disease (author's transl)]. Der Nervenarzt, 1982, Volume: 53, Issue:2 Topics: Antiparkinson Agents; Bromocriptine; Double-Blind Method; Drug Therapy, Combination; Humans; Parkinson Disease; Receptors, Dopamine	1982
[Bromocriptine in the treatment of patients with parkinsonism and dyskinesias induced by levodopa]. Nederlands tijdschrift voor geneeskunde, 1982, Apr-17, Volume: 126, Issue:16 Topics: Adult; Aged; Bromocriptine; Dyskinesia, Drug-Induced; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease	1982
Initial treatment of Parkinson's disease. Clinical neuropharmacology, 1982, Volume: 5 Suppl 1 Topics: Amantadine; Antiparkinson Agents; Bromocriptine; Carbidopa; Drug Administration Schedule; Drug Therapy, Combination; Humans; Levodopa; Parkinson Disease; Prognosis	1982
Behavioral alterations and the therapy of parkinsonism. Clinical neuropharmacology, 1982, Volume: 5 Suppl 1 Topics: Bipolar Disorder; Bromocriptine; Dementia; Depressive Disorder; Humans; Levodopa; Mental Processes; Parkinson Disease; Psychoses, Substance-Induced	1982
Bromocriptine combined with levodopa in Parkinson's disease. European neurology, 1982, Volume: 21, Issue:4 Topics: Aged; Bromocriptine; Drug Therapy, Combination; Humans; Levodopa; Middle Aged; Motor Skills; Parkinson Disease	1982
Sleep disruption in the course of chronic levodopa therapy: an early feature of the levodopa psychosis. Clinical neuropharmacology, 1982, Volume: 5, Issue:2 Topics: Aged; Bromocriptine; Carbidopa; Dreams; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Psychoses, Substance-Induced; Sleep Initiation and Maintenance Disorders; Sleep Stages	1982
[Bromocriptine as the 1st treatment of Parkinson's disease. Long term results]. Revue neurologique, 1982, Volume: 138, Issue:5 Topics: Adult; Aged; Bromocriptine; Female; Follow-Up Studies; Humans; Male; Middle Aged; Parkinson Disease	1982
[Bromocriptine - various pharmacological properties and indications for use]. Polski tygodnik lekarski (Warsaw, Poland : 1960), 1982, Jul-12, Volume: 37, Issue:22 Topics: Acromegaly; Bromocriptine; Female; Galactorrhea; Humans; Lactation; Parkinson Disease; Pregnancy; Prolactin	1982
Bromocriptine. Journal of the Iowa Medical Society, 1980, Volume: 70, Issue:5 Topics: Acromegaly; Amenorrhea; Bromocriptine; Female; Galactorrhea; Humans; Lactation; Male; Parkinson Disease; Pregnancy; Prolactin	1980
Galactorrhoea after withdrawal of bromocriptine. British medical journal, 1980, Sep-13, Volume: 281, Issue:6242 Topics: Adult; Bromocriptine; Female; Galactorrhea; Humans; Lactation Disorders; Parkinson Disease; Pregnancy; Prolactin; Substance Withdrawal Syndrome	1980
Lisuride in parkinsonism. Neurology, 1981, Volume: 31, Issue:4 Topics: Adult; Aged; Bromocriptine; Double-Blind Method; Ergolines; Humans; Lisuride; Middle Aged; Movement; Parkinson Disease; Placebos; Reaction Time; Receptors, Serotonin; Sleep	1981
Bilateral vocal cord paralysis in Parkinson's disease. Archives of otolaryngology (Chicago, Ill. : 1960), 1981, Volume: 107, Issue:4 Topics: Aged; Bromocriptine; Carbidopa; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Tracheotomy; Vocal Cord Paralysis	1981
[Treatment of Parkinson disease by bromocriptine in the black African]. Dakar medical, 1980, Volume: 25, Issue:2 Topics: Aged; Bromocriptine; Female; Humans; Male; Middle Aged; Parkinson Disease; Senegal	1980
[Improved therapeutic response to L-dopa in Parkinson's disease, when combined with bromocriptine (author's transl)]. Der Nervenarzt, 1981, Volume: 52, Issue:2 Topics: Adult; Aged; Bromocriptine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease	1981
Method of addition of bromocriptine to the drug regime of patients with advanced Parkinson's disease. The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques, 1981, Volume: 8, Issue:1 Topics: Aged; Bromocriptine; Carbidopa; Drug Combinations; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease	1981
[Long-term results of treatment of Parkinson's disease with bromocriptine and domperidone (author's transl)]. Revue neurologique, 1981, Volume: 137, Issue:1 Topics: Aged; Aromatic Amino Acid Decarboxylase Inhibitors; Benzimidazoles; Bromocriptine; Domperidone; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Piperidines	1981
Parkinson's disease: new treatments. Comprehensive therapy, 1981, Volume: 7, Issue:4 Topics: Acetylcholine; Amantadine; Apomorphine; Bromocriptine; Carbidopa; Counseling; Dopamine; Humans; Levodopa; Monoamine Oxidase Inhibitors; Neurologic Manifestations; Parkinson Disease; Physical Therapy Modalities; Receptors, Dopamine; Thalamus	1981
Bromocriptine and its use in Parkinsonism. Journal of the American Geriatrics Society, 1981, Volume: 29, Issue:6 Topics: Antiparkinson Agents; Bromocriptine; Humans; Levodopa; Parkinson Disease	1981
Treatment of Parkinson's disease: problems with a progressing disease. Journal of neural transmission, 1981, Volume: 51, Issue:1-2 Topics: Bromocriptine; Follow-Up Studies; Humans; Levodopa; Parkinson Disease; Prognosis; Receptors, Dopamine	1981
Bromocriptine in Parkinson's disease: a study of cardiovascular effects. Journal of neurology, neurosurgery, and psychiatry, 1981, Volume: 44, Issue:5 Topics: Benzimidazoles; Blood Pressure; Bromocriptine; Domperidone; Humans; Parkinson Disease; Piperidines; Pulse	1981
[Pleuro-pulmonary changes after bromocriptine treatment of parkinsonism]. Ugeskrift for laeger, 1981, Oct-05, Volume: 143, Issue:41 Topics: Adult; Aged; Bromocriptine; Female; Humans; Levodopa; Lung Diseases; Male; Middle Aged; Parkinson Disease; Pleural Diseases	1981
Bromocriptine. The Practitioner, 1981, Volume: 225, Issue:1360 Topics: Breast Diseases; Bromocriptine; Female; Humans; Lactation; Male; Parkinson Disease; Pituitary Neoplasms; Pregnancy; Prolactin	1981
"Long term evaluation of combined treatment of Parkinson disease with L-dopa, peripheral decarboxylase inhibitors and bromocreptine". Italian journal of neurological sciences, 1981, Volume: 2, Issue:4 Topics: Aged; Antiparkinson Agents; Bromocriptine; Carboxy-Lyases; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Parkinson Disease, Postencephalitic	1981
Sustained bromocriptine therapy in previously untreated patients with Parkinson's disease. Journal of neurology, neurosurgery, and psychiatry, 1981, Volume: 44, Issue:11 Topics: Adult; Aged; Bromocriptine; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease	1981
Bromocriptine in Parkinson's disease: report on 106 patients treated for up to 5 years. Advances in biochemical psychopharmacology, 1980, Volume: 23 Topics: Bromocriptine; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Levodopa; Middle Aged; Parkinson Disease	1980
Further experiences with low doses of bromocriptine in Parkinson's disease. Advances in biochemical psychopharmacology, 1980, Volume: 23 Topics: Bromocriptine; Carbidopa; Dose-Response Relationship, Drug; Humans; Levodopa; Parkinson Disease	1980
Levodopa compared with bromocriptine in the treatment of Parkinson's disease. Advances in biochemical psychopharmacology, 1980, Volume: 23 Topics: Aged; Bromocriptine; Humans; Levodopa; Middle Aged; Parkinson Disease	1980
The role of bromocriptine in the treatment of Parkinson's disease. Advances in biochemical psychopharmacology, 1980, Volume: 23 Topics: Bromocriptine; Carbidopa; Dose-Response Relationship, Drug; Humans; Levodopa; Middle Aged; Parkinson Disease	1980
A comparative study of bromocriptine and levodopa in Parkinson's disease. Advances in biochemical psychopharmacology, 1980, Volume: 23 Topics: Adult; Aged; Bromocriptine; Carbidopa; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease	1980
The role of D-1 and D-2 receptors. Nature, 1980, Jul-10, Volume: 286, Issue:5769 Topics: Adenylyl Cyclases; Bromocriptine; Growth Hormone; Humans; Levodopa; Lisuride; Metoclopramide; Parkinson Disease; Pimozide; Prolactin; Receptors, Dopamine	1980
Bromocriptine concentration in saliva plasma after long-term treatment of patients with Parkinson's disease. European journal of clinical pharmacology, 1980, Volume: 18, Issue:2 Topics: Aged; Blood Proteins; Bromocriptine; Female; Humans; Male; Middle Aged; Parkinson Disease; Protein Binding; Saliva; Time Factors	1980
Lisuride in the treatment of Parkinsonism. Acta neurologica Scandinavica, 1980, Volume: 62, Issue:6 Topics: Administration, Oral; Aged; Bromocriptine; Drug Therapy, Combination; Ergolines; Humans; Injections, Intravenous; Levodopa; Lisuride; Middle Aged; Parkinson Disease	1980
Neuroprotective mechanism of bromocriptine. Lancet (London, England), 1995, Nov-11, Volume: 346, Issue:8985 Topics: Amino Acid Transport System X-AG; Antiparkinson Agents; ATP-Binding Cassette Transporters; Biological Transport; Bromocriptine; Carrier Proteins; Dopamine Agonists; Glutamic Acid; HeLa Cells; Humans; Neuroprotective Agents; Parkinson Disease	1995
Treatment of Parkinson's disease. Australian family physician, 1995, Volume: 24, Issue:9 Topics: Antiparkinson Agents; Bromocriptine; Humans; Levodopa; Monoamine Oxidase Inhibitors; Parkinson Disease; Pergolide; Prognosis; Selegiline	1995
Parkinsonian medication one hour before meals improves symptomatic swallowing: a case study. Dysphagia, 1995,Summer, Volume: 10, Issue:3 Topics: Administration, Oral; Aged; Benserazide; Bromocriptine; Deglutition; Deglutition Disorders; Drug Administration Schedule; Eating; Humans; Levodopa; Male; Parkinson Disease	1995
Effect of disease and drug treatment on blood serotonin and monoamine oxidase B activity in Parkinson's disease. Clinical neurology and neurosurgery, 1995, Volume: 97, Issue:2 Topics: Adult; Aged; Amantadine; Blood Platelets; Bromocriptine; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Monoamine Oxidase; Parkinson Disease; Selegiline; Serotonin; Treatment Outcome	1995
Bromocriptine and psychosis: a literature review. The Psychiatric quarterly, 1995,Spring, Volume: 66, Issue:1 Topics: Amenorrhea; Bromocriptine; Female; Humans; Parkinson Disease; Psychotic Disorders; Puerperal Disorders	1995
Memantine, amantadine, and L-deprenyl potentiate the action of L-dopa in monoamine-depleted rats. Journal of neural transmission. General section, 1994, Volume: 98, Issue:1 Topics: Amantadine; Animals; Bromocriptine; Dopamine; Drug Synergism; Levodopa; Male; Memantine; Motor Activity; N-Methylaspartate; Parkinson Disease; Rats; Rats, Wistar; Selegiline	1994
Drenching sweats as an off phenomenon in Parkinson's disease: treatment and relation to plasma levodopa profile. Annals of neurology, 1995, Volume: 37, Issue:1 Topics: Aged; Bromocriptine; Cabergoline; Chorea; Dopamine Agonists; Ergolines; Female; Humans; Levodopa; Male; Middle Aged; Monitoring, Physiologic; Parkinson Disease; Pergolide; Sweating	1995
Seven-year follow-up study of bromocriptine therapy for Parkinson's disease. European neurology, 1994, Volume: 34 Suppl 3 Topics: Adult; Aged; Bromocriptine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Levodopa; Long-Term Care; Male; Middle Aged; Neurologic Examination; Neurons; Parkinson Disease; Substantia Nigra	1994
Day-night variation of urine volume in Parkinson's disease. The Japanese journal of psychiatry and neurology, 1994, Volume: 48, Issue:3 Topics: Adult; Aged; Amantadine; Bromocriptine; Circadian Rhythm; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Time Factors; Trihexyphenidyl; Urine	1994
On-off effects of dopamine receptor agonists in the hemi-parkinsonian rat. European journal of pharmacology, 1993, Sep-21, Volume: 242, Issue:1 Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Bromocriptine; Cocaine; Dopamine Agents; Dose-Response Relationship, Drug; Female; Injections, Intraperitoneal; Motor Activity; Oxidopamine; Parkinson Disease; Rats; Rats, Sprague-Dawley	1993
[Bromocriptine-induced pleuropneumopathy]. Deutsche medizinische Wochenschrift (1946), 1994, Nov-11, Volume: 119, Issue:45 Topics: Benserazide; Biperiden; Bromocriptine; Humans; Levodopa; Lung Diseases; Male; Middle Aged; Parkinson Disease; Pleural Effusion; Pulmonary Atelectasis; Pulmonary Fibrosis; Radiography; Selegiline; Time Factors	1994
[Diagnosis and treatment of Parkinson's disease in the elderly]. Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics, 1993, Volume: 30, Issue:12 Topics: Aged; Brain; Bromocriptine; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Sulpiride; Tiapamil Hydrochloride	1993
Severe evening dyskinesias in advanced Parkinson's disease: clinical description, relation to plasma levodopa, and treatment. Movement disorders : official journal of the Movement Disorder Society, 1994, Volume: 9, Issue:2 Topics: Aged; Antiparkinson Agents; Bromocriptine; Carbidopa; Chorea; Circadian Rhythm; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Dystonia; Female; Humans; Levodopa; Male; Middle Aged; Neurologic Examination; Parkinson Disease	1994
Dopaminergic hallucinosis with fluoxetine in Parkinson's disease. The American journal of psychiatry, 1993, Volume: 150, Issue:11 Topics: Aged; Bromocriptine; Carbidopa; Fluoxetine; Hallucinations; Humans; Levodopa; Male; Parkinson Disease; Visual Perception	1993
Short-term memory and temporal ordering in early Parkinson's disease: effects of disease chronicity and medication. Neuropsychologia, 1993, Volume: 31, Issue:9 Topics: Adult; Aged; Brain; Bromocriptine; Dementia; Female; Frontal Lobe; Humans; Language Tests; Levodopa; Male; Memory Disorders; Memory, Short-Term; Middle Aged; Neuropsychological Tests; Parasympatholytics; Parkinson Disease; Psychiatric Status Rating Scales; Reaction Time; Task Performance and Analysis	1993
Polysomnographic sleep measures in Parkinson's disease patients with treatment-induced hallucinations. Annals of neurology, 1993, Volume: 34, Issue:5 Topics: Aged; Bromocriptine; Carbidopa; Hallucinations; Humans; Levodopa; Parkinson Disease; Pergolide; Polysomnography; Sleep; Sleep, REM	1993
Combination therapy for PD. Neurology, 1993, Volume: 43, Issue:12 Topics: Antiparkinson Agents; Bromocriptine; Drug Therapy, Combination; Humans; Levodopa; Lisuride; Parkinson Disease; Randomized Controlled Trials as Topic	1993
Combination therapy for PD. Neurology, 1993, Volume: 43, Issue:12 Topics: Antiparkinson Agents; Bromocriptine; Carbidopa; Drug Therapy, Combination; Humans; Levodopa; Parkinson Disease; Randomized Controlled Trials as Topic	1993
Event-related potentials in Parkinson's disease: a 12-month follow-up study. Journal of the neurological sciences, 1993, Volume: 116, Issue:2 Topics: Adult; Aged; Bromocriptine; Cognition; Drug Therapy, Combination; Evoked Potentials, Auditory; Female; Follow-Up Studies; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Prospective Studies	1993
Parkinson's disease study. European journal of clinical pharmacology, 1993, Volume: 44, Issue:6 Topics: Benserazide; Bias; Bromocriptine; Drug Therapy, Combination; Humans; Levodopa; Parkinson Disease	1993
Amantadine withdrawal and neuroleptic malignant syndrome. Neurology, 1993, Volume: 43, Issue:10 Topics: Amantadine; Bromocriptine; Humans; Levodopa; Neuroleptic Malignant Syndrome; Parkinson Disease; Substance Withdrawal Syndrome	1993
Function of dopamine receptors in young-onset Parkinson's disease: prolactin response. Movement disorders : official journal of the Movement Disorder Society, 1993, Volume: 8, Issue:2 Topics: Adult; Bromocriptine; Humans; Hypothalamo-Hypophyseal System; Male; Middle Aged; Neurologic Examination; Parkinson Disease; Prolactin; Receptors, Dopamine; Receptors, Dopamine D2; Thyrotropin-Releasing Hormone	1993
Neuroprotection in Parkinson's disease. Lancet (London, England), 1996, Jan-20, Volume: 347, Issue:8995 Topics: Antiparkinson Agents; Bromocriptine; Dopamine Agonists; Humans; Neuroprotective Agents; Parkinson Disease	1996
Suggestive evidence for bromocriptine-induced pleurisy. The Netherlands journal of medicine, 1996, Volume: 48, Issue:6 Topics: Aged; Antiparkinson Agents; Bromocriptine; Humans; Male; Parkinson Disease; Pleurisy; Radiography	1996
Abnormal involuntary movements induced by subthalamic nucleus stimulation in parkinsonian patients. Movement disorders : official journal of the Movement Disorder Society, 1996, Volume: 11, Issue:3 Topics: Antiparkinson Agents; Bromocriptine; Combined Modality Therapy; Dominance, Cerebral; Electric Stimulation Therapy; Female; Humans; Levodopa; Male; Middle Aged; Motor Activity; Motor Skills; Neurologic Examination; Parkinson Disease; Thalamic Nuclei; Treatment Outcome	1996
Plasma levels of the beta-carbolines harman and norharman in Parkinson's disease. Acta neurologica Scandinavica, 1995, Volume: 92, Issue:6 Topics: Aged; Antiparkinson Agents; Bromocriptine; Carbolines; Female; Humans; Levodopa; Male; Middle Aged; Mitochondria; Parkinson Disease; Selegiline	1995
[Malignant-like neuroleptic syndrome: a sign to call attention to]. Anales de medicina interna (Madrid, Spain : 1984), 1995, Volume: 12, Issue:9 Topics: Aged; Antiparkinson Agents; Bromocriptine; Cephalosporins; Humans; Levodopa; Male; Neuroleptic Malignant Syndrome; Parkinson Disease	1995
Analyzer workshop on the treatment of Parkinson's disease. European neurology, 1997, Volume: 38 Suppl 1 Topics: Adult; Antiparkinson Agents; Bromocriptine; Cerebrovascular Disorders; Computer Simulation; Diagnosis, Differential; Forecasting; Humans; Levodopa; Middle Aged; Parkinson Disease; Supranuclear Palsy, Progressive; Tablets	1997
Hallucinosis in idiopathic Parkinson's disease. Journal of neurology, neurosurgery, and psychiatry, 1997, Volume: 63, Issue:4 Topics: Aged; Bromocriptine; Cognition Disorders; Depressive Disorder; Dopamine Agonists; Female; Hallucinations; Humans; Male; Middle Aged; Parkinson Disease; Pergolide; Psychomotor Disorders; Retrospective Studies; Severity of Illness Index; Time Factors	1997
[A comparative study of the effect of bromocriptine and pergolide on Parkinson disease]. Revista de neurologia, 1997, Volume: 25, Issue:145 Topics: Aged; Bromocriptine; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Movement Disorders; Muscle Rigidity; Parkinson Disease; Pergolide; Retrospective Studies; Tremor	1997
Prevalence of orthostatic hypotension in Parkinson's disease. Journal of neurology, neurosurgery, and psychiatry, 1997, Volume: 63, Issue:5 Topics: Aged; Antiparkinson Agents; Bromocriptine; Female; Humans; Hypotension, Orthostatic; Male; Middle Aged; Parkinson Disease; Prevalence; Severity of Illness Index	1997
[Psychosis due to the interaction of erythromycin and bromocriptine in Parkinson disease]. Neurologia (Barcelona, Spain), 1997, Volume: 12, Issue:9 Topics: Aged; Anti-Bacterial Agents; Antiparkinson Agents; Bromocriptine; Drug Interactions; Erythromycin; Female; Humans; Parkinson Disease; Psychoses, Substance-Induced	1997
Pleural disease during treatment with bromocriptine in patients previously exposed to asbestos. The European respiratory journal, 1997, Volume: 10, Issue:12 Topics: Adolescent; Adult; Aged; Antiparkinson Agents; Asbestos; Bromocriptine; Bronchoalveolar Lavage; Cohort Studies; Environmental Monitoring; Epidemiological Monitoring; Follow-Up Studies; Humans; Middle Aged; Occupational Exposure; Parkinson Disease; Pleural Diseases; Pulmonary Fibrosis; Radiography; Respiratory Function Tests; Risk Factors	1997
Pleural effusion during bromocriptine exposure in two patients with pre-existing asbestos pleural plaques: a relationship? The European respiratory journal, 1997, Volume: 10, Issue:12 Topics: Antiparkinson Agents; Asbestosis; Bromocriptine; Bronchoalveolar Lavage Fluid; Diagnosis, Differential; Humans; Male; Middle Aged; Parkinson Disease; Pleural Diseases; Pleural Effusion; Pulmonary Fibrosis; Tomography, X-Ray Computed	1997
Monitoring randomised controlled trials. Parkinson's disease trial illustrates the dangers of stopping early. BMJ (Clinical research ed.), 1998, Apr-18, Volume: 316, Issue:7139 Topics: Antiparkinson Agents; Bromocriptine; Decision Making; Humans; Levodopa; Parkinson Disease; Randomized Controlled Trials as Topic; Selegiline	1998
Ropinirole: new preparation. Wait for more convincing data. Prescrire international, 1998, Volume: 7, Issue:34 Topics: Antiparkinson Agents; Bromocriptine; Clinical Trials as Topic; Drug Evaluation; Drug Therapy, Combination; France; Humans; Indoles; Levodopa; Lisuride; Parkinson Disease; Time Factors; Treatment Outcome	1998
[A successfully treated parkinsonian patient with neuroleptic malignant syndrome complicated by status epilepticus and disseminated intravascular coagulation]. Rinsho shinkeigaku = Clinical neurology, 1999, Volume: 39, Issue:6 Topics: Anticoagulants; Antiparkinson Agents; Bromocriptine; Dantrolene; Disseminated Intravascular Coagulation; Female; Gabexate; Humans; Middle Aged; Muscle Relaxants, Central; Neuroleptic Malignant Syndrome; Parkinson Disease; Status Epilepticus	1999
Chronic constrictive pericarditis induced by long-term bromocriptine therapy: report of two cases. The Annals of pharmacotherapy, 1999, Volume: 33, Issue:10 Topics: Aged; Antiparkinson Agents; Bromocriptine; Chronic Disease; Dyspnea; Humans; Male; Middle Aged; Parkinson Disease; Pericarditis, Constrictive; Time Factors	1999
Hydroxyl radical and superoxide dismutase in blood of patients with Parkinson's disease: relationship to clinical data. Journal of the neurological sciences, 1999, Nov-30, Volume: 170, Issue:2 Topics: Age Factors; Age of Onset; Aged; Antiparkinson Agents; Bromocriptine; Disease Progression; Erythrocytes; Humans; Hydroxyl Radical; Levodopa; Middle Aged; Multiple System Atrophy; Parkinson Disease; Pergolide; Severity of Illness Index; Statistics as Topic; Superoxide Dismutase; Time Factors	1999
An overnight switch to ropinirole therapy in patients with Parkinson's disease. Short communication. Journal of neural transmission (Vienna, Austria : 1996), 1999, Volume: 106, Issue:9-10 Topics: Activities of Daily Living; Aged; Antiparkinson Agents; Bromocriptine; Female; Humans; Indoles; Male; Middle Aged; Parkinson Disease; Pergolide; Therapeutic Equivalency	1999
Repeated co-administration of caffeine and bromocriptine prevents tolerance to the effects of caffeine in the turning behavior animal model. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 1999, Volume: 9, Issue:6 Topics: Adrenergic Agents; Animals; Behavior, Animal; Bromocriptine; Caffeine; Central Nervous System Stimulants; Dopamine Agonists; Drug Therapy, Combination; Drug Tolerance; Male; Medial Forebrain Bundle; Motor Activity; Oxidopamine; Parkinson Disease; Rats	1999
Sleep attacks and Parkinson's disease treatment. Lancet (London, England), 2000, Apr-15, Volume: 355, Issue:9212 Topics: Accidents, Traffic; Aged; Antiparkinson Agents; Bromocriptine; Dopamine Agonists; Female; Humans; Lisuride; Male; Middle Aged; Narcolepsy; Parkinson Disease; Pergolide; Piribedil	2000
[A pleurisy that can speak of her]. La Revue de medecine interne, 2000, Volume: 21 Suppl 3 Topics: Aged; Antiparkinson Agents; Bromocriptine; Diagnosis, Differential; Female; Giant Cell Arteritis; Humans; Parkinson Disease; Pleurisy	2000
Bromocriptine markedly suppresses levodopa-induced abnormal increase of dopamine turnover in the parkinsonian striatum. Neurochemical research, 2000, Volume: 25, Issue:6 Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Bromocriptine; Corpus Striatum; Dopamine; Homovanillic Acid; Levodopa; Male; Parkinson Disease; Rats; Rats, Sprague-Dawley	2000
[Dopaminergic agonists in the treatment of Parkinson's disease]. Revue medicale de Bruxelles, 2000, Volume: 21, Issue:6 Topics: Aged; Antiparkinson Agents; Apomorphine; Benzothiazoles; Biological Availability; Bromocriptine; Catechols; Dopamine Agonists; Drug Combinations; Drug Hypersensitivity; Humans; Hypotension, Orthostatic; Indoles; Levodopa; Metabolic Clearance Rate; Nitriles; Parkinson Disease; Pergolide; Pramipexole; Selegiline; Thiazoles	2000
Neuroleptic malignant syndrome without neuroleptics. Singapore medical journal, 2001, Volume: 42, Issue:2 Topics: Antiparkinson Agents; Bromocriptine; Creatine Kinase; Diagnosis, Differential; Diagnostic Errors; Drug Therapy, Combination; Female; Humans; Levodopa; Middle Aged; Neuroleptic Malignant Syndrome; Parkinson Disease; Substance Withdrawal Syndrome	2001
Pergolide and Parkinson's disease: new preparation. No clear benefit. Prescrire international, 2000, Volume: 9, Issue:50 Topics: Antiparkinson Agents; Bromocriptine; Clinical Trials as Topic; Dopamine Agonists; Drug Therapy, Combination; Humans; Levodopa; Parkinson Disease; Pergolide; Treatment Outcome	2000
Efficacy and tolerability of dopamine agonists in a parkinsonian population. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2001, Volume: 22, Issue:1 Topics: Age of Onset; Aged; Aging; Benzothiazoles; Bromocriptine; Dopamine Agonists; Drug Administration Schedule; Drug Interactions; Drug Therapy, Combination; Drug Tolerance; Ergolines; Female; Follow-Up Studies; Humans; Indoles; Levodopa; Lisuride; Male; Middle Aged; Parkinson Disease; Pergolide; Pramipexole; Retrospective Studies; Thiazoles; Treatment Outcome	2001
Randomized clinical trials with added rescue medication: some approaches to their analysis and interpretation. Statistics in medicine, 2001, Oct-30, Volume: 20, Issue:20 Topics: Activities of Daily Living; Antiparkinson Agents; Bromocriptine; Humans; Indoles; Levodopa; Multicenter Studies as Topic; Parkinson Disease; Randomized Controlled Trials as Topic; Regression Analysis; Sensitivity and Specificity; Statistics as Topic; Treatment Outcome	2001
Cost-effectiveness analysis of dopamine agonists in the treatment of Parkinson's disease in Japan. PharmacoEconomics, 2001, Volume: 19, Issue:8 Topics: Aged; Bromocriptine; Cost-Benefit Analysis; Dopamine Agonists; Female; Hospitalization; Humans; Japan; Male; Markov Chains; Middle Aged; Parkinson Disease; Pergolide; Quality-Adjusted Life Years	2001
Effects of pharmacological agents upon a transgenic model of Parkinson's disease in Drosophila melanogaster. The Journal of pharmacology and experimental therapeutics, 2002, Volume: 300, Issue:1 Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; alpha-Methyltyrosine; alpha-Synuclein; Animals; Animals, Genetically Modified; Antiparkinson Agents; Bromocriptine; Disease Models, Animal; Drosophila melanogaster; Genotype; Levodopa; Motor Activity; Nerve Tissue Proteins; Neurons; Parkinson Disease; Pergolide; Postural Balance; Synapses; Synucleins	2002
Update on drug treatment of Parkinsonism. American family physician, 1977, Volume: 16, Issue:1 Topics: Amantadine; Bromocriptine; Carbidopa; Drug Combinations; Histamine H1 Antagonists; Humans; Levodopa; Parasympatholytics; Parkinson Disease	1977
Dopaminephilic properties of ergot alkaloids. Federation proceedings, 1978, Volume: 37, Issue:8 Topics: Acetonitriles; Animals; Bromocriptine; Corpus Striatum; Ergolines; Ergot Alkaloids; Haplorhini; Humans; Levodopa; Parkinson Disease; Receptors, Dopamine; Spiperone; Substantia Nigra; Synaptosomes; Tremor; Tyrosine 3-Monooxygenase	1978
Mental disturbances during bromocriptine and lergotrile treatment of Parkinson's disease. The American journal of psychiatry, 1978, Volume: 135, Issue:10 Topics: Aged; Bromocriptine; Confusion; Depression; Ergolines; Female; Hallucinations; Humans; Male; Mental Disorders; Middle Aged; Neurocognitive Disorders; Parkinson Disease; Schizophrenia, Paranoid	1978
Ergot derivatives for Parkinsonism. The Medical journal of Australia, 1978, Nov-04, Volume: 2, Issue:3 Suppl Topics: Bromocriptine; Ergolines; Humans; Parkinson Disease; Pyridines	1978
Lergotrile in Parkinson disease: further studies. Neurology, 1979, Volume: 29, Issue:2 Topics: Aged; Bromocriptine; Chemical Phenomena; Chemistry; Dopa Decarboxylase; Ergolines; Humans; Levodopa; Middle Aged; Parkinson Disease	1979
Letter: Growth-hormone response to bromocriptine in parkinsonism. Lancet (London, England), 1976, Jan-24, Volume: 1, Issue:7952 Topics: Bromocriptine; Ergolines; Growth Hormone; Humans; Parkinson Disease	1976
Letter: Growth-hormone responses in Parkinson's disease. Lancet (London, England), 1976, Feb-28, Volume: 1, Issue:7957 Topics: Bromocriptine; Growth Hormone; Humans; Levodopa; Parkinson Disease	1976
Letter: Psychosis in patient on bromocriptine and levodopa with carbidopa. Lancet (London, England), 1976, Sep-11, Volume: 2, Issue:7985 Topics: Bromocriptine; Carbidopa; Drug Therapy, Combination; Female; Humans; Hydrazines; Levodopa; Middle Aged; Parkinson Disease; Schizophrenia, Paranoid	1976
Digital vasospasm with bromocriptine. Lancet (London, England), 1976, Jul-24, Volume: 2, Issue:7978 Topics: Aged; Blood Vessels; Bromocriptine; Constriction, Pathologic; Female; Fingers; Humans; Middle Aged; Parkinson Disease	1976
Bromocriptine in parkinsonism. Lancet (London, England), 1976, Aug-21, Volume: 2, Issue:7982 Topics: Bromocriptine; Drug Evaluation; Humans; Parkinson Disease	1976
Long-term treatment of parkinsonism with bromocriptine. Lancet (London, England), 1978, Apr-08, Volume: 1, Issue:8067 Topics: Bromocriptine; Drug Evaluation; Drug Therapy, Combination; Humans; Levodopa; Parkinson Disease; Time Factors	1978
Drugs for Parkinson's disease. Lancet (London, England), 1978, Apr-08, Volume: 1, Issue:8067 Topics: Amantadine; Antiparkinson Agents; Bromocriptine; Drug Evaluation; Humans; Levodopa; Monoamine Oxidase Inhibitors; Parasympatholytics; Parkinson Disease; Phenethylamines	1978
Myoclonic attacks induced by L-dopa and bromocryptin in Parkinson patients: a sleep EEG study. Journal of neurology, 1978, Apr-14, Volume: 218, Issue:1 Topics: Aged; Bromocriptine; Electroencephalography; Female; Humans; Levodopa; Male; Middle Aged; Myoclonus; Parkinson Disease; Sleep	1978
Bromocriptine in Parkinson's disease. Lancet (London, England), 1978, Jun-10, Volume: 1, Issue:8076 Topics: Antiparkinson Agents; Bromocriptine; Drug Evaluation; Drug Therapy, Combination; Humans; Levodopa; Parkinson Disease	1978
Endocrine aspects of bromocriptine therapy in Parkinsonism. Journal of neural transmission, 1978, Volume: 43, Issue:2 Topics: Bromocriptine; Dose-Response Relationship, Drug; Growth Hormone; Humans; Long-Term Care; Middle Aged; Parkinson Disease; Prolactin; Thyrotropin; Thyrotropin-Releasing Hormone	1978
Oscillations in performance in levodopa-treated parkinsonians: treatment with bromocriptine and L-deprenyl. Clinical and experimental neurology, 1979, Volume: 16 Topics: Bromocriptine; Dyskinesia, Drug-Induced; Female; Humans; Levodopa; Male; Movement Disorders; Parkinson Disease; Phenethylamines; Selegiline	1979
Metabolic studies with bromocriptine in patients with idiopathic parkinsonism and Huntington's chorea. Transactions of the American Neurological Association, 1976, Volume: 101 Topics: Bromocriptine; Ergolines; Growth Hormone; Homovanillic Acid; Humans; Huntington Disease; Hydroxyindoleacetic Acid; Parkinson Disease; Prolactin	1976
[Neurology in 1977]. La Revue du praticien, 1977, Jun-21, Volume: 27, Issue:35 Topics: Bromocriptine; Defense Mechanisms; Dopamine; Facial Paralysis; gamma-Aminobutyric Acid; Hemiplegia; Humans; Huntington Disease; Nervous System Diseases; Ophthalmoplegia; Parkinson Disease; Prognosis; Serotonin	1977
Pre- and postsynaptic action of bromocriptine: its pharmacological effects on shcizophrenia and neurological diseases. Advances in biochemical psychopharmacology, 1977, Volume: 16 Topics: Animals; Bromocriptine; Cyclic AMP; Ergolines; Female; Humans; Huntington Disease; Male; Middle Aged; Motor Activity; Nervous System Diseases; Parkinson Disease; Rats; Schizophrenia; Stereotyped Behavior; Synapses	1977
In practice. Parkinson's disease. The New Zealand medical journal, 1979, Oct-10, Volume: 90, Issue:645 Topics: Amantadine; Basal Ganglia; Bromocriptine; Humans; Levodopa; Middle Aged; Movement; Parasympatholytics; Parkinson Disease; Prognosis; Synaptic Transmission	1979
Bromocriptine and parkinsonism. The New Zealand medical journal, 1978, Jun-28, Volume: 87, Issue:614 Topics: Bromocriptine; Drug Therapy, Combination; Humans; Levodopa; Parkinson Disease	1978
Bromocriptine mesylate in Parkinson's disease. New York state journal of medicine, 1979, Volume: 79, Issue:11 Topics: Bromocriptine; Edema; Humans; Mental Disorders; Middle Aged; Parkinson Disease	1979
[Experimental and clinical study on the dopaminergic receptor stimulating agents (author's transl)]. No to shinkei = Brain and nerve, 1977, Volume: 29, Issue:7 Topics: Adult; Aged; Animals; Bromocriptine; Dopamine; Female; Haplorhini; Humans; Male; Middle Aged; Parkinson Disease; Piperazines; Piribedil; Receptors, Dopamine; Tremor	1977
Parkinson's disease: search for better therapies. Science (New York, N.Y.), 1979, Feb-23, Volume: 203, Issue:4382 Topics: Bromocriptine; Humans; Levodopa; Oligopeptides; Parkinson Disease; Receptors, Dopamine	1979
Long-term treatment of Parkinson's disease with bromocriptine. Journal of neurology, neurosurgery, and psychiatry, 1979, Volume: 42, Issue:2 Topics: Adult; Age Factors; Aged; Bromocriptine; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Time Factors	1979
Drugs for parkinsonism. The Medical letter on drugs and therapeutics, 1979, May-04, Volume: 21, Issue:9 Topics: Amantadine; Bromocriptine; Carbidopa; Drug Combinations; Drug Therapy, Combination; Humans; Levodopa; Parasympatholytics; Parkinson Disease	1979
Niacin depletion in Parkinsonian patients treated with L-dopa, benserazide and carbidopa. Clinical science (London, England : 1979), 1979, Volume: 56, Issue:1 Topics: Adolescent; Adult; Benserazide; Bromocriptine; Carbidopa; Female; Humans; Hydrazines; Levodopa; Male; Micrococcus; Middle Aged; Nicotinamidase; Nicotinic Acids; Parkinson Disease; Tryptophan	1979
Pharmacokinetics of bromocriptine during continuous oral treatment of Parkinson's disease. European journal of clinical pharmacology, 1979, May-21, Volume: 15, Issue:4 Topics: Aged; Bromocriptine; Female; Humans; Kinetics; Male; Middle Aged; Parkinson Disease; Time Factors	1979
[Myoclonic attacks induced by bromocriptine in Parkinsonian patients]. Harefuah, 1979, Jan-15, Volume: 96, Issue:2 Topics: Bromocriptine; Catecholamines; Humans; Myoclonus; Parkinson Disease; Receptors, Drug	1979
EEG sleep patterns in Parkinsonian patients treated with bromocryptine and L-dopa: a comparative study. Journal of neural transmission, 1979, Volume: 45, Issue:4 Topics: Aged; Bromocriptine; Electroencephalography; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Receptors, Dopamine; Reticular Formation; Sleep	1979
Plasma dopamine beta hydroxylase (D.B.H.) activity in Parkinsonian patients under L-dopa, and 2-bromo-alpha-ergocriptine loading. Journal of neural transmission, 1979, Volume: 46, Issue:1 Topics: Bromocriptine; Dopamine beta-Hydroxylase; Humans; Kinetics; Levodopa; Parkinson Disease	1979
[Nycterohemeral variations of growth hormone and prolactin in 6 Parkinson's sufferers treated with bromocriptine (author's transl)]. La Nouvelle presse medicale, 1979, Oct-22, Volume: 8, Issue:40 Topics: Aged; Aging; Bromocriptine; Circadian Rhythm; Female; Growth Hormone; Humans; Male; Middle Aged; Parkinson Disease; Prolactin; Sex Factors; Sleep	1979
Determination of bromocriptine in plasma: comparison of gas chromatography, mass fragmentography and liquid chromatography. Journal of chromatography, 1979, Jul-01, Volume: 174, Issue:2 Topics: Bromocriptine; Chromatography, Gas; Chromatography, Liquid; Gas Chromatography-Mass Spectrometry; Humans; Parkinson Disease	1979
Bromocriptine-induced behavioral hypersensitivity: implications for the therapy of parkinsonism. Neurology, 1978, Volume: 28, Issue:11 Topics: Animals; Apomorphine; Behavior; Bromocriptine; Dextroamphetamine; Guinea Pigs; Humans; Male; Parkinson Disease; Stereotyped Behavior	1978
Bromocriptine in Parkinson disease: further studies. Neurology, 1979, Volume: 29, Issue:3 Topics: Adult; Aged; Bromocriptine; Carbidopa; Drug Evaluation; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease	1979
The role of bromocriptine in the treatment of parkinsonism. Neurology, 1979, Volume: 29, Issue:8 Topics: Aged; Bromocriptine; Female; Humans; Levodopa; Male; Middle Aged; Movement Disorders; Parkinson Disease	1979
Bromocriptine: decreased clinical effects at higher dosages. Neurology, 1979, Volume: 29, Issue:10 Topics: Bromocriptine; Humans; Parkinson Disease	1979
Interaction between bromocriptine and levodopa. Biochemical basis for an improved treatment for parkinsonism. Neurology, 1977, Volume: 27, Issue:6 Topics: Animals; Brain; Bromocriptine; Carbidopa; Dopamine; Drug Interactions; Ergolines; gamma-Aminobutyric Acid; Hydroxyindoleacetic Acid; Levodopa; Male; Parkinson Disease; Rats; Serotonin	1977
Treatment of Parkinson's disease with bromocriptine. The New England journal of medicine, 1977, Sep-01, Volume: 297, Issue:9 Topics: Bromocriptine; Ergolines; Humans; Levodopa; Parkinson Disease	1977
Bromocriptine--a versatile remedy. South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 1977, Jun-25, Volume: 51, Issue:26 Topics: Acromegaly; Bromocriptine; Ergolines; Female; Galactorrhea; Humans; Lactation Disorders; Parkinson Disease; Pregnancy	1977
Changes in pituitary hormones serum levels in bromocryptine-treated parkinsonian patients. Neuropsychobiology, 1977, Volume: 3, Issue:1 Topics: Aged; Bromocriptine; Ergolines; Female; Gonadotropins, Pituitary; Growth Hormone; Humans; Male; Middle Aged; Parkinson Disease; Pituitary Hormones, Anterior; Thyrotropin	1977
Bromocriptine alone or associated with L-dopa plus benserazide in Parkinson's disease. Journal of neurology, neurosurgery, and psychiatry, 1977, Volume: 40, Issue:12 Topics: Aged; Benserazide; Bromocriptine; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Hydrazines; Levodopa; Male; Middle Aged; Parkinson Disease	1977
Bromocriptine. The Medical letter on drugs and therapeutics, 1977, Dec-16, Volume: 19, Issue:25 Topics: Acromegaly; Amenorrhea; Bromocriptine; Female; Galactorrhea; Humans; Parkinson Disease; Pregnancy; Pregnancy Complications	1977
Effect of new dopamine-blocking agent (oxiperomide) on drug-induced dyskinesias in Parkinson's disease and spontaneous dyskinesias. British medical journal, 1978, Apr-15, Volume: 1, Issue:6118 Topics: Aged; Benzimidazoles; Bromocriptine; Dyskinesia, Drug-Induced; Female; Humans; Levodopa; Male; Middle Aged; Movement Disorders; Parkinson Disease	1978
Plasma pituitary hormones in patients with Parkinson's disease treated with bromocriptine. Journal of neural transmission, 1978, Volume: 42, Issue:2 Topics: Aged; Bromocriptine; Female; Follicle Stimulating Hormone; Growth Hormone; Humans; Luteinizing Hormone; Male; Middle Aged; Parkinson Disease; Prolactin	1978
[Bromocriptine (Parlodel) in parkinsonism]. Ugeskrift for laeger, 1978, May-29, Volume: 140, Issue:22 Topics: Bromocriptine; Humans; Parkinson Disease	1978
Role of ergot derivatives in the treatment of parkinsonism. Federation proceedings, 1978, Volume: 37, Issue:8 Topics: Acetonitriles; Animals; Bromocriptine; Disease Models, Animal; Ergolines; Humans; Liver; Parkinson Disease; Pyridines; Structure-Activity Relationship	1978
Comparison between lergotrile and bromocriptine in parkinsonism. Annals of neurology, 1978, Volume: 3, Issue:4 Topics: Acetonitriles; Adult; Aged; Bromocriptine; Carbidopa; Chemical Phenomena; Chemistry; Ergolines; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Receptors, Dopamine	1978
Bromocriptine in parkinsonism. A long-term study. Archives of neurology, 1978, Volume: 35, Issue:8 Topics: Anorexia; Bromocriptine; Carbidopa; Hallucinations; Humans; Levodopa; Middle Aged; Nausea; Parkinson Disease; Time Factors; Urinary Incontinence; Vasomotor System	1978
Brain dopamine receptor stimulation and the relief of Parkinsonism: relationship between bromocriptine and levodopa. Annals of neurology, 1978, Volume: 4, Issue:3 Topics: Benserazide; Brain; Bromocriptine; Female; Homovanillic Acid; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Receptors, Dopamine	1978
Bromocriptine. The Medical journal of Australia, 1978, Nov-04, Volume: 2, Issue:10 Topics: Acromegaly; Bromocriptine; Female; Humans; Parkinson Disease; Pregnancy; Prolactin	1978
Bromocriptine in Parkinson's disease. British journal of hospital medicine, 1978, Volume: 20, Issue:6 Topics: Bromocriptine; Humans; Levodopa; Parkinson Disease	1978
EEG sleep study in parkinsonian patients under bromocryptine treatment. European neurology, 1978, Volume: 17, Issue:6 Topics: Aged; Bromocriptine; Cerebral Cortex; Electroencephalography; Female; Humans; Male; Middle Aged; Parkinson Disease; Sleep	1978
Overview of present day treatment of Parkinson's disease. Journal of neural transmission, 1978, Volume: 43, Issue:3-4 Topics: Adult; Aged; Bromocriptine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Phenethylamines; Receptors, Dopamine; Selegiline	1978
Bromocriptine in lieu of levodopa for Parkinson's disease. The Medical journal of Australia, 1978, Nov-04, Volume: 2, Issue:3 Suppl Topics: Adult; Aged; Bromocriptine; Humans; Levodopa; Middle Aged; Parkinson Disease	1978
Brain dopamine turnover and the relief of parkinsonism. Archives of neurology, 1977, Volume: 34, Issue:10 Topics: Brain; Bromocriptine; Dopamine; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Parkinson Disease; Piperazines; Piribedil; Probenecid	1977
Bromocriptine. British journal of hospital medicine, 1977, Volume: 18, Issue:4 Topics: Acromegaly; Bromocriptine; Female; Humans; Hypogonadism; Lactation; Male; Parkinson Disease; Pregnancy; Prolactin	1977
[Combined therapy of parkinsonism with bromocriptine, L-dopa and decarboxylase inhibitor (author's transl)]. Harefuah, 1977, Volume: 93, Issue:5-6 Topics: Bromocriptine; Carboxy-Lyases; Drug Therapy, Combination; Humans; Levodopa; Parkinson Disease	1977
Brain dopamine turnover and the relief of parkinsonism. Advances in experimental medicine and biology, 1977, Volume: 90 Topics: Aromatic Amino Acid Decarboxylase Inhibitors; Bromocriptine; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Levodopa; Parkinson Disease; Piperazines; Piribedil; Probenecid; Receptors, Dopamine	1977
Treatment of parkinsonism. Advances in experimental medicine and biology, 1977, Volume: 90 Topics: Aromatic Amino Acid Decarboxylase Inhibitors; Bromocriptine; Carbidopa; Dopamine; Drug Therapy, Combination; Ergolines; Humans; Levodopa; Parkinson Disease; Receptors, Dopamine	1977
Studies with bromocriptine. Part 1. "On-off" phenomena. Neurology, 1976, Volume: 26, Issue:6 PT 1 Topics: Bromocriptine; Drug Evaluation; Drug Therapy, Combination; Ergolines; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease	1976
Editorial: The many faces of bromocriptine. JAMA, 1976, Jun-28, Volume: 235, Issue:26 Topics: Acromegaly; Bromocriptine; Ergolines; Female; Humans; Hypogonadism; Lactation; Lactation Disorders; Male; Parkinson Disease; Pregnancy	1976
Letter: Platelet and coagulation studies in patients treated with bromocriptine. British medical journal, 1976, Aug-28, Volume: 2, Issue:6034 Topics: Blood Coagulation; Bromocriptine; Ergolines; Female; Fibrinolysis; Humans; Male; Parkinson Disease; Platelet Aggregation	1976
Comparison of reflex effects of levodopa and bromocriptine in Parkinsonism. British medical journal, 1976, Jul-24, Volume: 2, Issue:6029 Topics: Bromocriptine; Ergolines; Humans; Levodopa; Parkinson Disease; Reflex	1976
Treatment of parkinson's disease with bromocriptine. The New England journal of medicine, 1976, Dec-16, Volume: 295, Issue:25 Topics: Aged; Bromocriptine; Delusions; Dopa Decarboxylase; Drug Evaluation; Ergolines; Female; Humans; Hypotension, Orthostatic; Levodopa; Male; Middle Aged; Parkinson Disease	1976
Developments in the treatment of parkinsonism. The New England journal of medicine, 1976, Dec-16, Volume: 295, Issue:25 Topics: Antiparkinson Agents; Bromocriptine; Drug Synergism; Ergolines; Humans; Parkinson Disease	1976
[Neuroendocrine aspects of Parkinson's disease. Therapeutic/effect of a prolactin inhibitor]. Minerva medica, 1976, Nov-03, Volume: 67, Issue:53 Topics: Aged; Bromocriptine; Drug Evaluation; Ergolines; Female; Humans; Middle Aged; Parkinson Disease; Prolactin	1976
Bromocriptine:dopamine-receptor agonist. American family physician, 1976, Volume: 14, Issue:6 Topics: Acromegaly; Aged; Bromocriptine; Ergolines; Female; Humans; Infertility, Female; Parkinson Disease; Pituitary Neoplasms; Receptors, Dopamine	1976
Bromocriptine in Parkinsonism: long-term treatment, dose response, and comparison with levodopa. Journal of neurology, neurosurgery, and psychiatry, 1976, Volume: 39, Issue:11 Topics: Aged; Bromocriptine; Dose-Response Relationship, Drug; Drug Evaluation; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Ergolines; Female; Follow-Up Studies; Growth Hormone; Humans; Levodopa; Male; Metoclopramide; Middle Aged; Parkinson Disease; Receptors, Dopamine	1976
[Treatment of Parkinson's disease with bromocriptine]. La Nouvelle presse medicale, 1976, Apr-23, Volume: 6, Issue:17 Topics: Aged; Bromocriptine; Drug Evaluation; Ergolines; Female; Humans; Male; Middle Aged; Parkinson Disease	1976
Clinical studies with bromocriptine in idiopathic parkinsonism. Transactions of the American Neurological Association, 1976, Volume: 101 Topics: Bromocriptine; Drug Evaluation; Ergolines; Humans; Parkinson Disease	1976
[Letter: Efficacy of bromocriptine in 2 cases of levodopa-resistant parkinsonism]. La Nouvelle presse medicale, 1976, Jan-24, Volume: 5, Issue:4 Topics: Aged; Bromocriptine; Drug Evaluation; Ergolines; Female; Humans; Male; Middle Aged; Parkinson Disease	1976
Editorial: Alternatives to levodopa. British medical journal, 1976, May-15, Volume: 1, Issue:6019 Topics: Apomorphine; Bromocriptine; Humans; Levodopa; Parkinson Disease	1976
Bromocriptine - an important advance. Drug and therapeutics bulletin, 1976, Apr-23, Volume: 14, Issue:9 Topics: Acromegaly; Bromocriptine; Depression, Chemical; Ergolines; Female; Humans; Lactation; Parkinson Disease; Pregnancy; Prolactin	1976
Pleuropulmonary changes during treatment of Parkinson's disease with a long-acting ergot derivative, cabergoline. The European respiratory journal, 1992, Volume: 5, Issue:2 Topics: Bromocriptine; Cabergoline; Dopamine Agents; Ergolines; Humans; Lung Diseases; Male; Middle Aged; Parkinson Disease; Pleural Effusion	1992
Dopamine agonists used as monotherapy in de novo PD patients: comparisons with selegiline. Neurology, 1992, Volume: 42, Issue:4 Suppl 4 Topics: Bromocriptine; Clinical Trials as Topic; Dopamine Agents; Humans; Levodopa; Middle Aged; Parkinson Disease; Selegiline	1992
[Clozapine, a valuable contribution for the treatment of psychoses in Parkinson disease]. Lakartidningen, 1992, Dec-02, Volume: 89, Issue:49 Topics: Aged; Bromocriptine; Clozapine; Drug Therapy, Combination; Humans; Levodopa; Male; Parkinson Disease; Psychoses, Substance-Induced	1992
No effect of chronic bromocriptine therapy on levodopa pharmacokinetics in patients with Parkinson's disease. Clinical neuropharmacology, 1992, Volume: 15, Issue:6 Topics: Aged; Bromocriptine; Drug Interactions; Female; Half-Life; Humans; Levodopa; Male; Middle Aged; Parkinson Disease	1992
Parkinson's disease and weight loss: a study with anthropometric and nutritional assessment. Clinical autonomic research : official journal of the Clinical Autonomic Research Society, 1992, Volume: 2, Issue:3 Topics: Aged; Anthropometry; Body Composition; Bromocriptine; Female; Humans; Levodopa; Male; Middle Aged; Nutrition Assessment; Parkinson Disease; Reference Values; Sex Characteristics; Weight Loss	1992
Acute respiratory failure from dopamine agonist withdrawal. Neurology, 1992, Volume: 42, Issue:9 Topics: Acute Disease; Bromocriptine; Female; Humans; Middle Aged; Parkinson Disease; Respiratory Insufficiency; Substance Withdrawal Syndrome	1992
Improvement of parkinsonian features correlate with high plasma levodopa values after broad bean (Vicia faba) consumption. Journal of neurology, neurosurgery, and psychiatry, 1992, Volume: 55, Issue:8 Topics: Aged; Bromocriptine; Carbidopa; Combined Modality Therapy; Fabaceae; Female; Humans; Levodopa; Lisuride; Male; Middle Aged; Neurologic Examination; Parkinson Disease; Plants, Medicinal	1992
A component analysis of the generation and release of isometric force in Parkinson's disease. Journal of neurology, neurosurgery, and psychiatry, 1992, Volume: 55, Issue:7 Topics: Bromocriptine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Isometric Contraction; Levodopa; Longitudinal Studies; Male; Middle Aged; Motor Neurons; Muscles; Neurologic Examination; Parkinson Disease; Reaction Time; Trihexyphenidyl	1992
Reduced D2 dopamine and muscarinic cholinergic receptor densities in caudate specimens from fluctuating parkinsonian patients. Annals of neurology, 1991, Volume: 30, Issue:2 Topics: Adult; Brain Tissue Transplantation; Bromocriptine; Caudate Nucleus; Down-Regulation; Humans; Levodopa; Middle Aged; Parkinson Disease; Pergolide; Quinuclidinyl Benzilate; Receptors, Cholinergic; Receptors, Dopamine; Receptors, Dopamine D2; Receptors, Muscarinic; Receptors, Neurotransmitter; Spiperone	1991
Cardiac beta-adrenoceptor sensitivity and Parkinson's disease. Fundamental & clinical pharmacology, 1991, Volume: 5, Issue:6 Topics: Aged; Aging; Blood Pressure; Bromocriptine; Dose-Response Relationship, Drug; Female; Heart Rate; Humans; Isoproterenol; Levodopa; Male; Middle Aged; Myocardium; Parkinson Disease; Piribedil; Receptors, Adrenergic, beta	1991
Somatostatin-like immunoreactivity in the cerebrospinal fluid of aged patients with Parkinson's disease. The effect of dopatherapy. Journal of the American Geriatrics Society, 1990, Volume: 38, Issue:1 Topics: Aged; Aged, 80 and over; Benserazide; Bromocriptine; Cognition Disorders; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Levodopa; Male; Parkinson Disease; Severity of Illness Index; Somatostatin	1990
The influence of bromocriptine on the pharmacokinetics of levodopa in Parkinson's disease. Clinical neuropharmacology, 1991, Volume: 14, Issue:6 Topics: Aged; Bromocriptine; Chromatography, High Pressure Liquid; Drug Interactions; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease	1991
[Pleural effusion and constrictive pericarditis secondary to bromocriptine treatment]. Neurologia (Barcelona, Spain), 1991, Volume: 6, Issue:9 Topics: Bromocriptine; Humans; Male; Middle Aged; Parkinson Disease; Pericarditis, Constrictive; Pleural Effusion	1991
Exteroceptive suppression of the masseter and temporalis muscles and parkinsonian rigidity. The Japanese journal of psychiatry and neurology, 1991, Volume: 45, Issue:4 Topics: Adult; Aged; Amantadine; Basal Ganglia; Bromocriptine; Electric Stimulation; Electromyography; Female; Humans; Levodopa; Male; Masseter Muscle; Middle Aged; Muscle Rigidity; Muscle Spindles; Parkinson Disease; Temporal Muscle; Trigeminal Nerve; Trihexyphenidyl	1991
[Patients with Parkinson disease: functional analysis of dopamine receptors by bromocriptine- thyrotropin-releasing hormone test]. Revista medica de Chile, 1991, Volume: 119, Issue:3 Topics: Analysis of Variance; Bromocriptine; Female; Humans; Hypothalamo-Hypophyseal System; Levodopa; Male; Parkinson Disease; Prolactin; Receptors, Dopamine; Thyrotropin-Releasing Hormone	1991
Hypothalamo-pituitary function and dopamine dependence in untreated parkinsonian patients. Acta neurologica Scandinavica, 1991, Volume: 83, Issue:3 Topics: Adult; Aged; Bromocriptine; Dopamine; Female; Growth Hormone; Humans; Hypothalamo-Hypophyseal System; Male; Middle Aged; Neurologic Examination; Parkinson Disease; Prolactin; Thyrotropin; Thyrotropin-Releasing Hormone	1991
Treating the progressive stages of Parkinson's disease. Postgraduate medicine, 1991, Volume: 90, Issue:1 Topics: Amantadine; Antiparkinson Agents; Bromocriptine; Carbidopa; Drug Combinations; Electroconvulsive Therapy; Humans; Levodopa; Parasympatholytics; Parkinson Disease; Pergolide; Selegiline	1991
Effects of withdrawal of antiparkinson medication on gait and clinical score in the Parkinson patient. Acta neurologica Scandinavica, 1991, Volume: 84, Issue:1 Topics: Aged; Antiparkinson Agents; Bromocriptine; Disability Evaluation; Drug Therapy, Combination; Female; Gait; Humans; Levodopa; Male; Middle Aged; Neurologic Examination; Parkinson Disease; Substance Withdrawal Syndrome	1991
Failure of oral administration of single rising doses of bromocriptine to produce acute anti-Parkinsonian effects. Journal of neurology, neurosurgery, and psychiatry, 1991, Volume: 54, Issue:2 Topics: Administration, Oral; Adult; Aged; Bromocriptine; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Levodopa; Male; Middle Aged; Neurologic Examination; Parkinson Disease	1991
Effects of levodopa and bromocriptine on blood pressure and plasma catecholamines in parkinsonians. Clinical neuropharmacology, 1991, Volume: 14, Issue:1 Topics: Aged; Blood Pressure; Bromocriptine; Epinephrine; Female; Humans; Levodopa; Male; Middle Aged; Norepinephrine; Parkinson Disease; Posture	1991
Retroperitoneal fibrosis, skin and pleuropulmonary changes associated with bromocriptine therapy. Australian and New Zealand journal of medicine, 1991, Volume: 21, Issue:1 Topics: Bromocriptine; Female; Humans; Male; Middle Aged; Parkinson Disease; Pulmonary Fibrosis; Retroperitoneal Fibrosis; Skin Diseases	1991
[Parkinson disease and photosensitive epilepsy]. Revue neurologique, 1990, Volume: 146, Issue:1 Topics: Bromocriptine; Dopamine Antagonists; Electroencephalography; Epilepsies, Myoclonic; Humans; Light; Male; Middle Aged; Parkinson Disease	1990
Pleuropulmonary fibrosis due to bromocriptine treatment for Parkinson's disease. Clinical and experimental neurology, 1990, Volume: 27 Topics: Aged; Benserazide; Bromocriptine; Drug Therapy, Combination; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Pulmonary Fibrosis; Serotonin	1990
A view from inside. British dental journal, 1990, Sep-22, Volume: 169, Issue:6 Topics: Accidental Falls; Antiparkinson Agents; Bromocriptine; Carbidopa; Dentists; Drug Combinations; Humans; Levodopa; Male; Northern Ireland; Parkinson Disease	1990
[Pleural effusion induced by bromocriptine]. Revue des maladies respiratoires, 1990, Volume: 7, Issue:2 Topics: Aged; Bromocriptine; Humans; Male; Parkinson Disease; Pleural Effusion	1990
[The treatment of Parkinson disease using the combination bromocriptine and levodopa]. Revue medicale de la Suisse romande, 1990, Volume: 110, Issue:6 Topics: Aged; Bromocriptine; Drug Therapy, Combination; Humans; Levodopa; Middle Aged; Parkinson Disease	1990
Parkinson disease: electrophysiological (CNV) analysis related to pharmacological treatment. Electroencephalography and clinical neurophysiology, 1986, Volume: 64, Issue:6 Topics: Bromocriptine; Contingent Negative Variation; Drug Therapy, Combination; Female; Humans; Levodopa; Middle Aged; Parkinson Disease	1986
[Retroperitoneal fibrosis after treatment by bromocriptine]. Presse medicale (Paris, France : 1983), 1989, Apr-15, Volume: 18, Issue:15 Topics: Bromocriptine; Humans; Male; Middle Aged; Parkinson Disease; Retroperitoneal Fibrosis	1989
[Retroperitoneal fibrosis after treatment with bromocriptine]. Presse medicale (Paris, France : 1983), 1989, Apr-22, Volume: 18, Issue:16 Topics: Bromocriptine; Humans; Male; Middle Aged; Parkinson Disease; Retroperitoneal Fibrosis	1989
Early dopamine agonist therapy in Parkinson's disease. Movement disorders : official journal of the Movement Disorder Society, 1989, Volume: 4 Suppl 1 Topics: Antiparkinson Agents; Brain; Bromocriptine; Dopamine Agents; Drug Therapy, Combination; Humans; Levodopa; Lisuride; Parkinson Disease; Pergolide; Receptors, Dopamine	1989
Concerns expressed about PATH program. The Nurse practitioner, 1989, Volume: 14, Issue:11 Topics: Advertising; Bromocriptine; Drug Industry; Humans; Nurse Practitioners; Parkinson Disease	1989
The influence of levodopa in the pharmacokinetics of bromocriptine in Parkinson's disease. Clinical neuropharmacology, 1989, Volume: 12, Issue:5 Topics: Adjuvants, Pharmaceutic; Aged; Bromocriptine; Drug Interactions; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease	1989
[A case of bromocriptine-induced interstitial pneumonitis in an iron factory worker exposed to sand dust]. Nihon Kyobu Shikkan Gakkai zasshi, 1989, Volume: 27, Issue:10 Topics: Bromocriptine; Dust; Environmental Exposure; Humans; Iron; Male; Metallurgy; Middle Aged; Parkinson Disease; Pulmonary Fibrosis	1989
[Bromocriptine]. Soins. Gynecologie, obstetrique, puericulture, pediatrie, 1989, Issue:102 Topics: Amenorrhea; Bromocriptine; Female; Humans; Male; Parkinson Disease	1989
Second interim report of the nation-wide collaborative study on the long-term effects of bromocriptine in the treatment of parkinsonian patients. European neurology, 1989, Volume: 29 Suppl 1 Topics: Adult; Aged; Aged, 80 and over; Bromocriptine; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease	1989
Falls and Parkinson's disease. Clinical neuropharmacology, 1989, Volume: 12, Issue:2 Topics: Accidental Falls; Accidents; Aged; Bromocriptine; Female; Humans; Levodopa; Male; Parkinson Disease; Physical Therapy Modalities; Posture; Risk Factors	1989
Subcutaneous apomorphine in Parkinson's disease. Journal of neurology, neurosurgery, and psychiatry, 1989, Volume: 52, Issue:4 Topics: Apomorphine; Bromocriptine; Drug Therapy, Combination; Humans; Injections, Subcutaneous; Levodopa; Middle Aged; Parkinson Disease	1989
Palilalia as a symptom of levodopa induced hyperkinesia in Parkinson's disease. Journal of neurology, neurosurgery, and psychiatry, 1989, Volume: 52, Issue:6 Topics: Aged; Bromocriptine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Echolalia; Humans; Hyperkinesis; Levodopa; Male; Parkinson Disease	1989
Agonist substitution in advanced Parkinson's disease. Neurology, 1989, Volume: 39, Issue:8 Topics: Aged; Bromocriptine; Drug Evaluation; Female; Humans; Male; Middle Aged; Parkinson Disease; Pergolide; Time Factors	1989
[L-dopa, biperiden and sebum excretion in Parkinson disease]. Arquivos de neuro-psiquiatria, 1989, Volume: 47, Issue:1 Topics: Aged; Aged, 80 and over; Aromatic-L-Amino-Acid Decarboxylases; Biperiden; Bromocriptine; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Piperidines; Sebum; Sex Factors	1989
A community survey of Parkinson's disease. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 1989, Sep-01, Volume: 141, Issue:5 Topics: Aged; British Columbia; Bromocriptine; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Rural Population	1989
[Bromocriptine and pulmonary responses]. Duodecim; laaketieteellinen aikakauskirja, 1989, Volume: 105, Issue:19 Topics: Aged; Bromocriptine; Humans; Male; Middle Aged; Parkinson Disease; Pleural Effusion; Pulmonary Fibrosis; Radiography	1989
Treatment of drug-induced exogenous psychosis in parkinsonism with clozapine and fluperlapine. European archives of psychiatry and neurological sciences, 1985, Volume: 235, Issue:1 Topics: Aged; Antipsychotic Agents; Benserazide; Bromocriptine; Clozapine; Delusions; Dibenzazepines; Dose-Response Relationship, Drug; Drug Therapy, Combination; Hallucinations; Humans; Hydrazines; Levodopa; Male; Middle Aged; Parkinson Disease; Psychoses, Substance-Induced; Tryptophan	1985
Retroperitoneal fibrosis and bromocriptine. Lancet (London, England), 1986, Aug-23, Volume: 2, Issue:8504 Topics: Bromocriptine; Humans; Hydronephrosis; Male; Middle Aged; Parkinson Disease; Retroperitoneal Fibrosis	1986
Parkinson's disease, depression, and the on-off phenomenon. Psychosomatics, 1989,Winter, Volume: 30, Issue:1 Topics: Bromocriptine; Carbidopa; Depressive Disorder; Drug Combinations; Drug Therapy, Combination; Humans; Levodopa; Male; Middle Aged; Motor Skills; Parkinson Disease	1989
Bromocriptine and pleuropulmonary disease. Archives of internal medicine, 1989, Volume: 149, Issue:2 Topics: Bromocriptine; Humans; Male; Middle Aged; Parkinson Disease; Pulmonary Fibrosis	1989
Comprehensive care of the patient with Parkinson's disease. The Journal of neuroscience nursing : journal of the American Association of Neuroscience Nurses, 1986, Volume: 18, Issue:3 Topics: Aged; Amantadine; Bromocriptine; Carbidopa; Drug Combinations; Humans; Levodopa; Male; Muscle Rigidity; Parasympatholytics; Parkinson Disease; Patient Care Planning; Patient Care Team; Tremor	1986
Progressive supranuclear palsy: nursing care implications. The Journal of neuroscience nursing : journal of the American Association of Neuroscience Nurses, 1988, Volume: 20, Issue:5 Topics: Bromocriptine; Diagnosis, Differential; Humans; Male; Middle Aged; Neurologic Examination; Parkinson Disease; Supranuclear Palsy, Progressive	1988
Platelet alpha 2 adrenoceptors in Parkinson's disease: decreased number in untreated patients and recovery after treatment. European journal of clinical investigation, 1985, Volume: 15, Issue:6 Topics: Aged; Blood Platelets; Bromocriptine; Cell Membrane; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Platelet Aggregation; Receptors, Adrenergic, alpha; Yohimbine	1985
Function of dopamine receptors in Parkinson's disease: prolactin responses. Neurology, 1986, Volume: 36, Issue:3 Topics: Aged; Bromocriptine; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Prolactin; Receptors, Dopamine; Thyrotropin-Releasing Hormone; Time Factors	1986
Bromocriptine holiday: effects on dopamine receptors and turning behavior in rats. Neurology, 1986, Volume: 36, Issue:3 Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Behavior, Animal; Binding Sites; Bromocriptine; Dopamine; Drug Administration Schedule; Hydroxydopamines; Male; Oxidopamine; Parkinson Disease; Parkinson Disease, Secondary; Rats; Rats, Inbred Strains; Receptors, Dopamine; Stereotyped Behavior; Substantia Nigra; Time Factors	1986
Chronic treatment with bromocriptine induces behavioral supersensitivity in rats. Life sciences, 1986, Aug-11, Volume: 39, Issue:6 Topics: Animals; Apomorphine; Bromocriptine; Dopamine Antagonists; Humans; Hydroxydopamines; Male; Oxidopamine; Parkinson Disease; Pyrrolidines; Rats; Rats, Inbred Strains; Receptors, Dopamine; Stereotyped Behavior	1986
Parkinson's disease in the elderly: a long-term efficacy study of levodopa/benserazide combination therapy. Pharmatherapeutica, 1986, Volume: 4, Issue:9 Topics: Aged; Aged, 80 and over; Benserazide; Bromocriptine; Confusion; Drug Combinations; Dyskinesia, Drug-Induced; Female; Humans; Hydrazines; Levodopa; Long-Term Care; Male; Middle Aged; Parkinson Disease	1986
Dopamine receptor function in Parkinson's disease--in vivo studies with prolactin responses. Advances in neurology, 1987, Volume: 45 Topics: Bromocriptine; Corpus Striatum; Humans; Metoclopramide; Parkinson Disease; Prolactin; Receptors, Dopamine; Thyrotropin-Releasing Hormone	1987
Current and future approaches to therapy. Advances in neurology, 1987, Volume: 45 Topics: Antiparkinson Agents; Benserazide; Bromocriptine; Carbidopa; Drug Therapy, Combination; Humans; Levodopa; Lisuride; Parkinson Disease; Selegiline	1987
Dopamine agonists as primary treatment in Parkinson's disease. Advances in neurology, 1987, Volume: 45 Topics: Antiparkinson Agents; Bromocriptine; Disability Evaluation; Drug Therapy, Combination; Ergolines; Humans; Levodopa; Lisuride; Long-Term Care; Parkinson Disease; Pergolide; Receptors, Dopamine	1987
Long-term effects of bromocriptine given to de novo patients with idiopathic Parkinson's disease. Advances in neurology, 1987, Volume: 45 Topics: Aged; Bromocriptine; Dose-Response Relationship, Drug; Humans; Long-Term Care; Parkinson Disease	1987
Long-term treatment with high-dosage bromocriptine in advanced Parkinson's disease. Advances in neurology, 1987, Volume: 45 Topics: Aged; Bromocriptine; Disability Evaluation; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Levodopa; Long-Term Care; Middle Aged; Parkinson Disease	1987
Parkinson's disease in the elderly: current management strategies. Geriatrics, 1987, Volume: 42, Issue:7 Topics: Aged; Amantadine; Antiparkinson Agents; Bromocriptine; Drug Administration Schedule; Drug Therapy, Combination; Humans; Levodopa; Parasympatholytics; Parkinson Disease; Selegiline	1987
Bromocriptine induced impotence in Parkinson's disease. British medical journal (Clinical research ed.), 1987, Aug-08, Volume: 295, Issue:6594 Topics: Adult; Bromocriptine; Erectile Dysfunction; Humans; Male; Middle Aged; Parkinson Disease	1987
Milestones in the development of modern Parkinson therapy. Journal of neural transmission. Supplementum, 1987, Volume: 25 Topics: 2,3-Diketogulonic Acid; Alloxan; Behavior; Bromocriptine; Drug Combinations; Drug Therapy, Combination; Ferric Compounds; Humans; Levodopa; Neurology; Parkinson Disease; Selegiline; Tryptophan	1987
Drugs for parkinsonism. The Medical letter on drugs and therapeutics, 1988, Dec-16, Volume: 30, Issue:781 Topics: Amantadine; Bromocriptine; Carbidopa; Drug Combinations; Humans; Levodopa; Parasympatholytics; Parkinson Disease; Selegiline	1988
The effects of dopamine agonists on human cardiovascular and sympathetic nervous systems. International journal of clinical pharmacology, therapy, and toxicology, 1985, Volume: 23, Issue:4 Topics: Adult; Aged; Apomorphine; Blood Pressure; Bromocriptine; Cardiovascular System; Catecholamines; Dopamine; Dopamine beta-Hydroxylase; Female; Heart Rate; Hemodynamics; Humans; Huntington Disease; Levodopa; Male; Middle Aged; Parkinson Disease; Pulse; Sympathetic Nervous System	1985
Pleuropulmonary disease during bromocriptine treatment of Parkinson's disease. Archives of internal medicine, 1988, Volume: 148, Issue:10 Topics: Aged; Antiparkinson Agents; Bromocriptine; Ergolines; Humans; Lung Diseases; Male; Middle Aged; Parkinson Disease; Pleural Diseases; Radiography	1988
Pleuropulmonary involvement during bromocriptine treatment. Chest, 1988, Volume: 94, Issue:5 Topics: Aged; Bromocriptine; Humans; Lung Diseases; Male; Middle Aged; Parkinson Disease; Pleural Effusion	1988
Early combination of dopamine agonist and levodopa in the treatment of Parkinson's disease. The Mount Sinai journal of medicine, New York, 1988, Volume: 55, Issue:2 Topics: Bromocriptine; Drug Therapy, Combination; Humans; Levodopa; Parkinson Disease	1988
International symposium on early dopamine agonist therapy of Parkinson's disease. Archives of neurology, 1988, Volume: 45, Issue:2 Topics: Animals; Bromocriptine; Carbidopa; Dopamine; Humans; Levodopa; Parkinson Disease; Pergolide; Time Factors	1988
Lack of pharmacokinetic influence on levodopa by bromocriptine. Clinical neuropharmacology, 1988, Volume: 11, Issue:1 Topics: Bromocriptine; Carbidopa; Chromatography, High Pressure Liquid; Drug Interactions; Female; Humans; Levodopa; Middle Aged; Parkinson Disease	1988
[Pleuropulmonary changes during treatment with bromocriptine]. Ugeskrift for laeger, 1988, May-02, Volume: 150, Issue:18 Topics: Aged; Bromocriptine; Humans; Lung; Male; Middle Aged; Parkinson Disease; Pleura	1988
Outpatient treatment of Parkinson's disease. European neurology, 1988, Volume: 28, Issue:3 Topics: Ambulatory Care; Benserazide; Bromocriptine; Carboxy-Lyases; Drug Combinations; Dyskinesia, Drug-Induced; Humans; Levodopa; Parkinson Disease; Retrospective Studies	1988
[Nursing homes patients with Parkinson disease: treatment]. Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 1988, Jun-20, Volume: 108, Issue:17-18 Topics: Aged; Bromocriptine; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Nursing Homes; Parkinson Disease	1988
Contractures of the extremities in parkinsonian subjects: a report of three cases with a possible association with bromocriptine treatment. Clinical neuropharmacology, 1988, Volume: 11, Issue:3 Topics: Bromocriptine; Contracture; Extremities; Female; Humans; Middle Aged; Parkinson Disease	1988
[Effect of bromocriptine on cerebral blood flow in Parkinson's disease]. Revue neurologique, 1988, Volume: 144, Issue:5 Topics: Administration, Oral; Bromocriptine; Cerebrovascular Circulation; Female; Humans; Male; Middle Aged; Parkinson Disease	1988
Low-dose, slow-increase bromocriptine in patients with progressive Parkinson's disease and complications of levodopa therapy. Bulletin of clinical neurosciences, 1986, Volume: 51 Topics: Aged; Aged, 80 and over; Bromocriptine; Dose-Response Relationship, Drug; Drug Tolerance; Humans; Levodopa; Middle Aged; Parkinson Disease	1986
Combined L-dopa and bromocriptine therapy for Parkinson's disease: a proposed mechanism of action. Clinical neuropharmacology, 1987, Volume: 10, Issue:4 Topics: Bromocriptine; Drug Therapy, Combination; Humans; Levodopa; Parkinson Disease; Receptors, Dopamine	1987
Levodopa-induced regional cerebral blood flow changes in normal volunteers and patients with Parkinson's disease. Lack of correlation with clinical or neuropsychological improvements. Movement disorders : official journal of the Movement Disorder Society, 1987, Volume: 2, Issue:4 Topics: Administration, Oral; Aged; Bromocriptine; Carbidopa; Cerebrovascular Circulation; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Neuropsychological Tests; Parkinson Disease; Regional Blood Flow; Tomography, Emission-Computed	1987
Early combination of bromocriptine and levodopa in the treatment of Parkinson's disease: a 5-year follow-up. Neurology, 1987, Volume: 37, Issue:5 Topics: Bromocriptine; Drug Therapy, Combination; Follow-Up Studies; Humans; Levodopa; Parkinson Disease	1987
Low dose bromocriptine ameliorates hallucinations in a demented parkinsonian patient. Journal of clinical psychopharmacology, 1987, Volume: 7, Issue:2 Topics: Aged; Bromocriptine; Dementia; Female; Hallucinations; Humans; Parkinson Disease	1987
Ocular motor and manual tracking in Parkinson's disease and the effect of treatment. Journal of neurology, neurosurgery, and psychiatry, 1987, Volume: 50, Issue:7 Topics: Adult; Aged; Bromocriptine; Eye Movements; Female; Hand; Humans; Levodopa; Male; Middle Aged; Movement; Parkinson Disease; Reaction Time; Saccades	1987
Bromocriptine long acting (LA) 50 mg intramuscular (IM) for the on-off phenomenon in Parkinson's disease. Acta neurologica Scandinavica, 1987, Volume: 75, Issue:6 Topics: Adult; Bromocriptine; Delayed-Action Preparations; Female; Humans; Injections, Intramuscular; Parkinson Disease	1987
[Neuropsychic side effects of bromocriptine in Parkinson's disease]. Revue neurologique, 1987, Volume: 143, Issue:8-9 Topics: Aged; Bromocriptine; Cognition Disorders; Delusions; Female; Hallucinations; Humans; Male; Mental Disorders; Middle Aged; Parkinson Disease	1987
Optimum symptomatic control of Parkinson's disease with dopaminergic therapy. The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques, 1987, Volume: 14, Issue:3 Suppl Topics: Aged; Bromocriptine; Drug Combinations; Humans; Levodopa; Middle Aged; Movement Disorders; Parkinson Disease; Time Factors	1987
The use of bromocriptine in parkinsonism after carbon monoxide poisoning. Clinical neurology and neurosurgery, 1987, Volume: 89, Issue:4 Topics: Adult; Aged; Bromocriptine; Carbon Monoxide Poisoning; Female; Humans; Male; Parkinson Disease	1987
[Experience with the use of parlodel in the treatment of Parkinson patients]. Zhurnal nevropatologii i psikhiatrii imeni S.S. Korsakova (Moscow, Russia : 1952), 1986, Volume: 86, Issue:2 Topics: Adult; Aged; Bromocriptine; Drug Therapy, Combination; Female; Humans; Hypoxia, Brain; Levodopa; Male; Middle Aged; Parkinson Disease; Parkinson Disease, Postencephalitic; Parkinson Disease, Secondary	1986
Bromocriptine: long-term low-dose therapy in Parkinson's disease. Clinical neuropharmacology, 1986, Volume: 9, Issue:2 Topics: Adult; Aged; Bromocriptine; Drug Administration Schedule; Female; Humans; Levodopa; Male; Middle Aged; Movement; Muscle Rigidity; Parkinson Disease; Tremor	1986
Retroperitoneal fibrosis and treatment of Parkinson's disease with high doses of bromocriptine. Clinical neuropharmacology, 1986, Volume: 9, Issue:2 Topics: Bromocriptine; Humans; Male; Middle Aged; Parkinson Disease; Retroperitoneal Fibrosis	1986
Pharmacotherapy: problems and practices. Clinical neuropharmacology, 1986, Volume: 9 Suppl 1 Topics: Amantadine; Bromocriptine; Carbidopa; Drug Combinations; Humans; Levodopa; Parasympatholytics; Parkinson Disease	1986
L-dopa induced "serotonin syndrome" in a parkinsonian patient on bromocriptine. Journal of clinical psychopharmacology, 1986, Volume: 6, Issue:3 Topics: Aged; Bromocriptine; Carbidopa; Drug Combinations; Drug Interactions; Humans; Levodopa; Male; Myoclonus; Parkinson Disease; Serotonin	1986
Drugs for parkinsonism. The Medical letter on drugs and therapeutics, 1986, Jun-20, Volume: 28, Issue:716 Topics: Amantadine; Antiparkinson Agents; Bromocriptine; Carbidopa; Drug Combinations; Drug Therapy, Combination; Humans; Levodopa; Parasympatholytics; Parkinson Disease	1986
Dystonia-Parkinson syndrome: differential effects of levodopa and dopamine agonists. Clinical neuropharmacology, 1986, Volume: 9, Issue:3 Topics: Adult; Bromocriptine; Carbidopa; Dystonia; Ergolines; Humans; Levodopa; Meige Syndrome; Middle Aged; Parkinson Disease; Pergolide; Torticollis	1986
[Revision of the treatment strategy in Parkinson disease]. Nederlands tijdschrift voor geneeskunde, 1986, May-17, Volume: 130, Issue:20 Topics: Amantadine; Antiparkinson Agents; Bromocriptine; Carboxy-Lyases; Humans; Levodopa; Monoamine Oxidase Inhibitors; Parkinson Disease; Patient Care Planning	1986
The drug treatment of parkinsonism. Scottish medical journal, 1986, Volume: 31, Issue:2 Topics: Bromocriptine; Carboxy-Lyases; Dopamine; Humans; Levodopa; Parkinson Disease	1986
Management of Parkinson's disease in general practice. Scottish medical journal, 1986, Volume: 31, Issue:2 Topics: Aged; Benserazide; Bromocriptine; Carbidopa; Drug Combinations; Family Practice; Humans; Levodopa; Medical Audit; Parkinson Disease	1986
Cognitive performances in parkinsonians before and after bromocriptine therapy. Acta neurologica, 1986, Volume: 8, Issue:3 Topics: Aged; Bromocriptine; Cognition; Humans; Middle Aged; Parkinson Disease	1986
Effect of antacid on levodopa therapy. Clinical neuropharmacology, 1986, Volume: 9, Issue:5 Topics: Aluminum Hydroxide; Bromocriptine; Carbidopa; Double-Blind Method; Drug Combinations; Drug Interactions; Humans; Levodopa; Magnesium; Magnesium Hydroxide; Parkinson Disease	1986
[Combination treatment in the early stages of Parkinson's disease]. Nordisk medicin, 1987, Volume: 102, Issue:1 Topics: Bromocriptine; Drug Therapy, Combination; Humans; Levodopa; Parasympatholytics; Parkinson Disease	1987
Low-dosage treatment in de novo patients with Parkinson's disease: a prospective study. Advances in neurology, 1987, Volume: 45 Topics: Aged; Bromocriptine; Carbidopa; Disability Evaluation; Dose-Response Relationship, Drug; Drug Combinations; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Orphenadrine; Parkinson Disease	1987
Tracers for paralysis agitans in epidemiological research. IV. Trends in national drug policy and measurement of the prevalence of the disease in Sweden. Neuroepidemiology, 1985, Volume: 4, Issue:3 Topics: Adolescent; Adult; Age Factors; Aged; Ambulatory Care; Antiparkinson Agents; Bromocriptine; Child; Child, Preschool; Drug Utilization; Epidemiologic Methods; Female; Humans; Infant; Infant Mortality; Levodopa; Male; Middle Aged; Parkinson Disease; Probability; Sweden; Time Factors	1985
[Parlodel]. Soins. Gynecologie, obstetrique, puericulture, pediatrie, 1985, Issue:48 Topics: Bromocriptine; Humans; Parkinson Disease	1985
Parkinson disease. Individualizing therapy. Hospital practice (Office ed.), 1985, Jan-15, Volume: 20, Issue:1 Topics: Aged; Bromocriptine; Carbidopa; Central Nervous System Diseases; Diagnosis, Differential; Gait; Humans; Levodopa; Male; Motor Activity; Parkinson Disease; Psychoses, Substance-Induced; Tremor	1985
Problems with inactivation of drugs used in Parkinson's disease. British medical journal (Clinical research ed.), 1985, Feb-09, Volume: 290, Issue:6466 Topics: Aged; Bromocriptine; Drug Stability; Female; Humans; Orphenadrine; Parkinson Disease; Suspensions	1985
Pleuropulmonary reactions in patients on bromocriptine treatment. European journal of respiratory diseases, 1986, Volume: 68, Issue:1 Topics: Aged; Bromocriptine; Humans; Lung; Male; Parkinson Disease; Pleura; Pleurisy	1986
Bromocriptine--an update. Iowa medicine : journal of the Iowa Medical Society, 1986, Volume: 76, Issue:3 Topics: Acromegaly; Bromocriptine; Female; Humans; Hyperprolactinemia; Hypotension, Orthostatic; Kinetics; Lactation; Male; Nausea; Parkinson Disease; Pregnancy	1986
[Dopaminergic agonists in Parkinson disease]. La Revue du praticien, 1986, Jan-21, Volume: 36, Issue:5 Topics: Aged; Bromocriptine; Dopamine; Ergolines; Humans; Levodopa; Lisuride; Parkinson Disease; Pergolide; Piribedil	1986
Hyperthermia after discontinuance of levodopa and bromocriptine therapy: impaired dopamine receptors a possible cause. Neurology, 1985, Volume: 35, Issue:2 Topics: Body Temperature Regulation; Bromocriptine; Carbidopa; Drug Combinations; Female; Fever; Humans; Levodopa; Malignant Hyperthermia; Middle Aged; Neuroleptic Malignant Syndrome; Parkinson Disease; Receptors, Dopamine	1985
Gynecological follow-up of parkinsonian patients on long-term bromocriptine treatment. Acta obstetricia et gynecologica Scandinavica, 1985, Volume: 64, Issue:1 Topics: Adult; Aged; Bromocriptine; Female; Follow-Up Studies; Humans; Middle Aged; Ovary; Parkinson Disease; Time Factors; Uterine Neoplasms; Uterus; Vagina; Vaginal Smears; Vulva	1985
Bromocriptine: problems with low-dose de novo therapy in Parkinson's disease. Clinical neuropharmacology, 1985, Volume: 8, Issue:1 Topics: Adult; Aged; Bromocriptine; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease	1985
[Dopamine agonists in the therapy of parkinson syndrome]. Der Nervenarzt, 1985, Volume: 56, Issue:2 Topics: Animals; Antiparkinson Agents; Binding, Competitive; Bromocriptine; Corpus Striatum; Dopamine; Humans; Levodopa; Lisuride; Neural Pathways; Parkinson Disease; Piribedil; Receptors, Dopamine; Substantia Nigra	1985
Bromocriptine dose and severity of Parkinson's disease. Neurology, 1985, Volume: 35, Issue:4 Topics: Bromocriptine; Humans; Parkinson Disease	1985
Result of chronic levodopa therapy and its modification by bromocriptine in Parkinson's disease. Acta neurologica Scandinavica, 1985, Volume: 71, Issue:2 Topics: Adult; Aged; Bromocriptine; Carbidopa; Disability Evaluation; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Motor Skills; Parkinson Disease	1985
Idiopathic dystonia-parkinsonism with marked diurnal fluctuation of symptoms. Annals of neurology, 1985, Volume: 17, Issue:1 Topics: Adult; Bromocriptine; Electromyography; Electrophysiology; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Trihexyphenidyl	1985
Chronic agonist therapy for Parkinson's disease: a 5-year study of bromocriptine and pergolide. Neurology, 1985, Volume: 35, Issue:5 Topics: Aged; Antiparkinson Agents; Bromocriptine; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Dystonia; Ergolines; Female; Hallucinations; Humans; Levodopa; Male; Middle Aged; Nausea; Outcome and Process Assessment, Health Care; Parkinson Disease; Pergolide; Time Factors	1985
Low-dose bromocriptine in Parkinson's disease. Journal of neurology, neurosurgery, and psychiatry, 1985, Volume: 48, Issue:4 Topics: Aged; Bromocriptine; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Parkinson Disease	1985
Three-year observation of mesulergine (CU 32-085) in advanced and newly treated parkinsonism. Journal of neurology, 1985, Volume: 232, Issue:1 Topics: Adult; Aged; Antiparkinson Agents; Bromocriptine; Drug Therapy, Combination; Ergolines; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease	1985
[Clinical significance of long-term treatment of L-dopa with bromocriptine in parkinsonian patients who showed declining efficacy during L-dopa therapy]. Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 1985, Volume: 74, Issue:3 Topics: Adult; Aged; Bromocriptine; Drug Resistance; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Levodopa; Male; Middle Aged; Parkinson Disease	1985
[Secondary effects of prolonged levodopa therapy in Parkinson's disease]. Medicina clinica, 1985, Jun-15, Volume: 85, Issue:3 Topics: Age Factors; Aged; Amantadine; Antidepressive Agents, Tricyclic; Aromatic Amino Acid Decarboxylase Inhibitors; Bromocriptine; Drug Therapy, Combination; Dystonia; Female; Humans; Levodopa; Male; Mental Disorders; Middle Aged; Parkinson Disease	1985
Combined bromocriptine-levodopa therapy early in Parkinson's disease. Neurology, 1985, Volume: 35, Issue:8 Topics: Bromocriptine; Disability Evaluation; Dose-Response Relationship, Drug; Drug Combinations; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Time Factors	1985
The treatment of Parkinson's disease. The Medical journal of Australia, 1985, Oct-14, Volume: 143, Issue:8 Topics: Aged; Bromocriptine; Carboxy-Lyases; Humans; Levodopa; Movement Disorders; Nausea; Parkinson Disease; Psychoses, Substance-Induced	1985
Pain in Parkinson's disease. Pain, 1985, Volume: 22, Issue:4 Topics: Aged; Bromocriptine; Female; Humans; Levodopa; Male; Middle Aged; Pain; Parkinson Disease	1985
Controversies in the treatment of Parkinson's disease. Rational drug therapy, 1985, Volume: 19, Issue:2 Topics: Bromocriptine; Humans; Levodopa; Movement Disorders; Parkinson Disease; Time Factors	1985
Parkinson's disease and hypertension: chronic bromocriptine treatment. Neurology, 1985, Volume: 35, Issue:11 Topics: Aged; Bromocriptine; Domperidone; Female; Humans; Hypertension; Male; Parkinson Disease	1985
[Bromocriptine in Parkinson's disease: pleuropulmonary toxicity]. Annales de medecine interne, 1985, Volume: 136, Issue:5 Topics: Bromocriptine; Humans; Male; Middle Aged; Parkinson Disease; Pleural Diseases; Pulmonary Fibrosis	1985
[Oral lisuride in Parkinson's disease]. Medicina clinica, 1985, Sep-21, Volume: 85, Issue:8 Topics: Adult; Aged; Bromocriptine; Drug Evaluation; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Ergolines; Female; Humans; Levodopa; Lisuride; Male; Middle Aged; Parkinson Disease	1985
Treatment of parkinsonism with bromocriptine. Lancet (London, England), 1974, Dec-07, Volume: 2, Issue:7893 Topics: Bromocriptine; Drug Evaluation; Drug Therapy, Combination; Ergolines; Humans; Levodopa; Parkinson Disease	1974